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Leptin is primarily an adipose-derived hormone that acts in the hypothalamus to 
regulate body fat levels by suppressing appetite and increasing metabolic rate. Pregnancy 
is characterised by increased food intake and fat mass to meet the metabolic demands of 
this physiological state. Leptin concentrations also increase during pregnancy, but this 
does not prevent the pregnancy-induced hyperphagia, suggesting a state of leptin 
resistance. The aims of this thesis were to measure hypothalamic leptin responsiveness 
during pregnancy and to investigate the potential mechanisms underlying pregnancy-
induced leptin resistance. 
The satiety response to intracerebroventricular (i.c.v) leptin was measured in fasted 
non-pregnant (diestrous), early pregnant (day 7), and mid-pregnant (day 14) rats. Serial 
blood samples collected from another group of rats demonstrated that despite initial 
elevated plasma leptin concentrations in pregnant rats, fasting significantly decreased 
leptin concentrations so that pregnant and non-pregnant groups had similar, low leptin 
concentrations. Leptin treatment significantly reduced food intake in non-pregnant and 
early pregnant rats but not in mid-pregnant rats. In addition, there was no post-fasting 
hyperphagic response in the pregnant rats. These results indicate that pregnant rats become 
resistant to the satiety action of leptin. 
To investigate the mechanisms underlying pregnancy-induced leptin resistance, 
leptin-induced activation of hypothalamic leptin-target neurons was examined. Signal 
transducer and activator of transcription 3 (STAT3) phosphorylation was measured in non-
pregnant and mid-pregnant rats following i.c.v. administration of leptin. Western blot and 
immunohistochemistry analysis indicated that leptin-induced STAT3 phosphorylation was 
significantly reduced in the ventromedial nucleus of the hypothalamus (VMH) during 
pregnancy. A suppression in the amount of leptin-induced STAT3 activation was observed 
in the arcuate nucleus during pregnancy, yet there was no overall change in the number of 
leptin responsive neurons compared to non-pregnant rats. This raises the possibility of a 
decrease in the degree of responsiveness of arcuate nucleus neurons to leptin during 
pregnancy. Using double-labelled immuno-histochemistry for alpha-melanocyte 
stimulating hormone ( a-MSH) and leptin-induced pST AT3 it was demonstrated that pro-
opiomelanocortin (POMC) neurons remain responsive to leptin during pregnancy. In the 
VMH, consistent with the reduced pSTAT3, pregnancy also induced a 2-fold reduction in 
mRNA for the long form of the leptin receptor (Ob-Rb), the only isoform with full signal 
transduction capabilities. Expression of mRNA for one of the short forms of the leptin 
receptor (Ob-Ra) in the choroid plexus was decreased in early and late pregnancy, 
suggesting that reduced leptin transport into the brain may contribute to pregnancy-induced 
leptin resistance. CSF/plasma leptin concentration ratios did not differ between pregnant 
and non-pregnant rats however, suggesting unimpaired leptin transport during pregnancy. 
These results indicate that pregnancy is a state of hypothalamic leptin resistance 
and is associated with impaired activation of the leptin-induced JAK/STAT3 signalling 
pathway in the VMH and arcuate nucleus, and reduced expression of Ob-Rb mRNA in the 
VMH. This state of leptin resistance represents an important adaptation of the maternal 
brain allowing increased food intake and fat mass so that the maternal body can meet the 
metabolic demands of pregnancy and prepare for the subsequent demands of lactation. 
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Chapter one: Literature review 
Leptin and appetite regulation 
Historical background 
Over a lifespan an animal's energy intake and expenditure remains relatively 
balanced, and this equality is primarily due to the regulation of food intake. It was 
proposed fifty years ago that body weight is maintained at a reasonably constant level by 
a signalling mechanism between the body's fat stores and the brain (Kennedy 1953). 
This feedback loop involved a peripherally produced factor that would relay information 
regarding fat stores to the hypothalamus, leading to adjustments in food intake to 
maintain body fat levels around a set point. 
Two mouse models of obesity, the ob/ob mouse and the db/db mouse both have 
the same obese phenotype, despite different chromosomal mutations. These mice are 
grossly obese and hyperphagic, as well as infertile and hyperinsulinemic. Parabotic 
studies during the 1970s using these mice provided further evidence for the existence of 
an appetite regulating feedback mechanism between brain and energy stores. Parabiotic 
studies involve surgically joining two animals so that they exchange blood throughout 
life. Parabiosis has been extensively used to investigate many physiological systems 
involving factors that circulate in the blood (Finerty 1952). Parabotic unions involving 
ob/ob mice paired with wild type litter mates result in hypophagia and decreased body 
weight in the ob/ob partner suggesting that these mice normally lack a blood borne factor 
rendering them hyperphagic and obese (Chlouverakis 1972; Coleman 1973). A union 
with db/db mice causes both ob/ob or wild type partners to lose weight and become 
hypophagic, eventually dying due to starvation once their fat reserves are lost. This 
suggests that db/db mice produce excessive amounts of this factor but unlike ob/ob or 
wild type mice, they are unable to response to the factor (Coleman et al. 1969; Coleman 
1973). These results led to the conclusion that the OB gene encoded the peri,pheral factor 
that was vital in regulating body weight, while the mutated gene in db/db mice encoded 
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the receptor for this factor (Coleman 1978). In 1994, Zhang and colleagues cloned and 
sequenced the OB gene which predicted a protein produced and secreted by adipocytes 
(Zhang et al. 1994). In the ob/ob mouse the ob gene was found to contain a non-sense 
mutation resulting in a non-secreted protein product (Zhang et al. 1994). 
Leptin 
The protein encoded from the OB gene was named leptin, from the greek leptos, 
meaning thin. Leptin is synthesised as a 167-amino acid protein, with an amino-terminal 
secretory signal sequence of 21 amino acids. Human and murine leptin have 84% amino 
acid homology (Zhang et al. 1994). Consistent with this secretory signal sequence, leptin 
is found in the blood circulation (Frederich et al. 1995; Maffei et al. 1995) and both 
messenger RNA for the OB gene and plasma leptin concentrations are closely correlated 
with body fat mass in humans and rodents (Maffei et al. 1995; Considine et al. 1996; 
Harris et al. 1996). While leptin is primarily produced and secreted by adipocytes (Zhang 
et al. 1994; MacDougald et al. 1995), there is evidence to suggest leptin production at 
other sites, including brown adipose tissue (BAT) (Moinat et al. 1995; Tsuruo et al. 
1996), skeletal muscle (Wang et al. 1998), the pituitary gland (Morash et al. 1999), 
placenta (Kawai et al. 1997; Amico et al. 1998) and the brain (Morash et al. 1999). The 
contribution to circulating concentrations of leptin derived from these non-adipose tissues 
is yet to be determined. 
Since the identification of leptin, evidence indicates that this hormone is vital in 
regulating appetite. The daily administration of recombinant mouse leptin to ob/ob mice 
results in decreases in food intake and body weight, reversing the obese phenotype of this 
mouse (Campfield et al. 1995; Halaas et al. 1995; Pelleymounter et al. 1995). 
Administration of leptin to wild type mice also results in decreased food intake and 
reduced body weight (Campfield et al. 1995; Halaas et al. 1995; Pelleymounter et al. 
1995). The satiety action of leptin has been demonstrated in a variety of species 
including rodents, sheep and primates (Cusin et al. 1996; Seeley et al. 1996; Ramsey et 
al. 1998; Clarke et al. 2001). Reduced food intake can be achieved with lower doses if 
exogenous leptin is administered into the lateral ventricle (Campfield et al. 1995) or the 
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3rd ventricle (Stephens et al. 1995). Intracerebroventricular (i.c.v.) administration of 
leptin can reduce food intake by 50% whereas the same dose given peripherally has no 
effect (Seeley et al. 1996). The dose-response curve for i.c.v. administration of leptin is 
steep, yet the dose response curve for peripheral leptin administration is only barely 
discernable (Halaas et al. 1995; Stephens et al. 1995). The lower dose required for more 
potent satiety action of leptin when administered centrally compared to peripherally is 
highly suggestive of a central target site. 
Complementary to suppressing appetite, leptin also acts to increase energy 
expenditure (Ahima et al. 2000). This was first shown when pair fed ob/ob mice did not 
lose as much weight as leptin-treated ob/ob mice, suggesting that leptin-induced weight 
loss was due to more than just decreases in food intake (Halaas et al. 1995). 
Administration of leptin to ob/ob mice raises body temperature, increases oxygen 
consumption and, in high doses, increases total activity to levels comparable to wild type 
mice (Halaas et al. 1995; Pelleymounter et al. 1995). Leptin regulation of energy 
expenditure involves an enhancement of non-shivering thermogenic energy expenditure 
by BAT (Lowell et al. 2000). Leptin induces an increase in uncoupling protein 1 
(UCPl), a mitochondria inner membrane protein which uncouples proton entry from ATP 
synthesis thereby mediating non-shivering thermogenesis in BAT (Scarpace et al. 1997; 
Scarpace et al. 1998). The sympathetic nervous system is an important part of the 
hypothalamic control of energy expenditure and mediates the central actions of leptin on 
BAT thermogensis (Scarpace et al. 1998; Lowell et al. 2000). Leptin also acts centrally 
to increase glucose uptake in BAT and skeletal muscle (Kamohara et al. 1997) 
As well as reversing the obesity in ob/ob mice, leptin administration normalises 
the hyperglycemia, hyperinsulinemia and infertility of the ob/ob mice (Campfield et al. 
1995; Halaas et al. 1995; Pelleymounter et al. 1995; Barash et al. 1996; Chehab et al. 
1996). The correction of these obesity-related conditions are not simply a result of the 
decreased food intake and diminished obesity. For example, while leptin administration 
restores fertility of ob/ob mice, pair fed ob/ob mice do not become fertile (Ahima et al. 
1996; Chehab et al. 1996). Furthermore, leptin has been shown to prevent the starvation-
induced changes in the gonadal, adrenal and thyroid axes suggesting that leptin is 
involved in the adaptation to starvation (Frederich et al. 1995; MacDougald et al. 1995; 
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Saladin et al. 1995; Ahima et al. 1996). Fasting suppresses leptin mRNA expression in 
adipocytes and plasma leptin concentrations in mice and rats (Becker et al. 1995; 
Frederich et al. 1995; MacDougald et al. 1995; Saladin et al. 1995). These decreased 
leptin concentrations are rapidly reversed once refeeding occurs (Becker et al. 1995; 
MacDougald et al. 1995; Saladin et al. 1995). Humans also demonstrate a rapid decrease 
of plasma leptin after short-term fasting, with recovery after refeeding (Boden et al. 1996; 
Considine et al. 1996). The fasting-induced decrease in leptin may act as an important 
signal that leads to neuroendocrine responses to fasting such as suppression of the adrenal 
axis, and reproductive and thyroid hormones (Campbell et al. 1977; Harris et al. 1978; 
Sakaguchi et al. 1988; Bergendahl et al. 1989; Pirke et al. 1989; Dallman et al. 1993; 
Bergendahl et al. 1996). In addition, it has been suggested that the ob/ob and db/db 
mice, where there is either a deficiency in or an insensitivity to leptin, could be 
considered examples of states of starvation despite their gross obesity (Ahima et al. 
2000). The lack of leptin signalling in the brains of these mice conveys a state of 
starvation, thus resulting in the expression of extreme examples of the compensatory 
metabolic and hormonal responses to starvation. 
The leptin receptor 
Less than a year after the discovery of leptin, the receptor for this hormone was 
identified. The nucleotide sequence for the receptor was obtained from a cDNA 
expression library, which was produced after the identification of a high affinity leptin-
binding site in the mouse choroid plexus (Tartaglia et al. 1995). The sequence for the 
predicted extracellular domain of the receptor was observed to contain many features of 
the class 1 cytokine receptor family (Tartaglia et al. 1995). A 23 amino acid predicted 
transmembrane domain and 34 amino acid short cytoplasmic domain were also identified. 
Tartaglia et al (1995) found the receptor sequence to be identical in both wild type 
and db/db mice, which had long be thought to lack the receptor for the appetite regulating 
circulating factor (Coleman 1973). Screening of a human infant total brain cDNA library 
resulted in the identification of the human leptin receptor, however this sequence encoded 
a protein with a longer intracellular domain compared to the mouse sequence (Tartaglia 
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et al. 1995). Using primers directed at the mouse transmembrane domain and the human 
intracellular domain, Chen et al ( 1996b) identified a form of the receptor that contained a 
302 amino acid intracellular domain in the mouse, indicating the existence of different 
isoforms of the receptor. The leptin receptor (Ob-R) isoforms share the same N-terminal 
exons which code for the extracellular domain and the transmembrane domain, but 
differing C-terminal exon usage results in mRNA that encode Ob-R proteins with 
different intracellular lengths (Lee et al. 1996; Chen et al. 1996b). The splice variants 
include a long form of the receptor, Ob-Rb, which has a large intracellular domain and 
several forms with short intracellular domains, Ob-Ra, Ob-Re, Ob-Rd and Ob-Rf. Ob-Rd 
and Ob-Rf have been identified only in mice and rats respectively. There is also a 
soluble form of the receptor, Ob-Re, which lacks the transmembrane region (Tartaglia 
1997). 
The db/db mouse was shown to have a point mutation (G to T) 108 base pairs 
after the splice acceptor site (Lee et al. 1996; Chen et al. 1996b). This results in the 
inclusion of the first 106 base pairs of the Ob-Ra sequence into the Ob-Rb sequence in 
the db/db mouse directly after the splice acceptor site, creating a premature stop codon in 
the Ob-Rb sequence resulting in the Ob-Ra protein instead of Ob-Rb. The db/db mouse 
is a very useful model to demonstrate the vital role of Ob-Rb in the actions of leptin; this 
mouse has no long form of the receptor and has a phenotype identical to that of the ob/ob 
mouse. The Zucker fa/fa rat is another rodent model of obesity due to a mutation in the 
leptin receptor. The fa mutation is the result of a point mutation at nucleotide 880 in the 
sequence for the leptin receptor leading to the conversion of glutamine to proline at 
amino acid position 269 in the gene product (Chua et al. 1996; Iida et al. 1996; Phillips et 
al. 1996; Yamashita et al. 1997; White et al. 1997b; da Silva et al. 1998). This altered 
amino acid sequence occurs in the extracellular domain of the receptor and greatly 
diminishes the ability of leptin to bind to the receptor and activate signal transduction 
pathways (Chua et al. 1996; Phillips et al. 1996; Yamashita et al. 1997; White et al. 
1997b; da Silva et al. 1998). 
The various functions of the different receptor isoforms are yet to be fully 
elucidated. The long form plays a major role in intracellular signal transduction, but less 
is known about the short forms of the receptor. Suggested functions for these isoforms 
I:, 
6 
include involvement in signal transduction, leptin transport into the brain, and clearance 
of leptin from the cerebrospinal fluid (Vaisse et al. 1996; Murakami et al. 1997; Tartaglia 
1997). The soluble form may have a role in binding to leptin in the bloodstream and 
modulating the hormone's bioactivity (Sinha et al. 1996; Gavrilova et al. 1997; Tartaglia 
1997). 
Leptin receptor distribution 
The leptin receptor has been detected in a wide range of tissues in the body, 
including liver, heart, kidneys, lungs, small intestine, testes, ovaries, spleen, pancreas, 
brain and adipose tissue (Kieffer et al. 1996; Lee et al. 1996; De Matteis et al. 1998; Chen 
et al. 1999). The short forms of the leptin receptor are the most predominant, but the 
hypothalamus has high expression levels of Ob-Rb. Using in situ hybridisation, mRNA 
for Ob-Rb has consistently been observed in the arcuate nucleus, the dorsomedial nucleus 
(DMH), the ventromedial nucleus (VMH), the lateral hypothalamus and the 
paraventricular nucleus (PVN) of the hypothalamus (Mercer et al. 1996b; Fei et al. 1997; 
Guan et al. 1997; Elmquist et al. 1998b). The protein for the leptin receptor has been 
detected in the arcuate nucleus, and more weakly in the ventromedial and dorsomedial 
nuclei, the paraventricular nucleus and the lateral hypothalamus (Diano et al. 1998; 
Hakansson et al. 1998; Shioda et al. 1998). Ob-Ra is also highly expressed in the 
hypothalamus, the choroid plexus, and the blood vessels and meninges of the brain 
(Mercer et al. 1996b; Fei et al. 1997; Guan et al. 1997; Elmquist et al. 1998b). 
Leptin entry into the brain 
The majority of leptin is produced in adipose tissue and secreted into the 
peripheral blood circulation. The primary site of leptin action is the hypothalamus, but 
very little is known about the mechanisms of leptin entry into the brain. Leptin may enter 
the brain from circulation at the blood-brain barrier and/or at the blood-cerebrospinal 
fluid (CSF) barrier. As a large polypeptide it is unlikely that leptin can simply diffuse 




be via an active transport mechanism which can be saturated (Banks et al. 1996; 
Koistinen et al. 1998). Due to the high expression levels of Ob-Ra and Ob-Re mRNA in 
the choroid plexus and cerebral microvessels, the leptin receptor has been proposed to be 
involved in mediating the transport of leptin into the brain at the blood-brain barrier and 
the blood-CSF barrier (Tartaglia et al. 1995; Guan et al. 1997; Wu-Peng et al. 1997; 
Bjorbaek et al. 1998a; Hileman et al. 2000; Hileman et al. 2002). 
The blood-brain barrier appears to be the main site of transport of leptin into the 
brain (Bjorbaek et al. 1998a; Kurrimbux et al. 2004). Human brain capillaries 
demonstrate the ability to bind and endocytose leptin by a process that is competitively 
inhibited as leptin concentrations increase, implying a saturable mechanism (Golden et al. 
1997). Furthermore, in epithelial cells, the slow unidirectional transcellular (apical to 
basal) transport of intact leptin involving Ob-Ra has been demonstrated, and as the apical 
surface of endothelial cells is positioned towards the vessel lumen, this mechanism has 
been suggested to transport leptin across the blood-brain barrier (Hileman et al. 2000). 
The choroid plexus has been proposed as both a site for leptin entry into the brain 
(Zlokovic et al. 2000) and a site mediating leptin clearance from the brain (Uotani et al. 
1999; Hileman et al. 2000). While the choroid plexus has the highest rate of leptin intake 
in the brain, this is not reflected in the CSF, indicating that the choroid plexus may take 
up leptin and tightly regulate its distribution in the brain (Kurrimbux et al. 2004). The 
affinity of leptin binding to the choroid plexus is similar to the affinity for leptin binding 
to cells transfected with Ob-Ra (Uotani et al. 1999). Furthermore, cultured porcine 
choroid plexus cells bind and rapidly internalise leptin (Peiser et al. 2000a). The apical 
surface of the choroid plexus epithelial cells face towards the CSF, however, suggesting 
that the transport mechanism described by Hileman et al (2000), favours a clearance role 
rather than an entry role for the choroid plexus in terms of receptor mediated transport. 
To further understand leptin transport into the brain, leptin uptake using 
radiolabelled leptin has been measured in a number of different rodent models. While 
db/db and wild type mice have comparable levels of leptin uptake into the brain, leptin 
uptake is decreased in total Ob-R knockout mice (Maness et al. 2000; Hileman et al. 
2002). Decreased leptin uptake in the brain, and reduced CSF/serum leptin ratios are 
seen in Koletsky rats where there is impaired post-translational modification of the leptin 
,-
8 
receptor, suggesting that the short form of the receptor contributes to the processes of 
leptin transport into the brain (Kastin et al. 1999). While these rodent models have 
decreased brain uptake of leptin, leptin transport into the brain is still apparent, indicating 
that there exist non-leptin receptor mediated transport mechanisms (Wu-Peng et al. 1997; 
Kastin et al. 1999; Hileman et al. 2002). Furthermore, in the diet-induced obese mouse, 
and the New Zealand obese mouse, the decrease in leptin uptake was not associated with 
a decrease in Ob-R mRNA expression in the cerebral microvessels (Hileman et al. 2002). 
Similarly, the increase in brain uptake of leptin during fasting is not associated with an 
increase in Ob-R mRNA expression in the cerebral microvessels (Hileman et al. 2002). 
This would suggest that changes in brain leptin uptake are not regulated by changes in 
Ob-R mRNA expression, although site-specific changes in receptor expression levels can 
not be ruled out. 
Hypothalamus as the major target site of leptin action 
The involvement of the hypothalamus in the regulation of appetite has been 
known for over 150 years after observations that hypothalamic injury or tumors in this 
area were associated with obesity (Bray et al. 1979). Furthermore, specific lesions to the 
lateral or the ventromedial hypothalamus lead to decreased food intake or increased food 
intake, respectively (Hetherington et al. 1940; Anand et al. 1951). The control of appetite 
regulation in the hypothalamus involves a complex neuronal network including both 
orexigenic and anorectic factors. These factors are constantly being modulated through 
stimulation or inhibition by many stimuli to maintain appetite at appropriate levels for the 
current energy expenditure of the body. 
Despite the fact that the mechanisms allowing leptin access to the brain are not 
well defined it is widely accepted that the major target site of leptin action is the 
hypothalamus. This is due to the greater effectiveness of leptin-induced hypophagia 
when centrally administered compared to peripherally, and the high expression levels of 
Ob-Rb found in areas of hypothalamus that have previously been implicated in regulating 
appetite. The administration of leptin directly into areas of the hypothalamus leads to 
reductions in food intake, with the arcuate nucleus being the most sensitive site (Jacob et 
.. , 
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al. 1997; Satoh et al. 1997). The arcuate nucleus is a key site in the hypothalamic 
regulation of energy homeostasis and has a high density of neurons that contain 
orexigenic or anorectic neuropeptides. Two of the most widely studied neuronal 
populations with well-characterised roles in appetite regulation are the pro-
opiomelanocortin (POMC) neurons and neuropeptide Y (NPY)/agouti related peptide 
(AgRP) neurons in the arcuate nucleus. These neuron populations are critical first order 
leptin responsive neurons. 
Mediators of leptin action in the hypothalamus: POMC 
The pro-opiomelanocortin (POMC) gene encodes the POMC precursor 
polypeptide, which through cleavage processing yields the opioid product, ~-endorphin, 
and melanocortin products including alpha-melanocyte stimulating hormone (a-MSH) 
and adrenocorticotropic hormone (ACTH). Changes in metabolic state influence the 
level of POMC mRNA in the arcuate nucleus (Brady et al. 1990; Bergendahl et al. 1992; 
Steiner et al. 1994). Mutations in the POMC gene lead to metabolic impairments in 
humans and mice (Krude et al. 1998; Yaswen et al. 1999) and POMC-deficient mice are 
hyperphagic and obese (Yaswen et al. 1999) implicating the POMC gene as a crucial 
anorectic component of the appetite regulation neural network . 
Since the identification of leptin it has become clear that POMC neurons are 
involved in the satiety actions of leptin. Leptin positively regulates levels of POMC 
mRNA expression in a subpopulation of POMC neurons concentrated in the rostral 
arcuate nucleus (Schwartz et al. 1997; Thornton et al. 1997). Indeed, following the 
administration of leptin the activation of both c-fos and SOCS3 mRNA in POMC 
neurons indicates the stimulatory effect of leptin on these neurons (Elias et al. 1999). 
When leptin signalling is low or absent, such as during fasting, or in ob/ob and db/db 
mice, POMC mRNA levels are reduced (Thornton et al. 1997; Mizuno et al. 1998; 
Schwartz et al. 1998; Mizuno et al. 1999). These fasting-induced decreases in POMC 
mRNA can be prevented by maintaining pre-fasted leptin concentrations in the fasted 
animals with exogenous leptin administration, suggesting that metabolic changes in 
POMC levels are due specifically to the changes in leptin concentrations. The direct 
,'.A 
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activation of POMC neurons by leptin is likely, as leptin receptor mRNA has been 
detected in POMC neurons (Cheung et al. 1997; Hakansson et al. 1998). Recently, it has 
been reported that transgenic mice with specific deletion of leptin receptors from POMC 
neurons are mildly obese, indicating that while leptin signalling in these neurons has an 
important role in the regulation of energy homeostasis by leptin, other signals are also 
involved (Balthasar et al. 2004). 
The actions of the POMC gene in appetite regulation are thought to be principally 
mediated by its cleavage product a-MSH. In POMC-deficient mice, the administration 
of a-MSH prevents the hyperphagia and weight gain associated with the lack of the 
POMC gene (Yaswen et al. 1999). In vitro, leptin rapidly leads to the release of a-MSH 
from fasted rat hypothalami (Kim et al. 2000) and central administration of a-MSH or an 
a-MSH agonist decreases food intake and increases energy expenditure (Poggioli et al. 
1986; Thiele et al. 1998; Yaswen et al. 1999). The anorectic actions of a-MSH are 
mediated through the melanocortin-3 (MC3-R) and melanocortin-4 (MC4-R) receptors 
which are highly expressed in the medial hypothalamus (Gantz et al. 1993; Mountjoy et 
al. 1994). MC4-R-deficient mice are hyperphagic and obese, whereas MC3-R-deficient 
mice are hypophagic but have increased fat mass, reduced lean body mass and a higher 
feed efficiency (Huszar et al. 1997; Chen et al. 2000). Furthermore, mice deficient in 
both receptor types are significantly more obese then the MC4-R deficient mice 
suggesting that these two receptors have different, non-redundant functions in the 
regulation of energy homeostasis (Chen et al. 2000). 
As well as playing a major role in the anorectic actions of leptin, POMC neurons 
may also have orexigenic functions. The opioid product of the POMC gene, ~-
endorphin, has also been implicated in appetite regulation. Opioids have long been 
known to stimulate appetite (Morley et al. 1983; Levine et al. 1989), and both ~-
endorphin, and dynorphin, another hypothalamic endogenous opioid peptide, have been 
shown to stimulate feeding when injected centrally (Grandison et al. 1977; Levine et al. 
1989). The role of the opioids in appetite regulation are not fully understood, although it 
has been suggested that ~-endorphin may be involved in modulating the interconnections 
of the orexigenic networks within the hypothalamus (Kalra et al. 1999). 
11 
Mediators of leptin action in the hypothalamus: NPY 
Neuropeptide Y (NPY) is a 36 amino acid peptide, first isolated from porcine 
brain tissue (Tatemoto 1982; Tatemoto et al. 1982) and is one of the most potent 
orexigenic factors known. NPY is produced both centrally and peripherally, and in the 
hypothalamus it is almost exclusively synthesised in the arcuate nucleus (Chronwall et al. 
1985; de Quidt et al. 1986). NPY neurons send projections to other areas of the 
hypothalamus such as the paraventricular, perifornical hypothalamus, dorsomedial and 
ventromedial hypothalamic nuclei (Bai et al. 1985; de Quidt et al. 1986; Baker et al. 
1995). The i.c.v. administration of NPY leads to increases in food intake (Clark et al. 
1985; Stanley et al. 1985) and fasting leads to increased expression of NPY in the arcuate 
nucleus (Sahu et al. 1988; Brady et al. 1990). Chronic i.c.v. NPY administration to rats 
results in increased body weight due to sustained hyperphagia (Zarjevski et al. 1993). 
The orexigenic actions of NPY have been demonstrated in a number of different species 
including rodents, sheep and primates (Clark et al. 1985; Miner et al. 1989; Larsen et al. 
1999). 
Due to its potent orexigenic effects, it is no surprise that leptin negatively 
regulates the production and secretion of NPY. The first demonstration of this was in 
isolated hypothalami where the application of the OB protein inhibited secretion of NPY 
(Stephens et al. 1995). Unlike POMC neurons, leptin administration induces the 
expression of SOCS-3 mRNA but not c-fos in NPY neurons, indicating an inhibitory 
effect of leptin (Elias et al. 1999). Further evidence has accumulated from ob/ob, db/db 
mice and fasted rodents. In fasted rodents, leptin or refeeding can reverse the fasting-
induced increased expression of NPY mRNA (Schwartz et al. 1998; Korner et al. 2001; 
Swart et al. 2002). Similar to fasted rodents, ob/ob mice and db/db mice have increased 
expression of NPY mRNA in the arcuate nucleus (Schwartz et al. 1996a). Leptin 
administration in the ob/ob mouse leads to decreases in the levels of NPY gene 
expression which does not occur in the db/db mouse under the same experimental 
conditions (Stephens et al. 1995; Schwartz et al. 1996a). This would indicate that the 
long form of the receptor is essential for leptin regulation of NPY, and consistent with 
this, many of the NPY -containing neurons in the arcuate nucleus express leptin receptors 





NPY-deficient ob/ob mice are obese compared to wild type mice, however their 
obesity is not as extreme as the ob/ob mice (Erickson et al. 1996). The requirement of 
NPY for the ob/ob mouse to display the full obese phenotype greatly implicates NPY as a 
mediator of the satiety action of leptin. NPY is clearly not the only orexigenic signal 
involved as the NPY-deficient ob/ob mice are still obese compared to wild type mice and 
NPY -deficient mice have normal body weight and food intake (Erickson et al. 1996; 
Erickson et al. 1996). 
Mediators of leptin action in the hypothalamus:AgRP 
Agouti-related protein (AgRP) is a 132 amino acid peptide that has a 25% 
homology to the agouti protein (Ollmann et al. 1997; Shutter et al. 1997). The agouti 
protein is expressed in hair follicles and inhibits black pigment synthesis by antagonisting 
the actions of a-MSH, therefore leading to a yellow hair colour (Bultman et al. 1992; 
Miller et al. 1993). AgRP is thought to act with similar effect on the brain melanocortin 
signalling system, antagonising the MC3- and MC4-receptors to prevent the a-MSH-
mediated anorectic activation of these receptors (Ollmann et al. 1997). The similarity 
between agouti and AgRP is demonstrated by the identical phenotype of obesity and 
hyperphagia when either of these peptides is overexpressed (Bultman et al. 1992; Graham 
et al. 1997). Administration of AgRP into the lateral ventricle or hypothalamic nuclei 
such as the PVN and DMH that contain MC3/4-receptors leads to increases in food intake 
(Rossi et al. 1998; Hagan et al. 2000; Wirth et al. 2000; Wirth et al. 2001; Kim et al. 
2002). The increased food intake induced by a single i.c.v. injection of AgRP can last up 
to a week (Rossi et al. 1998; Hagan et al. 2000). 
AgRP is exclusively localised to NPY neurons in the arcuate nucleus revealing an 
orexigenic population of neurons that is able to stimulate appetite by two different 
mechanisms (Broberger et al. 1998; Hahn et al. 1998). In response to fasting, AgRP 
mRNA is increased in both rats (Korner et al. 2001) and mice (Mizuno et al. 1999). 
Furthermore AgRP mRNA is significantly increased in ob/ob and db/db mice compared 
to wild type mice and fasting does not further increase AgRP in the ob/ob mouse 




ob/ob mice leads to decreases in AgRP mRNA, and Ob-Rb mRNA has been colocalised 
with AgRP mRNA suggesting that the effect of leptin is direct (Wilson et al. 1999). 
Other target populations 
As well as the anorectic POMC neurons and orexigenic NPY/AgRP neurons, 
leptin acts on a number of other neuron populations. Leptin receptors have been 
identified on neurons that contain corticotropin-releasing hormone (CRH), somatostatin, 
galanin, tyrosine hydroxylase and melanin-concentrating hormone (MCH) as well as 
NPY, POMC and ACTH (Hakansson et al. 1998). Leptin administration has also been 
shown to decrease the expression of mRNA for MCH and galanin, both with orexigenic 
properties and increase the expression of mRNA for neurotensin and corticotropin-
releasing hormone, both of which have demonstrated anorectic properties (Schwartz et al. 
1996c; Sahu 1998; Sahu 1998). 
Leptin signal transduction 
The intracellular signal transduction pathways activated by leptin-leptin receptor 
interactions have been the subject of many in vitro and in vivo studies. The early 
identification of the leptin receptor as a member of the class I cytokine receptor family 
suggested a JAK (Janus _!!ctivating kinase or Just Another Kinase)/STAT (.S.ignal 
Iransducer and Activator of Transcription) signalling pathway, and leptin-induced 
activation of this signalling pathway is now well established. Other signalling pathways 
activated by leptin are also beginning to emerge. 
The class I cytokine receptor family 
The leptin receptor has been classified as a member of the class I cytokine 
receptor superfamily based on sequence homology (Tartaglia et al. 1995). The class I 




extracellular (approximately 200 amino acid) region of structural homology. While the 
intracellular domains of family members differ considerably, there are a few common 
features. Most of the class I cytokine receptors contain a hydrophobic praline-rich motif 
close to the transmembrane domain ('box 1 ') and an acidic motif ('box 2'), 
approximately 30 amino acid in length. These two segments are putative JAK interaction 
sites and are involved in the activation of signal transduction pathways by these receptors 
(Murakami et al. 1991). Another motif ('box 3 ') situated in the middle of the 
cytoplasmic region is conserved in a subset of class I cytokine receptors (Baumann et al. 
1994). 
The cytokine receptors lack intrinsic intracellular tyrosine kinase domains but 
always are associated with cytoplasmic protein tyrosine kinases, mostly of the JAK 
family (Ihle et al. 1995). Generally, ligand binding leads to receptor dimerisation and the 
transphosphorylation of the JAK molecules, which then leads to the phosphorylation of 
tyrosine residues on the receptors. The phosphorylation of tyrosine residues activates 
intracellular signalling by recruiting specific signalling proteins with specialised 
phosphotyrosine binding domains called src homology 2 (SH2) domains (Koch et al. 
1991). Alternative SH2 domain isoforms in signalling proteins bind phosphorylated 
tyrosines in differing amino acid motifs, thus each tyrosine phosphorylation site recruits 
specific downstream signalling proteins based on its surrounding amino acid sequence. 
The most well characterised pathway activated by class I cytokine receptors is the 
JAK/STAT signal transduction pathway. 
Leptin activation of the receptor 
While it is generally considered that activation of cytokine receptors is due to the 
formation of dimers induced by ligand binding (Taga et al. 1996), in vitro evidence 
suggests that the leptin receptors may inherently form dimers without leptin stimulation. 
When the extracellular domain of the receptor is expressed in baculovirus-infected insect 
cells in the absence of leptin, the purified proteins behave as dimers when analysed by gel 
filtration chromatography (Devos et al. 1997) and in transfected COS7 cells the Ob-R 





al. 1997), suggesting that formation of dimers is an intrinsic property of the receptor. 
Furthermore, using a quantitative bioluminescence resonance energy transfer approach, 
Couturier and Jockers (2003) demonstrated that under both basal and leptin-stimulated 
conditions Ob-R exist as constitutive dimers and leptin stimulation leads to conformation 
changes in the receptor dimer (Couturier et al. 2003). It is possible that in vivo leptin 
induces conformational changes rather than dimerisation of the receptors, resulting in the 
activation of the receptor. 
The activation of JAKs is a prerequisite for the activation of downstream 
signalling pathways of cytokine receptors (Ihle et al. 1995). Ob-Rb has the putative JAK 
binding sites (box 1 and 2), and also the STAT binding site (box 3) whereas Ob-Ra only 
has one putative JAK binding site (Ihle et al. 1995; Schindler et al. 1995; Stahl et al. 
1995; Tartaglia et al. 1995; Ghilardi et al. 1996; Tartaglia 1997). In transfected cells Ob-
Rb has been shown to activate JAK2, though there is inconsistency in regard to whether 
the short form of the receptor has this ability (Bjorbaek et al. 1997; Ghilardi et al. 1997). 
The activation of JAKs results in the phosphorylation of the leptin receptor. The 
long form of the receptor has three intracellular tyrosine residues, Y985, Yl077 and 
Yl138 (Tartaglia et al. 1995; Tartaglia 1997). Y985 and Y1138 are both situated in 
hydrophilic motifs which are likely to be accessible to the JAK2 tyrosine kinase, whereas 
Y 1077 is surrounded by hydrophobic sequences and therefore is likely to be hidden 
within the folded protein and inaccessible (Tartaglia et al. 1995; Banks et al. 2000a). In 
vitro, after leptin treatment Y985 and Y1138 both become phosphorylated and when 
Y985 and Y 113 8 are mutated, the ability of the leptin receptor to become phosphorylated 
is abolished despite the presence of Yl077 (Banks et al. 2000a). The tyrosine 
phosphorylation of Y985 and Y1138 on Ob-Rb mediate the subsequent intracellular 
signalling mechanisms of the receptor. 
Leptin signal transduction: JAKISTA T pathway 
Following the JAK2-mediated phosphorylation of the leptin receptor, multiple 
signalling pathways are activated. The most well-characterised of these pathways 






proteins that are activated by a range of extracellular signalling polypeptides and 
influence gene transcription. Currently seven different mammalian STAT genes have 
been identified, STATl-4, Sa, Sb and 6. All STAT proteins contain a DNA binding 
region, SH3 and SH2 domains and a tyrosine residue which becomes phosphorylated 
during activation of the molecule (Darnell 1997). The activation of STA Ts requires three 
tyrosine phosphorylation steps; firstly phosphorylation of the JAKs, then of the 
cytoplasmic region of the receptor to create docking sites for the SH2 domain, and lastly 
of the STAT molecules themselves once they are recruited to the docking sites (Darnell 
1997). Once phosphorylated, STAT molecules form dimers and translocate to the 
nucleus where they modify gene transcription. 
In cells transfected with Ob-Rb, leptin stimulation has been shown to activate 
STAT3 (Baumann et al. 1996; Ghilardi et al. 1996). There is conflicting evidence 
regarding the ability of leptin to activate other STAT molecules in vitro (Baumann et al. 
1996; Ghilardi et al. 1996). In vivo, leptin administration exclusively activates STAT3 in 
the hypothalamus (McCowen et al. 1998). The activation of STAT3 by leptin is 
dependent on the long form of the receptor, as leptin administration does not activate 
ST A T3 in the hypothalamus of dbl db mice (V aisse et al. 1996) or in cells transfected 
with Ob-R cloned from either db/db mice or fa/fa rats (Ghilardi et al. 1996; Rosenblum et 
al. 1996). Phosphorylation of Y1138 on Ob-Rb is critical for the leptin-induced 
activation of STAT3 (Baumann et al. 1996; Bjorbaek et al. 1997; White et al. 1997a; 
Carpenter et al. 1998; Banks et al. 2000a). This tyrosine residue is positioned three 
amino acids along from a glutamine residue (YXXQ) generating a STAT binding mofit 
(Stahl et al. 1995; Tartaglia 1997). 
In the hypothalamus, ST AT3 is found at relatively high levels in the arcuate 
nucleus, with lesser levels in the supraoptic nucleus (SON), PVN, suprachisamatic 
nucleus, DMH and VMH (Hakansson-Ovesjo et al. 2000; Stromberg et al. 2000). There 
is also high colocalisation of STAT3 and Ob-R in neurons in the hypothalamus 
(Hakansson et al. 1998). The translocation of STAT3 after an acute dose of leptin has 
been mapped, and shown to be localised to neurons in the arcuate nucleus, VMH, DMH 




Suppressors of cytokine signalling (SOCS) molecules are one of the known 
families of immediate-early genes that are transcriptionally regulated by STATs (Starr et 
al. 1997). Currently there are eight different SOCS proteins in the SOCS family and they 
all contain a SH2 domain and a conserved C-terminal domain called the 'SOCS box' 
(Hilton et al. 1998). SOCS proteins are induced by cytokines and are involved in 
intracellular negative feedback loops leading to decreased cytokine signalling. Leptin 
induces the expression of SOCS-3 mRNA in the hypothalamus (Bjorbaek et al. 1998b; 
Emilsson et al. 1999), and in cells transfected with Ob-Rb but not Ob-Ra (Bjorbaek et al. 
1999). Furthermore, leptin-induced activation of STAT3 and SOCS-3 is inhibited when 
cells have high levels of SOCS-3 (Bjorbaek et al. 1999). Phosphorylation of Yl 138 on 
Ob-Rb is required for the activation of SOCS-3 mRNA by leptin, strongly implicating 
STAT3 as the mediator of leptin-induced SOCS-3 gene transcription (Banks et al. 
2000a). The induction of SOCS-3 has been determined to be a useful marker of leptin 
activation of neurons (Bjorbaek et al. 1999; Elias et al. 1999). 
In vitro, mutations of Y985 do not significantly alter short term ST AT3 tyrosine 
phosphorylation (Carpenter et al. 1998), however long term stimulation with a non-
functional Y985 site results in increased levels of STAT3 activity (Bjorbaek et al. 2000; 
Banks et al. 2000a). SOCS-3 has been shown to associate with the phosphorylated Y985 
residue (Bjorbaek et al. 2000) and it is likely that this interaction with Y985 is involved 
in inhibiting the JAK/STAT pathway, but the mechanisms behind the inhibitory effect are 
yet to be fully elucidated. 
JAKISTAT signalling in leptin responsive neurons 
In the arcuate nucleus, STAT3 immunoreactivity is present in both NPY and 
POMC-containing neurons (Hakansson et al. 1998) and leptin induces SOCS-3 mRNA 
expression in both POMC and NPY neurons (Elias et al. 2000), implying that the 
JAK/STAT pathway has been activated in these neurons. Two mouse models of 
disrupted JAK/STAT3 signalling have been developed and further define the role of this 
pathway in the actions of leptin. In the sis mouse, Ob-Rb does not contain the Y1138 




to investigate leptin induced signalling of this tyrosine residue (Banks et al. 2000a). Due 
to the disrupted leptin receptor-STAT3 signalling, this mouse is hyperphagic and obese, 
but unlike db/db mice and ob/ob mice, it is also fertile, displays normal linear length and 
is less hyperglycaemic, similar to the NPY-deficient ob/ob mice (Bates et al. 2003). The 
conclusion reached from this mouse model is that leptin regulation of energy balance is 
mediated by leptin-induced JAK/STAT3 signalling pathways whereas leptin actions on 
fertility, growth and glucose homeostasis may be mediated through other pathways 
(Bates et al. 2003). The levels of various neuropeptides in the sis mouse suggests that the 
JAK/STAT pathway mediates the regulation of the POMC mRNA and, to some extent, 
AgRP mRNA by leptin, but STAT3-independent pathways mediate leptin regulation of 
NPY mRNA in the hypothalamus (Bates et al. 2003). The involvement of JAK/STAT 
signalling in the regulation of POMC by leptin is support by other results. In vitro it has 
been shown that STAT3 phosphorylation is essential for leptin-induced POMC promoter 
activity while in vivo phosphorylated STAT3 is colocalised with a-MSH in POMC 
neurons in the arcuate nucleus (Munzberg et al. 2003). 
Mice with a neural-specific deletion of STAT3 are phenotypically the same as 
db/db and ob/ob mice suggesting that STAT3 can account for all the effects of leptin on 
energy balance and neuroendocrine function (Gao et al. 2004). This difference from the 
sis mouse suggests that while the actions of leptin in fertility, growth and glucose 
homeostasis, and NPY regulation require STAT3, it does not act through the activation of 
the Y 1138 residue on the leptin receptor. The mechanisms behind this Y 1138-
independent activation of ST AT3 are unknown as without Y 1138 both in vitro (Banks et 
al. 2000a) and in vivo (Bates et al. 2003) leptin does not induce the phosphorylation of 
STAT3. The differing results from these two mouse models emphasise the need for 
further investigation of the interactions of the JAK/ST AT signalling pathway and the 
actions of leptin. 





Insulin is another hormone that has been proposed as a bloodborne signal that 
indicates body fat levels to the brain. While insulin is secreted from the pancreatic ~-
cells in response to high blood glucose levels and hence insulin concentrations vary 
accordingly at any given time, long term insulin levels reflect body fat stores (Bagdade et 
al. 1967). Insulin is involved in decreasing blood glucose levels, and actions include 
increasing in the facilitated diffusion of glucose into cells, increasing conversion of 
glucose into glycogen and increasing synthesis of fatty acids (lipogenesis). Insulin is 
involved in the regulation of appetite and total insulin deficiency results in hyperphagia 
(Si pols et al. 1995). Insulin receptors are located in appetite regulating areas of the brain 
(Marks et al. 1990) and central administration of insulin reduces food intake (Benoit et al. 
2002; Niswender et al. 2003) consistent with a central role for insulin in appetite 
regulation. It has also been shown that insulin can regulate the expression of mRNA for 
NPY and POMC in the arcuate nucleus similar to leptin (Schwartz et al. 1992; Benoit et 
al. 2002). 
Insulin-induced signal transduction pathways in peripheral tissues have been well 
characterised (Saltiel et al. 2002). The activation of the insulin receptor by insulin leads 
to phosphorylation and activation of insulin receptor intrinsic tyrosine kinases that then 
recruit and subsequently phosphorylates insulin receptor substrate proteins (IRSI-4). 
Once phosphorylated IRS molecules bind SH2-domain-containing signalling proteins, 
including phosphatidylinositol 3-kinases (PI3-K) that then activate PIP3 resulting in a 
number of further downstream actions. In the arcuate nucleus it has recently been shown 
that insulin signalling involves IRS-I and -3 interactions with PI3-K and the subsequent 
activation of protein kinase B (Niswender et al. 2003). 
Leptin activation of Insulin-like signalling pathways 
In a number of different peripheral tissues, leptin has been shown to induce 







concentrations (Zhao et al. 1998; Zhao et al. 2000). Cyclic AMP is an intracellular 
mediator that is influence by many stimuli, including hormonal stimulation of cell-
surface receptors. Reduced cAMP concentrations have been shown to be mediated 
through PI3-K-dependent activation of the cAMP-degrading phosphodiesterase 3B 
(PDE3B) (Zhao et al. 2000). The identification of leptin activation of this pathway in 
peripheral tissue posed the question of whether leptin activates similar pathways in the 
hypothalamus. 
Hypothalamic cAMP activity and cAMP-dependent processes have been shown 
to be influenced by feeding status. The administration of cAMP analogs or agents that 
increase endogenous cAMP concentrations result in increased food intake in rats (Gillard 
et al. 1997; Gillard et al. 1998). Food deprivation results in increases in cAMP response 
element (CRE) binding activity, CRE-mediated gene induction and CRE-binding protein 
(CREB) phosphorylation in the hypothalamus, specifically the arcuate nucleus (Sheriff et 
al. 1997; Shimizu-Albergine et al. 2001). The changes in activity of this pathway 
induced by fasting can be reversed not only by refeeding (Sheriff et al. 1997) but also by 
the peripheral or central administration of leptin (Shimizu-Albergine et al. 2001). 
Furthermore, after leptin administration, hypothalamic cAMP levels are decreased 
suggesting that leptin is involved in the feeding related changes in this pathway in the 
hypothalamus (Zhao et al. 2002). 
Leptin signal transduction leading to reduced cAMP concentrations is thought to 
be mediated through PI3-K-dependent activation of PDE3B. Leptin-induced reductions 
of cAMP levels are associated with increases in both PI3-K and PDE3B activity in the 
hypothalamus and inhibitors of either PI3-K or PDE3B prevent the leptin-induced 
decrease in food intake (Niswender et al. 2001; Zhao et al. 2002; Rahmouni et al. 2003). 
The prevention of leptin-induced hypophagia via the inhibition of PDE3B is also 
associated with the suppression of STAT3 phosphorylation and DNA binding activity of 
STAT3, suggesting that increases in PDE3B, presumably resulting in reduced cAMP is 
required for activation of the JAK/STAT3 signalling pathway (Zhao et al. 2002). 
Interestingly, the activation of this insulin-like signalling pathway in hepatocytes 
is thought to be due to the short form of the receptor, as this cell type has little to no 







hypothalamus through the short forms of the receptor can not be ruled out, and warrants 
further examination. 
Leptin signal transduction: Mitogen-activated protein kinase (MAPK) 
activity 
Activation of MAPK, otherwise known as ERK (Extracellular Regulating Kinase) 
is induced by leptin in the hypothalamus (Bjorbaek et al. 2001; Bates et al. 2003). In 
vitro, there appears to be two different ways by which leptin stimulates this pathway. 
Both the long form of the receptor, and the most common short form (Ob-Ra) have 
demonstrated the ability to active this pathway in vitro, although the level of activation 
by the short form was considerably less than that induced by the long form (Bjorbaek et 
al. 1997; Murakami et al. 1997). For the maximal response of MAPK by leptin, the 
tyrosine 985 of Ob-Rb is required (Banks et al. 2000a). A reduced amount of MAPK, 
however, can be activated by a JAK-2-dependent pathway that does not require the 
phosphorylation of Ob-Rb (Banks et al. 2000a; Bjorbaek et al. 2001). It is by this second 
method of activation that Ob-Ra is likely to mediate the MAPK pathway as this receptor, 
despite its short intracellular domains, still contains a JAK association motif. 
The SH2 domain-containing protein tyrosine phosphatase 2 (SHP-2) is widely 
expressed in cells and generally acts to positively regulate signals. SHP-2 can be 
recruited to a SH2 domain docking site on the phosphorylated leptin receptor (Carpenter 
et al. 1998). Activation of SHP-2 has been shown to be vital for leptin-induced MAPK 
signalling pathways. SHP-2 has phosphatase properties and can also act as an adaptor 
protein. The phosphatase activity of SHP-2 is required for both the Ob-Rb dependent and 
independent leptin induced activation of MAPK, while the phosphorylation of SHP-2, to 
function as an adaptor protein, is only required for the Ob-Rb dependent pathway 
(Bjorbaek et al. 2001). As SHP-2 binds to the Y985, the same as SOCS molecules, it is 
possible that SHP-2 may act as a positive regulator of ST AT signalling pathways by 
preventing SOCS-induced inhibition of STAT signalling (Bjorbaek et al. 2001). 
The MAPK pathway is not activated in the hypothalamus of db/db mice (Bates et 







induced MAPK activation may not occur in the hypothalamus, or may be a artifact of the 
in vitro methodologies. Despite the leptin-induced activation of the MAPK pathway in 
the hypothalamus of wild type mice (Bjorbaek et al. 2001; Bates et al. 2003), the 
involvement of this pathway in appetite regulation has not been determined. The sis 
mouse still has MAPK-signal transduction capacity but is hyperphagic, suggesting that 
this pathway does not play a major role in the satiety action of leptin (Bates et al. 2003). 
Acute effects of leptin 
As well as leptin-induced regulation of gene transcription, leptin also elicits acute 
changes in neuronal activity within the hypothalamus that are involved in the satiety 
action of this hormone. Glaum et al (1996) was the first to demonstrate that leptin can 
rapid modulate synaptic transmission after applying this hormone to hypothalamic slices 
(Glaum et al. 1996). Using hypothalamic slices containing green fluorescent protein 
(GFP)-labelled POMC neurons, leptin has been shown to increase the frequency of action 
potentials in these anorectic neurons in the arcuate nucleus by two mechanisms (Cowley 
et al. 2001). Firstly the POMC neurons are depolarised through a non-specific cation 
channel. Secondly leptin acts on the NPY neurons that synapse with the POMC neurons 
(Horvath et al. 1992) to prevent the release of GABA and therefore disinhibiting the 
POMC neurons (Cowley et al. 2001). 
Another method employed to identify neuron populations while measuring the 
activity of neurons is to examine the response to glucose. Glucosensing neurons use 
glucose not only as a fuel but also as a signalling molecule to alter their activity. There 
are two types of glucosensing neurons; glucose sensitive (G-S) neurons where neuronal 
activity is the reciprocal of ambient glucose levels and glucose responsive (G-R) neurons 
where activity parallels changes in ambient glucose levels. Therefore when surrounding 
glucose levels increase G-S decrease their firing rates, while G-R neurons increase their 
firing rates whereas when glucose levels decrease the opposite occurs. The 
administration of leptin to dispersed hypothalamic neurons, brain slices and anaesthetised 
rats has been shown to excite G-R neurons in the ventromedial nucleus of the 




(Shiraishi et al. 1999; Davidowa et al. 2000; Shiraishi et al. 2000). This is not observed 
in the neurons of fa/fa rats indicating that Ob-Rb mediates these effects (Shiraishi et al. 
1999). 
Leptin has been shown to regulate intracellular Ca2+ concentrations in neurons in 
the arcuate nucleus and VMH. Changes in intracellular Ca2+ concentrations are a useful 
indicator of the activity of neurosecretory cells. Leptin can inhibit the increase in 
intracellular Ca2+ concentrations induced by low glucose in G-S neurons within the 
arcuate nucleus and lateral hypothalamus, whereas administration of leptin increases 
intracellular Ca2+ concentrations in the VMH (Funahashi et al. 1999). Further to this, in 
NPY neurons, decreases in intracellular Ca2+ concentrations are induced by leptin 
whereas similar to G-R VMH neurons, intracellular Ca2+ concentrations are increased in 
POMC neurons after leptin treatment (Muroya et al. 2004). This would support an 
inhibitory action of leptin on NPY neurons and a stimulatory action of leptin on POMC 
neurons and VMH neurons. 
It has also been demonstrated that leptin hyperpolarises a subset of G-R neurons 
via the activation of ATP-sensitive KATP channels in both the arcuate nucleus and the 
VMH (Spanswick et al. 1997). While a subpopulation of POMC neurons are glucose 
responsive and express KATP channels (Ibrahim et al. 2003), the subset of neurons 
demonstrating this leptin-induced hyperpolarisation are suggested to be NPY / AgRP 
containing neurons. Leptin inhibition of these neurons would lead to a decrease in 
transmitter release consistent with decreases in release of appetite stimulating factors 
(Harvey et al. 2003). Similar to leptin, insulin also hyperpolarises a subset of G-R 
neurons in the arcuate nucleus (Spanswick et al. 2000). Interestingly, both the actions of 
leptin and insulin on these neurons requires a fully functional leptin receptor, as these 
effects are not observed in neurons from obese Zucker rats (Spanswick et al. 1997; 
Spanswick et al. 2000). The similar effects of both leptin and insulin may represent a 
convergence in the pathways inducing satiety by these two hormones (Niswender et al. 
2003). 
The hyperpolarisation of G-R neurons in the VMH observed by Spanswick et al 
(1997), is not supported by the results of others indicating depolarisation of these neurons 







leptin administration has been shown to increase expression of c-fos in the VMH 
(Elmquist et al. 1997; Elmquist et al. 1998a) which suggests stimulatory activation by 
leptin rather than inhibition (Elias et al. 1999). Furthermore, the stimulation of VMH 
neurons by leptin is consistent with the classical satiety role of the VMH. The reasons 
for the conflicting reports regarding leptin activation of G-R neurons in the VMH are not 
clear, but have been suggested to be due to the differing concentrations (pharmacological 
vs. physiological) of leptin used (Shiraishi et al. 1999). 
The activation of PI3-K by leptin is suggested to mediate some of the acute 
membrane effects of leptin in hypothalamic neurons (Niswender et al. 2003). The 
phenotype of the neural-specific disrupted ST A T3 mouse indicates that no other pathway 
can compensate for this lack of signalling (Gao et al. 2004). The implication that the 
JAK/ST AT3 pathway is an absolute requirement for leptin function suggests that the role 
of other pathways are only supportive. One model that has-been developed to explain 
this suggests that in the hypothalamus acute membrane responses to leptin are mediated, 
at least in part, by PI3-K pathways but genomic functions are mediated by STAT3, and 
the genomic functions include STAT3-mediated transcription of key elements of other 
leptin-induced pathways (Niswender et al. 2003). 
The modulation of synaptic transmission by leptin may be involved in the 
mediation of short-term effects of leptin on feeding behaviour, that can be observed as 
early as one hour after the administration of leptin (Seeley et al. 1996). The regulation of 
gene transcription by leptin is likely to be involved in the mechanisms influencing long-
term regulation of body weight. 
Leptin Resistance 
The identification of leptin and its satiety action was a major step forward in 
terms of understanding appetite regulation. The dramatic changes in the leptin-deficient 
ob/ob mice after exogenous leptin treatment led to the prospect of leptin as an anti-





leptin in reducing body weight in healthy humans (Heymsfield et al. 1999; Hukshorn et 
al. 2000). In cases of extreme obesity in humans with genetic leptin deficiency, leptin 
treatment has dramatically reduced appetite and body weight, but this condition is very 
rare (Montague et al. 1997; Farooqi et al. 1999). In proportion to the increased fat mass, 
obese humans have higher leptin concentrations than non-obese humans (Caro et al. 
1996; Schwartz et al. 1996b). Obesity, therefore, appears to be associated with a 
resistance to the effects of leptin, and at present the mechanisms of this resistance are 
unknown. Potential sites for leptin resistance include impaired transport of leptin into the 
brain, and impaired leptin signal transduction in target neurons. 
There are a number of animal models that have been used to study the regulation 
of appetite, including genetically obese animals due to abnormalities in the leptin system. 
While these genetic models are useful tools to investigate leptin action, they are not so 
useful in investigating mechanisms of leptin resistance, as only very few cases of obesity 
in humans are due to deficiencies in either leptin (Montague et al. 1997) or the leptin 
receptor (Clement et al. 1998; Rolland et al. 1998). Currently there are a number of 
rodent models of leptin resistance that are used to investigate the mechanisms underlying 
leptin resistance. 
Diet-induced leptin resistance 
It is well documented that in many strains of rodents, continuous high fat diets 
will led to obesity. Within some strains (Sprague Dawley rats, F344XBN rats) there are 
two populations with regard to the development of diet-induced obesity. Some of the rats 
will develop diet-induced obesity when fed high fat diets while others will gain no more 
weight or body fat than normally fed controls indicating two substrains: diet-induced 
obese prone rats and diet-resistant rats (Levin et al. 1987; Levin et al. 1997; Levin et al. 
1998; Wilsey et al. 2003). Diet-induced obesity in rodents is associated with many 
similar characteristics as human obesity, such as insulin resistance, hyperinsulinemia and 
increases in free fatty acids and triglycerides (Frederich et al. 1995; Wickelgren 1998; 
Dhillon et al. 2001; Spiegelman et al. 2001). Also, similar to human obesity, diet-
induced obese rodents have increased plasma leptin concentrations in parallel with 





increased fat mass with no suppression of food intake suggesting a state of leptin 
resistance (Frederich et al. 1995; Maffei et al. 1995; Widdowson et al. 1997; Dhillon et 
al. 2001; Spiegelman et al. 2001). 
There are strain differences in response to exogenous leptin administration in diet-
induced obese rodent. Diet-induced obese Wistar rats, C57BL/6J mice and diet-induced 
obese prone Sprague Dawley rats do not respond to central leptin administration, 
therefore demonstrating a central leptin resistance (Widdowson et al. 1997; Lin et al. 
2000; Levin et al. 2002). Other models, such as diet-induced obese AKR/J mice and 
New Zealand obese mice respond to centrally, but not peripherally, administrated leptin 
(Halaas et al. 1997; Van Reek et al. 1997). These results suggest that genetic background 
may play an important role in the mechanisms underlying leptin resistance. 
Downregulation of leptin receptor expression in the hypothalamus has been 
investigated as a mechanisms for leptin resistance in diet-induced obesity, however there 
is conflicting evidence as to whether this is involved. Lin et al. (2000) found that after 8 
weeks of high fat diet, C57BL/6J mice have increased mRNA for Ob-Rb in the arcuate 
nucleus, but by 15 weeks Ob-Rb mRNA was decreased compared to mice that had been 
on the high fat diet for only 1 week (Lin et al. 2000). Others have not found any changes 
in mRNA for Ob-Rb in the hypothalamus of diet-induced obese mice or rats (El-
Haschimi et al. 2000; Madiehe et al. 2000; Peiser et al. 2000b; Sahu et al. 2002; 
Munzberg et al. 2004). Despite the lack of change in mRNA for Ob-Rb, proteins levels 
of Ob-Rb have been shown to decrease during diet-induced obesity, suggesting that there 
may be post-transcriptional changes in the leptin receptor during the state of leptin 
resistance (Madiehe et al. 2000). Furthermore, leptin resistance in diet-induced obese 
rats is associated with defective nutritional regulation of Ob-Rb mRNA expression in the 
hypothalamus; the fasting-induced increase in Ob-Rb mRNA is not observed in diet-
induced obese rats (Sahu et al. 2002). Therefore it may not be a simple downregulation 
of receptor but the impairment of the normal regulation of Ob-Rb in the hypothalamus 
that is involved in the mechanisms of leptin resistance. 
The lack of satiety response to leptin has been associated with a decreased in the 
ability of leptin to activate STAT3 signalling in the hypothalamus of diet-induced 





in leptin-responsive neurons (El-Haschimi et al 2000). It has been suggested that 
increases in inhibitors of leptin signal transduction pathways may be a potential 
mechanism for leptin resistance (Bjorbaek et al. 1999). In both rat and mouse models of 
diet-induced obesity, however, mRNA for SOCS-3 and protein inhibitor of activated 
STAT 3 (PIAS-3), both intracellular molecules that inhibit leptin-induced STAT3 
activation, are not up-regulated in the hypothalamus (El-Haschimi et al. 2000; Peiser et 
al. 2000b). When the areas of the hypothalamus are examined individually diet-induced 
C57BL/6J mice have a reduced number of leptin-induced pSTAT3 positive cells and an 
increase in SOCS3 mRNA specially in the arcuate nucleus compared to control mice 
suggesting that impaired signal transduction associated with leptin resistance is region 
specific (Munzberg et al. 2004). 
Age-induced leptin resistance 
The F-344XBN rat, a rodent model for late-onset obesity, is leptin resistant 
(Scarpace et al. 2000a). This rat strain exhibits steady increases in body fat into early 
senescence, followed by a decline (Li et al. 1997). These age-induced obese rats have 
increased serum leptin levels and a decreased response to both central and peripheral 
exogenous leptin administration (Shek et al. 2000; Scarpace et al. 2000a). Hypothalamic 
leptin-induced activation of STAT3 is reduced in age-induced obese rats, compared to 
young rats, and Ob-Rb protein levels are also reduced (Scarpace et al. 2001). Consistent 
with this decreased activation of leptin responsive neurons, is an impaired response of 
hypothalamic NPY and POMC mRNA levels to leptin in these aged rats (Scarpace et al. 
2000a; Scarpace et al. 2002b ). As well as reduced anorectic responses to leptin in old 
obese rats, the thermogenic response to leptin is blunted. The leptin-induced increase in 
oxygen consumption and increases in UCP-1 gene expression in BAT are reduced 
indicating suppression of leptin-induced energy expenditure (Shek et al. 2000; Scarpace 
et al. 2000a; Scarpace et al. 2000b; Scarpace et al. 2001). Old Wistar rats are also leptin 
resistant, and similar to aged F-344XBN rats, Ob-Rb protein levels are reduced in the 





Leptin-induced leptin resistance 
While it is generally accepted that leptin resistance is a feature of diet-induced 
and age-induced obesity, the cause of this insensitivity is unknown. One hypothesis is 
that the constant exposure of the brain to high leptin concentrations may result in 
decreasing sensitivity to leptin. Rodent models of chronic exposure to high leptin 
concentrations have been developed to investigate this hypothesis. The chronic infusion 
of exogenous leptin initially decreases food intake then after a period of approximately 
two weeks, this response becomes attenuated. The extent of this attenuation varies from 
a complete inhibition of the anorectic responses to leptin, to slight increases in food 
intake which are still reduced compared to control animals (Chen et al. 1996a; Halaas et 
al. 1997; Martin et al. 2000; Dhillon et al. 2001; Beretta et al. 2002; Sahu 2002; Scarpace 
et al. 2002a; Scarpace et al. 2002b ). The variation in the degree of insensitivity to leptin 
induced by chronic leptin infusion is likely due to a myriad of reasons including leptin 
dose, route of administration, and rodent strains. Work from Scarpace and colleagues 
using young, middle-aged mildly obese and old obese rats has demonstrated that central 
long-term leptin gene therapy results in leptin resistance in all cases, however the onset of 
leptin-induced leptin resistance is greatly accelerated by age and/or the initial level of 
obesity (Scarpace et al. 2002a; Scarpace et al. 2002b; Scarpace et al. 2003). The 
attenuation of leptin responses to chronically high leptin is also accelerated by high fat 
diets in the diet-resistant rats (Wilsey et al. 2003). 
Untreated rodents, pair fed to the leptin-treated rodents, have increased body 
weights suggesting that the pair fed rats have decreased energy expenditure to maintain 
body weight while the leptin-treated group have increased energy expenditure due to the 
high leptin concentrations (Sahu 2002). Scarpace et al (2002a) found that the 
thermogenic response to chronically high leptin concentrations in mildly obese rats 
becomes attenuated later than the anorexic responses to leptin. 
After the chronic infusion of leptin in aged rats (Scarpace et al. 2002b) and in 
young rats treated for two weeks (Pal et al. 2003), an insensitivity of NPY levels to 
response to leptin has been demonstrated. In contrast to this, after 6 weeks of high leptin 
concentrations in young rats, NPY mRNA expression was still decreased in response to 








leptin (Scarpace et al. 2002b). In chronic leptin infused rats which have reached a point 
where food intake is similar to controls, further administration of leptin does not reduce 
food intake, however administration of a melanocortin agonist does decrease food intake, 
suggesting that the insensitivity to leptin is at the level of the leptin responsive neurons 
(Scarpace et al. 2003). The responses to chronically high leptin concentrations are 
variable, depending on the strain, diet, and level of obesity of rodents. Furthermore 
leptin-induced leptin resistance has been shown to be accompanied by persistent 
activation of the JAK/STAT signalling pathway (Scarpace et al. 2002b; Pal et al. 2003). 
The mechanisms behind leptin resistance are yet to be determined but evidence 
would suggest that diet-induced and age-induced obesity are associated with decreased 
leptin sensitivity. Whether leptin resistance is a cause or consequence of obesity still 
remains to be determined, as does the role of leptin in the development of leptin 
resistance, although it would appear that long term high levels of leptin does result in 
decreased sensitivity to leptin. 
Pregnancy 
It is now established that the hormone leptin is central to the regulation of 
appetite, and is a key signal for neuroendocrine changes in response to starvation. Leptin 
resistance is a state that is associated with obesity and renders the body insensitive to the 
satiety actions of leptin. There are certain situations during life that require substantial 
increases in appetite and fat mass and during this time the regulation of appetite must 
adapt to the new conditions. Pregnancy is one such physiological state. 
It has long been accepted that there is a causal relationship between nutritional 
resources and fertility. When energy availability is low, activities required for survival 
such as basic cellular functions, are maintained at the expense of functions, such as 
reproduction, that are not essential for the short term survival of the individual. From an 
alternative perspective, considering the enormous metabolic requirements of pregnancy 
and lactation, a mechanism linking energy resources to reproductive ability is an 
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advantageous system. This ensures that resources are not wasted when reproductive 
efforts are unlikely to be successful due to inadequate energy stores. The energy 
demands of pregnancy and the subsequent period of lactation, however, far exceed the 
minimal energy reserves required to maintain fertility. Therefore during these phases of 
the reproductive cycle the regulation of appetite and metabolism in the maternal body is 
modified to support these increased energy demands. 
The maintenance of a successful pregnancy puts great demands on the resources 
of the mother. Changes to appetite and metabolism are a feature of pregnancy in all 
mammals. These adaptations are required to meet the demands of pregnancy, which are 
ensuring the growth and development of the fetus in utero including the deposition of 
energy stores of the fetus, and preparing the maternal body with adequate energy reserves 
for the subsequent period of lactation. While these demands are in competition for the 
available energy of the maternal body, for successful reproduction both of these 
requirements must be met. The pregnancy-induced changes in metabolism and appetite 
are also important to protect the maternal body and conceptus against the negative effects 
of possible periods of restricted energy intake during pregnancy and lactation. 
The early stages of pregnancy are associated with increased anabolic activity 
combined with increased food intake, leading to the accumulation of fat. Adipose tissue 
is an important metabolic organ, not only for its role as an energy storage facility but also 
for its role in the determination of circulating metabolic fuels. When energy intake 
exceeds energy requirements adipose tissue takes up glucose and free fatty acids from the 
blood stream and stores them as triglycerides within the adipocytes. When energy 
requirements exceed energy intake triglycerides are converted into glycerol and fatty 
acids by lipolysis, a process which is catalysed by enzymes called lipases. Adipose tissue 
has an almost unlimited capacity for energy storage and during early pregnancy there is a 
predominance of the lipogenic pathway resulting in the accumulation of energy stores in 
the form of adipose tissue. This anabolic action is driven, at least in part, by the 
increased insulin responsiveness of adipocytes during early pregnancy, leading to 
increase insulin-induced lipogenic and antilipolytic activity (Ramos et al. 2003). 
While the distribution of the increased fat mass has not clearly been defined, it 







1980; Naismith et al. 1982; Moore et al. 1984a; Moore et al. 1984b; Lopez-Luna et al. 
1991). However, increases are not uniform across the fat depots within the maternal 
body. For example, subcutaneous fat can account for the largest proportion of fat 
increase (Naismith et al. 1982). Increases in fat mass are due to increased cell size not 
due to an increase number of adipocytes (Flint et al. 1979; Moore et al. 1984b; Ramos et 
al. 2003). Body composition also undergoes dramatic changes in pregnant women, with 
increases in fat mass (Butte et al. 1997; Highman et al. 1998). This process of maternal 
energy storage has been described as facilitated anabolism (Freinkel 1980), and this 
anabolic phase predominates metabolic activities until the onset of rapid conceptus 
growth in the 2nd trimester. 
The maternal metabolism at later stages of pregnancy is characterised by a 
process of accelerated starvation, such that the increased maternal energy stores can be 
rapidly mobilised (Freinkel 1980). During pregnancy, the mother eats periodically but 
must continuously supply the fetus with nutrients for rapid growth. The idea of 
accelerated starvation means that between feeding periods, the maternal metabolism 
rapidly is induced into a state similar to starvation to maintain the availability of fuels for 
the growing conceptus. Changes in substrate metabolism are a key feature in the 
adaptation of the maternal body in regard to supplying the fetus with the fuels required 
for development. 
Glucose is one of the most important substrates crossing the placenta, supplying 
the fetus with nutrients for growth (Herrera et al. 1985; Lasuncion et al. 1987). The rate 
of gluconeogenesis is increased during pregnancy and the high rate of glycerol usage to 
synthesise glucose is a predominate feature in fasting pregnant rats (Herrera et al. 1969; 
Herrera 2000). While glucose production is increased during pregnancy, maternal 
hypoglycemia is characteristic of late pregnancy, and this is especially apparent during 
fasting (Bleicher et al. 1964; Herrera et al. 1969). Peripheral insulin resistance at this 
time reduces the glucose uptake into most maternal tissues, whereas glucose uptake of the 
placenta and fetal tissue is high (Ryan et al. 1985; Nolan et al. 1994). The maternal 
tissues utilise other fuels saving glucose for the fetus. In addition, the increased use of 
glycerol as a substrate for glucose allows amino acids, which are more commonly used 
for gluconeogenesis in the non-pregnant state, to be supplied to the fetus. 
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The break down of fat in the later stages of gestation plays a key role in both fetal 
development and maternal energy requirements. During late pregnancy there is increased 
lipolysis (Knopp et al. 1970; Chaves et al. 1980), which is evident in the decreased fat 
mass in the final stages of pregnancy (day 21 in the rat) compared to the previous days 
(Lopez-Luna et al. 1991). At these later stages, insulin resistance is involved in the lower 
antilipolytic and lipogenic activity in adipose tissue (Ramos et al. 2003) consistent with 
this progressive shift from anabolic to catabolic metabolism during pregnancy. The state 
of accelerated starvation involves the more rapid use of triglycerides for maternal energy 
conserving glucose for fetal energy demands between feeding periods. Maternal 
hypertriglyceridemia benefits the fetus and mother in a number of ways (Herrera 2000). 
Firstly, it allows for the rapid supply of a substrate for enhance ketone body synthesis in 
the liver in times of fasting during pregnancy (Scow et al. 1964; Herrera et al. 1969; 
Zorzano et al. 1986). In the fetus, ketone bodies can be used as both an oxidative fuel 
and as a lipogenic substrate by the fetal brain. Secondly, the increased triglycerides act 
as a supply of essential fatty acids for the fetus after processing in the placenta (Herrera 
2000). Thirdly, it allows for rapid break down to glycerol that is then used for glucose 
synthesis. Also, in the very late stages of pregnancy circulating triglycerides are involved 
in milk synthesis in preparation for lactation (Herrera et al. 1994). 
To deal with the increased energy demands, the maternal body needs to develop a 
state where energy balance becomes positive. Positive energy balance during pregnancy 
is mainly achieved by increased food intake. In the rat, food intake is increased by the 
second week of pregnancy (Cripps et al. 1975; Naismith et al. 1982; Shirley 1984; Sahu 
et al. 1988). The timing of this increase in food intake varies and has been shown to be 
significantly increased as early as day five of pregnancy (Terada et al. 1998). Food 
intake remains elevated throughout pregnancy until the day before parturition, when food 
intake is decreased (Shirley 1984). Following parturition, food intake steadily increases 
and remains high until the pups are weaned. Food intake can be increased by 300% 
compared to non-pregnant levels during lactation (Cripps et al. 1975). While the 
pregnancy-induced hyperphagia is not as pronounced as food intake during lactation, 
robust increases still occur, averaging approximately 20-40% more than non-pregnant 
[ " 
33 
levels. Humans increase food intake by approximately 10-15% during pregnancy and 20-
25% during lactation (Wade et al. 1992). 
Energy expenditure also undergoes modifications during pregnancy. In the rat, 
unlike the increased thermogenesis due to the hyperphagia associated with obesity, the 
hyperphagia of pregnancy does not result in increased thermogenesis (Abelenda et al. 
1987). Combined with a decrease in physical activity during pregnancy (Slonaker 1924), 
these features of pregnancy also aid in the development of a state of positive energy 
balance. Whether decreased physical activity is a specific adaptation of the maternal 
body or secondary to extra strain on the body due to the conceptus is unknown. In 
support of the former suggestion is the decrease in activity in animals with increased 
progesterone concentrations similar to pregnancy (Slonaker 1924; Brobeck et al. 1947). 
This suggests that decreased activity is due, at least in part, to changes in the hormonal 
environment during pregnancy. 
Increased fat stores and the hyperphagia required for this increased fat deposition 
are vital for a successful pregnancy outcome. Reduced food intake during pregnancy can 
result in smaller litter sizes and can extend the period of gestation in the rat (Woodside et 
al. 1987; Wade et al. 1992). Furthermore, decreased food consumption during pregnancy 
has a number of negative consequences for the offspring, such as increased susceptibility 
to obesity, type 2 diabetes and hypertension (Anguita et al. 1993; Vickers et al. 2000). 
The altered intrauterine environment due to malnutrition has been hypothesised to led to 
the development of metabolic adaptations in the fetus to survive in a substrate-limited 
environment which persists in to postnatal life (Barker 1995). The increased fat mass is 
also important to prepare for the higher energy demands of lactation. Indeed, fat mass 
accumulated during pregnancy is rapidly mobilised during lactation, but remains if 
lactation does not take place (Naismith et al. 1982). 
Pregnancy is associated with numerous changes in hormone secretion that are 
involved in the adaptation of the maternal body to the gestational conditions. Changes in 
appetite regulation and metabolism are thought to be induced by the changes in the 
hormonal environment that occur during pregnancy. Progesterone and placental lactogen 
increase during pregnancy and have been shown to be involved in changes to 









Aerts et al. 1980). Both of these hormones have orexigenic properties and hence, may be 
involved in pregnancy-induced hyperphagia (Hervey et al. 1967; Gerardo-Gettens et al. 
1989a; Gerardo-Gettens et al. 1989b; Sauve et al. 1996; Grattan 2001; Grueso et al. 
2001). 
Leptin during pregnancy 
As part of the gestational changes in the hormonal environment it is now well 
established that leptin concentrations are increased during pregnancy. This has been 
observed in rats (Kawai et al. 1997; Amico et al. 1998; Lopez-Soriano et al. 1998; Garcia 
et al. 2000; Seeber et al. 2002), mice (Gavrilova et al. 1997; Tomimatsu et al. 1997), bats 
(Widmaier et al. 1997; Kronfeld-Schor et al. 2001) sheep (Ehrhardt et al. 2001), baboon 
(Henson et al. 1999; O'Neil et al. 2001) and humans (Butte et al. 1997; Tomimatsu et al. 
1997; Sivan et al. 1998; Stock et al. 1999). 
The increased leptin concentrations do not correlate with the amount of adipose 
tissue, as has been demonstrated in pregnant rats, mice and humans (Butte et al. 1997; 
Gavrilova et al. 1997; Hardie et al. 1997; Kawai et al. 1997; Tomimatsu et al. 1997). The 
source of the increase in leptin concentrations above that which can be accounted for due 
to increased fat mass remains unknown. While it has been reported that the placenta 
produces increasingly high levels of leptin during gestation in the rat and mouse 
(Hoggard et al. 1997; Amico et al. 1998; Garcia et al. 2000), a number of studies in both 
rats and mice have detected only minimal levels of leptin mRNA in the placenta 
(Gavrilova et al. 1997; Kawai et al. 1997; Tomimatsu et al. 1997). Also, when it has 
been detected, expression levels of leptin mRNA are much lower in the placenta 
compared to expression levels in adipose tissue (Amico et al. 1998). Furthermore, in 
vitro, the mouse placenta has not demonstrated the ability to secrete any detectable levels 
of leptin (Kronfeld-Schor et al. 2000). In the rat, leptin mRNA levels in adipose tissue 
have been shown to increase during pregnancy, suggesting that higher leptin 
concentrations may be due to augmented leptin production and secretion from the 
increasing amounts of adipose tissue (Kawai et al. 1997; Garcia et al. 2000). 










thought to be due, in part, to increased amounts of leptin binding protein in mice 
(Gavrilova et al. 1997). In bats, placental leptin appears to account for a large proportion 
of the increased leptin concentrations (Kronfeld-Schor et al. 2001). Leptin mRNA has 
been consistently detected in human placenta, as has the protein (Green et al. 1995; 
Hassink et al. 1997; Masuzaki et al. 1997; Senaris et al. 1997). Expression levels of 
placental-derived leptin mRNA is not consistent however, and there are reports of both 
lower levels (Green et al. 1995) and higher levels (Hassink et al. 1997) compared to 
adipose tissue. The role of placental leptin and its possible functions during pregnancy 
remain unknown, but it does appear that the mechanisms behind the increased plasma 
leptin concentrations during pregnancy vary between species. 
Pregnancy and leptin resistance 
The increased food intake during pregnancy despite hyperleptinemia suggests a 
state of leptin resistance. This physiological state of leptin resistance would represent a 
desirable condition during pregnancy allowing for a positive energy balance to increase 
fat mass without any subsequent decrease in food intake. Previously it has been shown in 
mice that there are increased levels of leptin-binding protein during pregnancy (Gavrilova 
et al. 1997), and in rats, an increase in leptin interaction with binding proteins (Seeber et 
al. 2002), suggesting peripheral leptin resistance. There is also evidence that at the end of 
pregnancy, there is a central resistance to leptin (Johnstone et al. 2001). Hypothalamic 
leptin signal transduction has not been examined during pregnancy, and there are 
conflicting reports of pregnancy-induced changes in leptin receptor expression. Garcia et 
al (2000) found a decrease in mRNA for the long form of the receptor in the 
hypothalamus during pregnancy whereas others have demonstrated that mRNA levels 
and protein levels are not down regulated (Seeber et al. 2002; Rocha et al. 2003). Seeber 
et al (2002) found an initial increase in the receptor during early pregnancy, which then 
returned to non-pregnant levels, suggesting that this up-regulation was involved in a 
resetting of the sensitivity of the hypothalamus to leptin in the later stages of pregnancy. 
Similar to other situations involving leptin resistance the mechanisms behind this 




Leptin is primarily an adipose derived hormone that has a major role in the 
hypothalamic regulation of appetite. Leptin resistance is associated with high levels of 
leptin and an attenuation of the satiety action of leptin. Leptin resistance appears to be 
one of the adaptations that is seen during pregnancy to allow for increased energy stores 
in the form of adipose tissue, without the subsequent decrease in food intake. The 
general aims of this thesis were to confirm that pregnancy in the rat is a state of leptin 
resistance and to further investigate the potential mechanisms underlying this 
insensitivity to the satiety action of leptin during pregnancy. In particular I have focused 
on the leptin-induced activation of the JAK/STAT pathway in the hypothalamus as the 








Successful reproduction puts great demands on the resources of the mother. Not 
only does the maternal body supply all the nutritional requirements of the growing 
conceptus but the body must also prepare for the subsequent energy demands of lactation. 
During pregnancy the metabolic activities of the mother are modified to cope with the 
increasing demands placed on her body. 
It is well documented that during pregnancy food intake increases. In the rat this 
increase appears around the start of the second week of gestation and hyperphagia is 
maintained throughout the third and final week of gestation. However, the timing of this 
increase in food intake has not clearly been defined, with reports ranging from late in the 
first week of pregnancy to the end of the second week (Cripps et al. 1975; Naismith et al. 
1982; Moore et al. 1984b; Terada et al. 1998; Seeber et al. 2002; Rocha et al. 2003). 
Food intake increases by approximately 25% of the non-pregnant level and peak 
consumption occurs around day 18 or 19 of pregnancy (Shirley 1984; Moore et al. 
1984a). Whether or not rats give birth on day 21 or 22, food intake has consistently been 
observed to decrease on day 21 of pregnancy (Shirley 1984). 
The hyperphagia of pregnancy is associated with an accumulation of fat mass 
(Steingrimsdottir et al. 1980; Naismith et al. 1982; Moore et al. 1984b; Lopez-Luna et al. 
1991). Hence, food intake is increased above and beyond that required for growth of the 
conceptus. Similar to pregnancy-induced hyperphagia, the reported timing of the 
increase in fat mass varies considerably, mainly due to methods employed to measure 
these changes. Whether fat mass has been measured by dissection of fat pads or 
extraction of total fat content from carcasses, these methods are carried out after death 
therefore continuous monitoring throughout gestation is not possible. Despite this 





The feedback loop between fat mass and the regulation of appetite normally 
maintains body weight around a set point. Current body fat levels are relayed to the 
appetite controlling centres in the brain by the hormone leptin. In the long term, low 
leptin concentrations reflect low fat mass levels and result in increased appetite. 
Conversely, high leptin concentrations reflect high levels of body fat and subsequently 
decrease appetite. During pregnancy there is both increased fat mass and hyperphagia 
suggesting that this feedback loop is disrupted. Furthermore, in accordance with 
increased body fat levels, serum leptin concentrations are increased during pregnancy. 
There have a been a number of studies demonstrating increased leptin concentrations 
during pregnancy, with levels becoming significantly higher than the non-pregnant state 
from about midgestation (Kawai et al. 1997; Amico et al. 1998; Lopez-Soriano et al. 
1998; Garcia et al. 2000; Seeber et al. 2002). The hyperphagia observed during 
pregnancy despite elevated leptin concentrations, suggests a state of leptin resistance. 
Further evidence for a change in leptin sensitivity during pregnancy comes from ob/ob 
mice, which due to daily treatment of leptin are fertile (Chehab et al. 1996). In pregnant 
ob/ob mice, food intake increases from midgestation despite daily leptin treatment, 
consistent with the hypothesis that a state of leptin resistance develops during pregnancy 
(Mounzih et al. 1998). 
The satiety action of leptin can be assessed by measuring the feeding response 
following administration of exogenous leptin. A state of leptin resistance can be 
supported by a diminished hypophagic response to exogenous leptin, as has been 
demonstrated in age-induced and diet-induced obese rats (Halaas et al. 1997; Widdowson 
et al. 1997; Shek et al. 2000; Scarpace et al. 2000b). The aim of this study was to 
confirm that food intake, leptin concentrations and fat mass increase during pregnancy 
and, in particular, to define when the changes become apparent in our rats. Furthermore, 
the feeding response to i.e. v. leptin administration was measured to test the hypothesis 
that pregnancy is a state of hypothalamic leptin resistance. Higher endogenous leptin 
concentrations in the pregnant rats may prevent accurate interpretation of results when 
comparing the effects of exogenous leptin administration between pregnant and non-
pregnant rats. To overcome this, rats were fasted as this is known to rapidly reduce leptin 
concentrations in the non-pregnant state (Maffei et al. 1995). While fasting reduces 
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leptin concentrations in pregnant rats (Garcia et al. 2003), how these values compare to 
fasted non-pregnant rats has yet to be determined. To compare leptin concentrations 
during conditions similar to the leptin resistance testing procedure, changes in plasma 
leptin concentrations were measured during a period of fasting and refeeding in both non-
pregnant and pregnant rats. 
Methods 
Characterisation of leptin feedback loop during pregnancy 
Food intake measurements 
Animals were obtained from the colony at the University of Otago, and all 
protocols for experimental manipulation were approved by the University of Otago 
Animal Ethics Committee. Female Sprague Dawley rats were individually housed under 
a 14 hour light : 10 hour dark cycle and allowed access to water and food ad libitum. 
Temperature was maintained at 22 ± 1 °C. Food intake was measured daily by weighing 
food pellets; the weight difference from the previous day was deemed to be total food 
intake for the past 24 hour period. This measurement did not take into account any food 
that was spilled by the rat. Rats were weighed daily and vaginal smears were taken to 
monitor estrous cycles. Briefly, a moist cotton bud was inserted into the vagina and 
gently rotated. The cotton bud was then applied to a glass slide therefore transferring 
displaced epithelial cells. To this, 2 to 3 drops of 0.05% Toluidine Blue solution were 
applied for approximately one minute. Excess solution was removed and slides were 
observed under a light microscope at low magnification. The stages of the estrous cycle 
were determined by the characteristics of the observed epithelial cells. 
After three consecutive estrous cycles, on the morning of proestrus female rats 
were housed overnight with a male rat and mating was confirmed by the presence of 
sperm in vaginal smears the following morning. Food intake was not measured for the 
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night of mating but continued throughout pregnancy and lactation. Food intake was 
measured between the hours of 0800 and 1000, and was deemed to be the food intake 
measurement associated with the stage of the estrous cycle determined at the same time. 
Body weight and water intake was also measured daily. 
Fat mass measurements and serum collection 
Female rats were killed at five specific time points: diestrus, day 7, day 14, and 
day 21 of pregnancy and day 7 of lactation. Rats were decapitated between 0900 h and 
1100 h, and trunk blood was collected then allowed to clot overnight at 4°C. The 
following day serum was removed and stored at -20°C until further analysis. 
After collection of the serum, the abdominal cavity was exposed by cutting down 
the midline on the ventral surface starting directly inferior to the sternum. The abdominal 
walls were then reflected back. The uterus, including the ovaries, down to the cervix was 
removed, as was all white adipose tissue (WAT) that was attached to these structures. 
The attached WAT was then separated from the uterus and ovaries. This WAT was 
deemed to be the periuterine/ovarian fat pad. For all groups excluding the lactating rats, 
the ovaries were then removed and the uterus ( containing the conceptus in the cases of 
the pregnant groups) were weighed. Remaining WAT in the abdominal cavity was then 
dissected out and weighed. WAT surrounding the kidneys and lumbar area was weighed 
together and deemed to be the lumbar/retroperitoneal fat pad. WAT attached to the small 
and large intestine, and surrounding the pancreas and stomach was classified as the 
mesenteric fat pad. Total abdominal fat mass was the combined weight of the three fat 
pads. Once the fat had been removed from the body, it was placed on pre-weighed pieces 






Plasma leptin concentrations during fasting and refeeding 
Experimental design 
For serial blood collection from pregnant and non-pregnant rats, the right jugular 
vem was cannulated. Surgery took place on proestrus or day 11 of pregnancy. 
Collection of blood samples began at 1800 h the day following surgery (estrus or day 12 
of pregnancy) and 300 µl samples were collected every 4 hours for the following 72 
hours. The 72 hours of sampling was divided into three phases to determine leptin 
concentrations before, during and after fasting. During the first 24 hours, the rats had 
free access to food and water. At 1800 h on the second day of sampling, food was 
removed and rats underwent a 24 hour fast. During the fasting period rats had free access 
to water. Food was returned to rats for the final 24 hours of the sample period. Estrous 
cycles were monitored in non-pregnant rats to ensure normal cycling after surgery and 
fasting. 
Construction of cannula 
The cannula consisted of two pieces of silicone tubing, the main piece was a 15 
cm long piece of 0.025" x 0.047" tubing. This was threaded through a 3 mm long piece 
of 0.062" x 1.25" tubing thus creating a 'collar' on the long piece of tube. The collar was 
positioned exactly 28 mm from the end of the main piece of tubing and silicone sealant 
was used to secure the collar in this position. The position of the collar was precisely 
determined so that the short end of the cannula would be placed in the right atrium, 
therefore blood samples are taken directly from the systemic circulation. 
Surgical procedure 
Once anaesthetised with halothane gas, the rat was positioned ventral side up and the 
jugular vein was identified both visually through the skin and by finding the pulse. This 
area was then shaved and washed three times with hibitane. A 1.5 cm incision was made 








forceps to expose the vein. Before proceeding, the pectoralis and the sternocleidomastoid 
muscles were identified for reference points. Using a suture thread, a loose knot was tied 
around the vein. The short end of the cannula was attached to a bent needle purpose built 
for this procedure and the long end was attached to a syringe filled with 1 % heparinised 
saline. The needle was then threaded through the suture knot and into the vein lumen. In 
one fluid motion the needle was threaded along the inside the vein and pulled out through 
the pectoralis muscle so that the total distance covered was approximately 5 mm. This 
meant that the cannula was positioned so that the collar was adjacent to the opening in the 
vein lumen, and the short end of the cannula was exposed through the pectoralis muscle. 
The needle was removed from the short end of the cannula and then the cannula was 
flushed with heparinised saline. Following this, the cannula was pulled back out of the 
pectoralis muscle so that only the tip of the short end was in the vein lumen. The cannula 
was then advanced into the vein lumen until the collar was once more at the opening of 
the vein but the tip of the short end of the cannula was positioned in the right atrium of 
the heart. The correct functioning of the cannula was then ensured by the presence of 
blood in the tube once a vacuum had been created in the attached syringe. The cannula 
was flushed with heparinised saline and a knot was tied just superior to the collar of the 
cannula to secure it in place yet not so tight as to impede blood flow. 
The rat was then positioned dorsal side up and a hole was pierced in the skin at the 
back of the neck with a hollow 16-gauge needle. The needle was pushed through the 
connective tissue, just deep to the skin, to the site of the jugular vein, creating a 
subcutaneous tunnel between these two sites. Once the cannula was detached from the 
syringe and plugged with a 1 cm blunt metal plug, the long end of the cannula was 
threaded through the hollow needle to emerge at the dorsum of the neck. The needle was 
then removed and the incision at the site of the jugular vein was secured closed by the 
application of 3 or 4 wound clips. The cannula was trimmed so only approximately 4 cm 
of tubing was on the exterior, allowing it to be readily accessible to take blood samples 
but out of the reach of the rat. Finally the cannula was flushed once again with 
heparinised saline. After surgery, the cannula was flushed daily with heparinised saline 






Collection and processing of blood samples 
For the duration of the blood sampling procedure the rats remained in their cages and 
at the time of each sample an account of the behaviour and general appearance was 
recorded. Body weight was measured directly after each sample was taken. Food intake 
and water intake were also measured every day during the blood sampling procedure. 
When sampling took place during the dark phase a dim yellow light was used for 
illumination. 
Each rat was assigned a connecting tube, three 1 ml syringes and a 22-gauge needle. 
The connecting tube consisted of a 10 cm long piece of 0.025" x 0.047" silicone tubing 
with a 2.5 cm hollow metal tube inserted in one end and the other end attached to a blunt 
22-gauge needle. Prior to every sample the first syringe was filled with heparinised 
saline (SO U/ml) and the second was rinsed with heparin. Heparin was used to prevent 
the collected blood from clotting. The third syringe was filled with the red blood cells 
from the previous sample using the 22-gauge needle. The red blood cells were 
resuspended in approximately 200 µl of sterile saline and stored at 4 °C until the next 
sampling time. After each sample was collected, the equipment was washed in water and 
rinsed with saline. 
To collect each blood sample the following procedure was carried out. Once the 
plug was removed, the cannula was connected to the first syringe via the connecting tube. 
A vacuum was created in the syringe and blood was allowed to flow until it just entered 
the syringe. The first syringe was then detached from the blunt needle of the connecting 
tube and replaced by the second syringe. Approximately 300 µl of blood was collected in 
this heparinised syringe. The second syringe was removed from the blunt needle to 
which the third syringe was then attached. The suspension of red blood cells in sterile 
saline was slowly returned back into the blood circulation of the rat. The third syringe 
was then replaced with the first syringe and the connecting tube was flushed with the 
remaining heparinised saline to ensure all red blood cells were returned to the animal and 
the cannula filled with heparinised saline. Following this, the connecting tube was 







The collected blood samples were transferred to 0.5 ml microfuge tubes and 
centrifuged for approximately four minutes, separating the red blood cells from the 
plasma. Approximately 150 - 180 µl of plasma was removed from the microfuge tube 
and placed in another labeled 0.5 ml microfuge tube. These plasma samples were then 
stored at -20°C until required for further analysis. 
Feeding response to i.e. v leptin administration 
Experimental design 
The feeding response to intracerebroventricular (i.c.v.) leptin administration was 
determined in non-pregnant (diestrus), early pregnant (day 7) and mid-pregnant (day 14) 
rats. Cannulae (Plastics One, Roanoke, VA) were surgically implanted into the left 
lateral ventricle of the rats and surgery took place on diestrus for the non-pregnant rats, 
day 1 of pregnancy for the early pregnant rats, and day 7 for the mid-pregnant rats. 
Following surgery, rats were housed individually and food intake, water intake and 
weight gain were monitored daily. For the non-pregnant rats, only rats that showed two 
consecutive normal estrous cycles after surgery were used during this experiment. 
On day 6 or 13 of pregnancy, and on metestrus for the non-pregnant rats, food 
was removed from the cages one hour prior to the start of the dark phase. Food intake 
was measured for the 24 hours prior to the removal of food. Fasting was required for this 
experiment so that all groups had similar, low endogenous leptin concentrations at the 
time of injection. Half of the rats from each of the three time points were randomly 
selected to receive 4 µg of recombinant mouse leptin (obtained from Dr. A. R. Parlow, 
National Hormone and Pituitary Program, NIDDK, Torrance, CA, USA) diluted in 
artificial cerebrospinal fluid (CSF) at a concentration of 2 µglµl, while the remaining rats 
received vehicle (artificial CSF). After fasting for twenty four hours, rats received the 2 
µl injection of either leptin or vehicle into the left lateral ventricle. One hour post-
injection, directly before the start of the dark phase, pre-weighed food pellets were 
returned to the rats. The amount of food consumed 3 hours and 24 hours after the return 








Measuring food intake 
As the absolute level of food intake was the experimental variable, more accurate 
measurements were required then those used for routine monitoring. To this end, when 
food intake was measured, rats were housed on wire-bottomed cages. A plastic tray (10 
cm x 10 cm) was positioned under the wire floor, directly beneath the food hopper, to 
collect food spilled by the rat whilst eating the pellets. To determine food intake, the 
amount of pellets left in the hopper was weighed and this weight was subtracted from the 
original weight of pellets. Non-food items were removed from the plastic tray and the 
weight of the combined tray and spilled food was measured. Spillage was then 
determined by subtracting the weight of the empty tray from the weight of the tray with 
the food that was spilled. Food intake for a specific period of time was determined to be 
the change of weight in pellets during this time minus weight of spillage. Evaporation of 
moisture content of food was measured but deemed to be negligible ( < 0.05 g during a 24 
hour period). 
Surgical procedure 
Rats were anaesthetised with an intraperitoneal (i.p.) injection of a 1:4 mixture of 
2% xylazine hydrochloride (4 mg/kg) and ketamine hydrochloride (80 mg/ml). The head 
of rat was shaved and prepared for surgery by wiping three times with hibitane antiseptic 
solution. The head of the rat was then placed in a stereotaxic instrument for small 
animals. Ear bars were situated in the aural canals of the rat head so the head could only 
move in the sagittal plane about the interaural axis. The incisor bar was placed behind 
the upper incisors and the nose bar was then tightened to prevent further movement of the 
head in the sagittal plane. A surgical drape consisting of a piece of plastic large enough 
to cover the rat, with a small square removed to act as a window, was placed over the rat. 
The drape allowed access to the site of surgery via the window but assisted in 
maintaining the sterile field required during the operation. Using a scalpel a small 





The connective tissue and periosteum covering the top of the skull was cleared away 
using the scalpel blade followed by a sterile cotton bud. Three holes were drilled into the 
skull, each hole positioned in one of the four quadrants of the skull created by bregma. 
Bregma, an anatomical landmark, is deemed to be the interception of the sagittal suture 
with the coronal suture positioned on the crown of the skull. Screws were then placed in 
these three holes to anchor the cannula in position. Another hole was drilled in the exact 
position 1.3 mm lateral to the midline at bregma (0.0 anterior/posterior position). A 23-
gauge stainless steel guide cannula was positioned directly over this opening, level with 
the top of the skull, then inserted 3 mm below the level of the skull. The location for the 
placement of the cannula was determined using the rat brain atlas (Paxinos et al. 1997). 
Powdered dental cement was then placed on the skull, surrounding the screws and the 
cannula, to which acrylic liquid was then applied. Care was taken to ensure that the 
dental cement mixture was totally surrounding all the screws and cannula. Once the 
dental cement mixture hardened, the open end of the cannula was sealed with a plastic 
cap until the time of injection. Following surgery, rats were housed individually and food 
intake, water intake and body weight were monitored daily. 
Injection procedure 
For the 2-3 days before the injection took place, rats were handled and subjected to 
the injection procedure, without the insertion of the injection cannula, to familiarise the 
rats with the process. This meant that at the time of actual injection, rats were relatively 
unperturbed by the procedure and apparently stress free . 
The stainless steel injection cannula was connected to a 2 µl Hamilton syringe via 
a piece of silicon tubing (internal diameter 0.025" by 0.037") and loaded with 2 µ1 of the 
treatment solution. The injection cannula was designed to protrude 2 mm beyond the tip 
of the guide cannula. Once the plastic cap was removed, the injection cannula was 
inserted its full length into the guide cannula. The injection was carried out over a 20 
second period and the injection cannula was left in position for an additional 30 seconds. 





of the injected solution. Once the procedure was completed, rats were returned to their 
cage. 
Leptin Radioimmunoassay 
Concentrations of leptin in the serum and plasma samples collected during these 
experiments were determined by radioimmunoassay (RIA). The RIA requires a specific 
antiserum to the antigen of interest and a radioactive labelled form of the antigen (tracer) 
which can be quantified. The basic principle that is used in the RIA is the competition 
between tracer and unlabelled antigen for a limited and constant number of binding sites 
provided by the antibody. The distribution of the antigen between the bound (antigen-
antibody complex) and free phases is directly proportional to the amount of antigen 
present. When there is unlabelled antigen in the system, then the amount of tracer that 
binds to the antibody will correspond to the proportion of total antigen in the system that 
is labelled. When the unlabelled antigen concentration is low, greater amounts of tracer 
will be bound. Conversely, when unlabelled antigen concentration is high, lower amounts 
of tracer will be bound. The amount of bound tracer can then be measured, after the 
removal of free tracer, by counting the radioactivity. A standard curve is set up with 
increasing concentrations of standard unlabelled antigen and from this curve the amount 
of antigen in unknown samples can be calculated. 
The RIAs performed in this thesis used a commercially available rat leptin RIA 
kit (Linco Research, Inc, St Charles, MO). Reagents for a leptin RIA were also supplied 
by the National Institute of Health (U.S.A) and a number of standard curves were 
performed with the intent to determine conditions for a leptin RIA using these reagents 
for our laboratory. The results indicated that the antibody supplied, which was raised 
against mouse leptin, only had low affinity for rat leptin despite high sequence homology, 
meaning that these reagents were not suitable for detecting rat leptin concentrations. 
The Linco rat leptin RIA is a completely homologous assay as the antibody was 
raised against highly purified rat leptin, and the standards and tracer are prepared with rat 
leptin. The manufactor's procedure was followed, with the exception that only half 







shown to give satisfactory results. Standards and samples were incubated with the guinea 
pig anti-rat leptin antiserum overnight at room temperature. Tracer (1251-labelled rat 
leptin) was added to all tubes and left to incubate for a further 24 hours at room 
temperature. Cold precipitating reagent, including the secondary antibody (goat anti-
guinea pig IgG serum) was then added and incubated for 20 minutes at 4°C. After the 
separation of bound and free tracer by centrifugation, the radioactivity of the bound 
fraction was measured. Leptin concentrations of the samples were calculated by 
comparison with a standard curve of known leptin concentrations using the Assay Zap 
computer software (figure 2.1). All samples from chapter two and three were measured 
in one assay, and the intraassay coefficient of variation was 11.8%. 
Statistical analysis 
Statistical data were analysed by one-way ANOV A except for the sequential 
plasma samples, where leptin concentration data were assessed by repeated-measures 
ANOVA. Fisher's post hoc tests were applied where appropriate. The significance level 
for all statistics was set a P < 0.05. 
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Figure 2.1: Leptin standard curve from the RIA used to measure serum and plasma leptin 
conc'entrations. The x-axis shows the concentration of the standard and the y-axis shows 













Characterisation of leptin feedback loop during pregnancy 
Daily food intake 
Food intake levels across the estrous cycle displayed the well characterised 
pattern of significantly reduced food intake at the time of estrus (figure 2.2)(Tarttelin et 
al. 1971). During pregnancy food intake increased, and by day 11 of pregnancy food 
intake had significantly increased compared to the first day of pregnancy. Food intake 
was significantly greater compared to the day before mating from day 4 of pregnancy 
onwards (figure 2.2). Peak consumption was observed to be on days 18 and 19 of 
pregnancy. Food intake during lactation reached levels significantly greater than cycling 
and pregnant rats (figure 2.2). Food intake continued to increase during lactation until 
day 18, which was the last time point measured. At this stage, however, it is likely that 
the consumption of food pellets by the pups was also contributing to this measurement. 
Weight gain and fat mass 
In both the continuously monitored rats (experimental group 1) and the groups of 
rats killed at specific reproductive stages ( experimental group 2), body weight was 
significantly greater than diestrus or day O of pregnancy at both day 14 and day 21 of 
pregnancy (table 2.1 and 2.2). The initial body weight of rats in experimental group 2 
was smaller than experimental group 1 and this difference remained at every time point. 
Despite these differences in body weights, however, the same trends were observed in the 
two groups during pregnancy. Furthermore, from the second experimental group, 
conceptus-free maternal body weight was significantly increased from diestrous rats by 
day 14 and day 21 of pregnancy (table 2.2). There was no further increase in conceptus-
free maternal body weight between day 14 and 21 of pregnancy despite a significant 
increase in total body weight (table 2.2). This period of time was associated with rapid 
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weight gain of the conceptus. None of the pregnant groups were significantly older than 
the diestrous control group. 
Abdominal fat mass increased during pregnancy and by day 7 of lactation fat 
mass had decreased back to levels that were not significantly different to diestrous and 
early pregnant levels (figure 2.3A). By day 14 of pregnancy fat mass had increased to 
levels significantly greater than non-pregnant levels. On day 21 of pregnancy, there was 
almost twice as much adipose tissue present compared to diestrus. The same overall 
trend was observed when the three different fat pads were analysed separately, except 
that on day 7 of lactation, the lumbar/retroperitoneal fat mass was still significantly 
increased compared to diestrus (figure 2.4). 
Serum leptin concentrations 
Serum leptin concentrations were significantly increased by day 7 of pregnancy, 
but by day 21 of pregnancy leptin values had dropped back to non-pregnant levels (figure 
2.3B). During lactation leptin concentrations were significantly lower than non-pregnant 
leptin concentrations. In diestrous rats, abdominal fat mass and serum leptin 
concentrations were positively correlated (figure 2.3C). Pregnant fat mass values and 













Table 2.1: Body weight during pregnancy in continuously monitored rats 
(experimental group 1) 
52 
Expt group 1 DayO Day7 Day 14 Day21 Lactation 
(day 7) 
Body weight 287.7 ± 4.8a 301.5 ± 4.6a 337.3 ± 6.0b 442.8 ± 7.7c 341.1 ± 8.9b 
Values with different superscripts are significantly different (n=ll). 
Table 2.2: Weight data from different time points during pregnancy 
( experimental group 2) 
Expt group 2 Diestrus Day 7 Day 14 Day 21 Lactation 
(day 7) 
BW day O 260.9 ± 6.4 253.4 ± 3.4 253.0 ± 11.1 253.5 ± 6.8 269.4 ± 5.1 
BW death 260.9 ± 6.4a 275.3 ± 4.la 307.3 ± 10.2b 400.7 ± 12.9c 325.2 ± 5.lb 
uterus/conceptus 0.51 ± 0.02 0.74 ± 0.03 12.0 ± 0.76a 106.3 ± 4.5b 
C-free BW 
age (days) 
260.4 ± 6.3a 274.5 ± 4.la 295.3 ± 9.9b 294.4 ± 3.8b 
93.0 ± 5.1 90.9 ± 2.6 101.6 ± 7.8 104.7 ± 3.8 121.0 ± I.la 
Values (mean± sem) with different superscripts are significantly different (N=7-9). 
BW day O =bodyweight on day O of pregnancy, or day of death for diestrous rats. 
BW death = body weight on day of death. 
Uterus/conceptus = combined weight of uterus and conceptus on day of death. 
C-free BW = maternal body weight not including uterus and conceptus (if present). 

















o-~.~ ....... ""'""'~.--~.~..-.""'""'~.--~--~.--~.--~.---~.--~.--~.----,-,--~ ........ ~.----:-, ...... 
B 
E D E D E D 2 4 6 8 10 12 14 16 18 20 
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Figure 2.2: A Mean ± sem food intake during three estrous cycles (E = estrus, D = 
diestrus) in non-pregnant rats and the following 21 days of pregnancy after successful 
mating on the night of proestrus (n=ll). * significant with respect to non-pregnant values 
(P < 0.05). t significantly different to average food intake of other stages of the estrous 
cycle (P < 0.05). Dotted line indicates average food intake in the non-pregnant state. B 
Mean± sem food intake on proestrus (Pro), day 21 of pregnancy (preg), and days 1, 7, 
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Figure 2.3: Abdominal fat mass (A) and serum leptin concentrations (B) during pregnancy. 
Serum leptin concentrations (ng/ml) and total abdominal fat mass (g) were measured on 
diestrus, day 7 (D7), 14 (D14), and 21 (D21) of pregnancy, and day 7 of lactation (Lact) 
Values represent the mean ± sem (n=6-8). * significant with respect to non-pregnant 
values (P < 0.05). Scatter plot for serum leptin concentrations vs. fat mass during diestrus 
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Figure 2.4: Lumbar/retroperioneal (RP) (A), periuterine/ovarian (B) and mesenteric (C) 
fat pads during pregnancy. Fat mass (g) was measured on diestrus, day 7 (D7), 14 (D14), 
and 21 (D21) of pregnancy, and day 7 of lactation (Lact). Values represent the mean± 




Serial plasma leptin concentrations 
Changes in leptin concentrations for the 72 hours of blood sampling in the 
pregnant and non-pregnant rats are shown in figure 2.SA. In the 24 hours prior to fasting, 
both non-pregnant and pregnant rats displayed a nocturnal increase in plasma leptin 
concentrations. However, leptin concentrations remained significantly higher in pregnant 
rats compared to non-pregnant rats throughout the first 24 hours (figure 2.SA). Fasting 
significantly decreased plasma leptin concentrations in all rats compared to pre-fasting 
levels. Furthermore, there was no significant difference between pregnant and non-
pregnant leptin concentrations during fasting. Once food was returned, leptin 
concentrations increased in all rats but there was no evidence of a nocturnal increase in 
concentrations during the refeeding period. Leptin concentrations were not significantly 
different between groups until 24 hours after the end of the fasting period, at which point 
the leptin concentrations in pregnant rats were once again significantly greater than non-
pregnant rats. 
Feeding response to i.e. v. leptin administration 
To determine whether pregnant rats are resistant to the satiety action of leptin, 
food intake was measured following i.c.v. administration of leptin to food-deprived non-
pregnant and pregnant rats (Figure 2.SB). Injections were timed such that they were 
administered one hour before the end of fasting, when endogenous leptin concentrations 
were still very low (see figure 2.SA). During the 24 hours prior to fasting, mid-pregnant 
rats had significantly higher food intake levels compared to the non-pregnant rats. Food 
intake for the early pregnant rats, however, was not significantly different to the non-
pregnant group. In non-pregnant rats, leptin treatment resulted in a significant reduction 
in food intake compared to vehicle-treated non-pregnant rats after 3 and 24 hours. 
Similarly, in early pregnant rats, leptin treatment also resulted in significantly decreased 
food intake compared to the vehicle-treated early pregnant rats. In the mid-pregnant rats, 
however, there was no difference in food intake between the leptin-treated and vehicle-





There was a significant increase between pre- and post-fasting food intake levels 
in the vehicle-treated non-pregnant rats. On day 14 of pregnancy, the leptin- and vehicle-
treated rats consumed similar amounts of food during the days before and after the 24 
hour period of fasting. In the vehicle-treated early pregnant rats there was a trend for 
increased food intake after fasting, but this was not significant. Hence, pregnant rats at 
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Figure 2.5: A Plasma leptin concentrations for 72 hours, including a 24 hour fasting 
period, in non-pregnant (n=6) and mid pregnant (n=5) rats. Dark period of the light 
cycle indicated by black bars on x-axis. Values represent the mean± sem. * significant 
with respect to non-pregnant leptin concentration at the same time point. t significant 
with respect to prefasting leptin concentrations for each physiological group (P < 0.05). 
B Food intake for the 24 hours before fasting and cumulative food intake for the 3 and 
24 hours after leptin or vehicle i.e. v. administration. Values represent the mean ± sem. 
Although conditions were the same for rats before fasting, 24 hour prefasting food intake 
bars are split to show food intake for the different treatment groups. Experiment was 
carried out over days 6-8 for early pregnant rats, and days 13-15 for mid pregnant rats, 
and injections were recieved just prior to the dark phase on day 7 for early pregnant rats 
and day 14 for mid pregnant rats. * significant with respect to prefasted 24 hour food 
intake in vehicle-treated non-pregnant group. t significant with respect to vehicle-treated 
group of same physiological gstate (P < 0.05) 
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Discussion 
Pregnancy led to the expected increases in food intake, adipose tissue and serum 
leptin concentrations, similar to previous observations (Cripps et al. 1975; Naismith et al. 
1982; Kawai et al. 1997; Garcia et al. 2000; Seeber et al. 2002). Increased food intake in 
the presence of elevated leptin concentrations suggests a state of leptin resistance during 
pregnancy. To directly test this hypothesis the feeding response to exogenous leptin was 
measured in pregnant rats. Following central administration of exogenous leptin, the 
satiety action of leptin was not observed in mid-pregnant rats whereas a marked decrease 
in food intake was observed in non-pregnant rats and early pregnant rats. Furthermore, 
the pregnant rats did not display a compensatory hyperphagic response to food 
deprivation. These results demonstrate that day 14 pregnant rats are resistant to the 
satiety actions of leptin in the hypothalamus. A state of leptin resistance would be 
advantageous during pregnancy to allow the increase in food intake required to ensure 
energy demands of the growing conceptus are met and to prepare for the subsequent 
energy demands of lactation. 
In agreement with our result, it has been shown that during late pregnancy (day 17 
onwards) daily i.c.v. infusion of leptin for six days does not decrease food intake until the 
day after parturition (Johnstone et al. 2001). Day 14 of pregnancy was used in the 
present study, as at this time food intake, fat mass and leptin concentrations were all 
significantly increased compared to non-pregnant values. The earlier time point of day 7 
of pregnancy was also used, because our initial results indicated that food intake and 
leptin concentrations were significantly increased at this time compared to non-pregnant 
values. This suggested that a state of leptin resistance was present in the early stages of 
pregnancy. When the early pregnant rats were used in a separate experiment to measure 
the feeding response after leptin administration, however, food intake was not increased 
compared to the non-pregnant rats during the 24 hours before fasting. This discrepancy 
is also reflected in the literature, where previous studies report a wide range of time 
points during pregnancy at which food intake becomes significantly increased compared 




al. 1984a; Moore et al. 1984b; Seeber et al. 2002; Rocha et al. 2003). It is possible that 
the surgical intervention required in this experiment delayed the progression of food 
intake increases, such that it was not yet significantly different from non-pregnant 
controls when examined in the early pregnant rats. The procedure for collection of the 
food intake measurements in our initial results, where food spillage was not taken into 
account, may also contribute to this difference. 
In contrast to results obtained in rats, i.c.v. leptin administration to mice decreases 
food intake during all stages of pregnancy (Mistry et al. 2002). Mice have increased 
levels of leptin binding proteins in the blood during pregnancy suggesting that leptin 
resistance in mice may be due to increased interaction with binding proteins rather than a 
central insensitivity to leptin (Gavrilova et al. 1997). Although no increase in binding 
proteins have been detected in the rat (Gavrilova et al. 1997), an increase in plasma leptin 
binding activity has been reported from midgestation onwards (Seeber et al. 2002). Due 
to the delivery method, our results demonstrate a central resistance to leptin but do not 
rule out the possibility that peripheral sites may also contribute to the state of leptin 
resistance during mid-pregnancy. Furthermore, while the early pregnant rats did not 
display a central resistance to leptin, these results do not rule out the possibility that there 
is peripheral leptin resistance at this time. This seems unlikely, however, as increases in 
binding activity have not be detected in the early stages of pregnancy (Seeber et al. 
2002). In other models of leptin resistance, such as diet-induced obese mice and age-
related obese rats, defects in both the ability of leptin to enter the brain, and leptin signal 
transduction in the hypothalamus appear to contribute to leptin resistance (EI-Haschimi et 
al. 2000; Shek et al. 2000; Scarpace et al. 2001). The absence of any difference in food 
intake between leptin- and vehicle-treated rats by day 14 of pregnancy in this study, 
however, indicate that this insensitivity to leptin at the central level is more than adequate 
to suppress the satiety actions of leptin during pregnancy. Nevertheless, redundancy in 
this system would not be unexpected as maternal malnutrition during pregnancy has a 
number of negative consequences for the offspring, such as increased susceptibility to 
obesity, type 2 diabetes and hypertension (Anguita et al. 1993; Vickers et al. 2000). 
The early pregnant rats demonstrated a similar hypophagic response to leptin as 






day 14 of pregnancy develops between days 7 and 14 of pregnancy. This state of leptin 
resistance appears to develop after the significant increase in food intake suggesting that 
leptin resistance may not be the primary cause of pregnancy-induced hyperphagia. In this 
study, the leptin dose used is a maximal dose to reduce food intake and induce STAT3 
phosphorylation (Mccowen et al. 1998; Scarpace et al. 2001). Therefore an alternative 
interpretation is that the day 7 pregnant rats may be in the early stages of the developing 
state of central leptin resistance and the maximal dose used in this study was able to 
overcome the reduced sensitivity to leptin. Supporting this hypothesis is the increased 
leptin concentrations on day 7 of pregnancy while food intake remains the same as non-
pregnant rats, suggesting reduced sensitivity at this time. One hypothesis is that leptin 
sensitivity progressively decreases until a state of total leptin insensitivity is reached. 
Therefore, decreasing leptin sensitivity may, in part, account for the increase in food 
intake during pregnancy. The role of leptin resistance in the generation of pregnancy-
induced hyperphagia, whether facilitative or causative, is yet to be determined. 
Examining leptin sensitivity by measuring the response to lower doses of leptin may 
provide useful information in the future to elucidate the relationship between these two 
features of pregnancy. 
While it is established that food intake, fat mass and, more recently, leptin 
concentrations are increased during pregnancy, due to the variation in previous literature, 
it was also vital to clearly define when these changes take place in our pregnant animals. 
Hyperphagia is an accepted adaptation to pregnancy, however there is no general 
consensus as to what time during pregnancy food intake becomes significantly increased 
compared to non-pregnant levels and a wide range of time points have previously been 
reported. The general time frame appears to be from late in the first week of pregnancy 
to the end of the second week (Cripps et al. 1975; Naismith et al. 1982; Moore et al. 
1984b; Terada et al. 1998; Seeber et al. 2002; Rocha et al. 2003). There are many 
possible reasons for the variation between results, including different rat strains, the 
methods employed to measure food intake and control values used for comparisons. One 
major problem in comparing results is that previous reports have used the average food 
intake of a specific group of days during pregnancy (Naismith et al. 1982; Seeber et al. 




pregnancy (Cripps et al. 1975; Rocha et al. 2003). These methods limit the ability to 
determine specific time points when food intake is increased, however in the present 
study, food intake was measured daily throughout pregnancy so the exact timing of the 
increase could be determined. 
Pregnant food intake levels were compared to those observed in the three estrous 
cycles directly prior to pregnancy. It is possible that if another group of control age-
matched animals were used for comparison then a significance may not be apparent until 
slightly later in pregnancy similar to other reports (Rocha et al. 2003). While food intake 
can gradually increase with age in rats no significant increase in food intake was 
observed over the course of the three estrous cycles indicating that the increase during 
pregnancy is not due to age. It was decided that using the same rats for the non-pregnant 
and pregnant food intake levels would avoid between animal variation and be more 
accurate to determine pregnancy-induced changes in food consumption levels. 
Furthermore, Terada et al (1998), who specifically used aged-matched non-pregnant rats, 
found that food intake was increased at their first time point, day 5 of pregnancy, similar 
to our results. 
For this measurement the amount of food that each rat spilled while feeding was 
not taken into account. Food intake was determined by weighing food in the hopper each 
morning and subtracting this value from the value from the previous day, so any food that 
was spilled was included in this measurement. Therefore one assumption with this 
method is that the rats are consistent in the percentage of food they spill. Despite this, 
these methods were sensitive enough to measure the estrogen-induced decrease in food 
intake on the night of proestrus. As we were initially only interested in the relative 
increase in food intake induced by pregnancy, this method was deemed to be sufficient. 
Our results indicate that serum leptin concentrations are increased in both early 
(day 7) and mid (day 14) pregnant rats, but were low on day 21 of pregnancy, the day 
before parturition. Previous studies with more frequent sampling at the end of pregnancy 
have shown that leptin concentrations in fact remain high throughout pregnancy and this 
decrease only occurs the day before parturition (Kawai et al. 1997; Amico et al. 1998; 
Lopez-Soriano et al. 1998; Garcia et al. 2000; Seeber et al. 2002). We found leptin 





point during pregnancy, day 7, similar to others who have used this time point (Ramos et 
al. 2003) but not all (Seeber et al. 2002). Similar to the increase in food intake, the 
timing of the significant increase in leptin concentrations during pregnancy is not fully 
determined, with reports ranging from day seven to day 18 of pregnancy (Chien et al. 
1997; Kawai et al. 1997; Amico et al. 1998; Lopez-Soriano et al. 1998; Garcia et al. 
2000; Seeber et al. 2002; Ramos et al. 2003). Most of these inconsistencies can be 
attributed to a lack of time points examined during the early stages of pregnancy. In 
general, leptin concentrations increase until approximately the middle of pregnancy and 
then remain elevated until the day before parturition (Chien et al. 1997; Kawai et al. 
1997; Amico et al. 1998; Lopez-Soriano et al. 1998; Garcia et al. 2000; Seeber et al. 
2002; Ramos et al. 2003). The results from this study are similar to many other reports 
indicating that in the rat, pregnancy induces a 2-fold increase in leptin concentrations 
(Chien et al. 1997; Kawai et al. 1997; Seeber et al. 2002; Rocha et al. 2003). It must also 
be noted that Terada et al. (1998) observed that leptin concentrations did not increase 
during pregnancy, attributing this difference to using aged matched non-pregnant control 
rats. The diestrous rats in the present study, however, did not significantly differ in age 
from any of our pregnant groups and significant increases in leptin concentrations were 
observed during pregnancy. 
Similar to non-pregnant rats, leptin concentrations during pregnancy displayed a 
nocturnal increase. Both light and dark phase leptin concentrations in pregnant rats were 
increased compared to non-pregnant rats. Previously it has been reported that during the 
dark phase, there was no difference between leptin concentrations in pregnant and non-
pregnant rats (Johnstone et al. 2001). The reasons for this inconsistency between studies 
is unknown. Fasting induced significant decreases in plasma leptin concentrations in the 
mid-pregnant rats as well as in the non-pregnant rats. This suggests that any placental 
production and secretion of leptin must be regulated in the same manner as that from 
adipose tissue. Measuring leptin mRNA in the placenta before and after fasting would 
demonstrate whether placental production is suppressed by fasting similar to adipose 
tissue. Alternatively this observation is consistent with the hypothesis that the placenta 





Body weights increased during pregnancy. As a measure, total body weight does 
not reveal any information about body composition and can be variable depending on 
such factors as gut content. Body weight can be easily measured daily in each rat, 
however, whereas it is not possible to measure body composition and fetal growth on a 
daily basis. Fat mass and conceptus growth were measured at three time points during 
pregnancy in a second experimental group of rats. These data combined with the daily 
body weight gain data are useful in revealing some of the changes that occur in the 
maternal body during pregnancy. The day 14 pregnant rats had greater conceptus-free 
body weights compared to the body weight of non-pregnant rats indicating increased 
mass of the maternal body. The day 21 pregnant rats had similar conceptus-free body 
weights indicating that while the conceptus increased 8-fold, maternal body weight did 
not change between these time points. Some of this gain in conceptus-free body weight 
can be attributed to increased fat mass, as total abdominal fat mass was increased on both 
day 14 and 21 of pregnancy. As well as fat mass and fetal growth, other major factors 
contributing to this increased body weight are the increased blood volume during 
pregnancy, and the development of the mammary glands. Also some organs, such as the 
liver, increase in weight during pregnancy, although this is not true for all organs, and 
some, such as the gastrointestinal tract remains unchanged in terms of weight during 
pregnancy (Cripps et al. 1975). 
Interestingly, both the early and mid-pregnant rats did not have a compensatory 
hyperphagic response when food was returned after 24 hours of food deprivation, 
although the vehicle-treated day 7 pregnant rats did tend to eat more after fasting this was 
not significant. As the day 7 pregnant rats were responsive to exogenous leptin but did 
not significantly increase food intake when refeeding these results also supports a 
transitional stage, where the animals are not leptin resistant but have decreased sensitivity 
to leptin compared to non-pregnant rats. Little is known about the exact causes of the 
fasting-induced hyperphagic response observed in the vehicle-treated non-pregnant rats. 
The administration of exogenous leptin to fasted animals can prevent the compensatory 
hyperphagic response (Seeley et al. 1996). Furthermore, when endogenous leptin 
concentrations do not decrease in response to fasting, such as in the cortiotropin-releasing 






(Jeong et al. 2004). Reduced leptin signalling, it would appear, is involved in the 
generation of hyperphagia in response to fasting. 
The anorectic affects of leptin are thought to involve neural circuits that connect 
the leptin-responsive neurons in the arcuate nucleus with caudal brainstem neurons in the 
nucleus tractus solitarius (NTS) (Schwartz et al. 2000; Woods et al. 2000; Baskin et al. 
2001). Neurons in the NTS respond to peripheral satiety signals, such as cholecystokinin 
(CCK) and gastric distension, which are generated by the presence of food in the 
gastrointestinal tract and cause feeding to stop, thereby limiting the. amount of food 
consumed during individual meals. Hyperphagia in animal models of leptin deficiency 
are associated with increased meal size (Becker et al. 1977; McLaughlin et al. 1981; Ho 
et al. 1988) and leptin reduces food intake by selectively decreasing meal size (Eckel ~t 
al. 1998; Flynn et al. 1998; Kahler et al. 1998). The anorectic effects of leptin are, at 
least in part, due to modulation of the sensitivity of the brainstem to CCK. 
Administration of leptin combined with CCK enhances the actions of CCK (Emond et al. 
1999) while hypoleptinemia due to fasting impairs the satiety response to exogenous 
CCK (McMinn et al. 2000). Furthermore, blocking CCK receptors prevents the 
hypophagic response to exogenous central leptin administration implying that CCK 
activity is required for the satiety actions of leptin (Buyse et al. 2001). 
The importance of the connections between the hypothalamus and brainstem in 
the long-term regulation of food intake have been observed using the decerebrate rat 
model. Decerebrate rats have a complete transection of the neuraxis at the 
mesodiencephalic junction (Grill et al. 2002). While these rats respond to CCK, 
decreased gastrointestinal stimulation and variations in taste similar to control rats, the 
decerebrate rat does not response to food deprivation by increasing food intake (Adolph 
1947; Grill et al. 1988; Grill et al. 1992; Kaplan et al. 1993; Seeley et al. 1994). Thus, 
the caudal brainstem can integrate stimuli that effect short term food intake, but long term 
maintenance, such as responding to food deprivation, requires the interactions between 
the hypothalamus and caudal brainstem nuclei (Grill et al. 2001). Indeed, fasting-induced 
reduction in leptin activation of descending pathways from the hypothalamus has been 





important factor in the hyperphagia associated with reduced leptin signalling during 
fasting (McMinn et al. 2000). 
Increased food intake during pregnancy is associated with longer meal duration, 
reflective of increased meal size, with no increase in meal frequency (Strubbe et al. 
1980). Both pregnant and fasting rats are similar in terms of their decreased leptin 
signalling, due to leptin resistance and hypoleptinemia respectively, and it is likely then 
that similar to fasted rats (McMinn et al. 2000), sensitivity to CCK is reduced during 
pregnancy resulting in the increased meal size observed at this time (Strubbe et al. 1980). 
Therefore, the leptin resistance state during pregnancy will mean that even after 
exogenous leptin administration CCK sensitivity will not be increased and this may 
contribute to the absence of a hypophagic response in the pregnant rats. Furthermore, in 
the vehicle-treated non-pregnant rats, the decrease in leptin-induced CCK sensitivity has 
been demonstrated to be involved in the compensatory hyperphagia associated with 
fasting (McMinn et al. 2000). It is tempting to speculate that the leptin resistance 
conveys a constant starvation signal to the maternal brain, leading to a hypothesised 
permanent state of compensatory hyperphagia through mechanisms, at least partly, 
involving reduced sensitivity to CCK. In support of this, vehicle-treated non-pregnant 
rats had similar food intake levels to both mid-pregnant treatment groups suggesting that 
increases in food consumption due to reduced leptin signalling can account for similar 
hyperphagic levels observed in pregnancy. 
In conclusion, our results indicate that by day 14 of pregnancy, i.c.v. leptin 
administration is unable to suppress food intake as it does in non-pregnant rats, thus 
supporting the hypothesis that a state of leptin resistance develops during pregnancy. Our 
method of leptin delivery indicates that there is a central site of leptin resistance. The 




Chapter three: Leptin-induced phosphorylation of 
STAT3 in the hypothalamus during pregnancy 
Introduction 
67 
The activation of the JAK/STAT pathway in leptin responsive neurons in the 
hypothalamus is essential for the regulation of appetite by leptin. This is illustrated by 
the sis mouse that lacks the Y1138 phosphorylation site on Ob-Rb rendering the leptin 
receptor unable to activate ST AT3 molecules. Consequently, appetite regulation is 
disrupted in these mice, leading to obesity (Bates et al. 2003). Neuron-specific STAT3 
deficient mice display the same phenotype as the ob/ob mouse, illustrating the vital role 
of this signalling molecule in the actions of leptin (Gao et al. 2004). 
In the previous chapter, i.c.v. leptin administration did not suppress food intake in 
mid-pregnant rats demonstrating a central leptin resistance. Impaired signalling of the 
JAK/ST AT3 pathway in hypothalamic leptin-target neurons may be involved in the loss 
of satiety action of leptin during pregnancy. This hypothesis is supported by the 
observation of impaired activation of STAT3 signalling in a number of other leptin 
resistant animal models. In age-related obese rats maximum leptin-induced 
phosphorylation of STAT3 is less than that of young rats, and the leptin-induced increase 
in pSTAT3 transcription factor binding is impaired in the old rats (Scarpace et al. 2001). 
In diet-induced obese mice, there is reduced STAT3 transcription activity in response to 
leptin compared to control mice (El-Haschimi et al. 2000). The activation of STAT3 by 
leptin has not been investigated during pregnancy.- The aim of this study was to examine 
hypothalamic STAT3 activation in response to leptin during the state of leptin resistance 
observed on day 14 of pregnancy. The phosphorylation of STAT3 was used as a measure 
of the activation of the JAK/STAT signalling pathway, as it a vital step in this process 
(McCowen et al. 1998). Western blot analysis was used to determine relative levels of 
ST A T3 and phosphorylated ST AT3 after leptin treatment in microdissected areas of the 
hypothalamus. Immunohistochemistry was also used to visualise the location of the 







For this study, groups of non-pregnant (diestrous) and day 14 pregnant rats were 
used and i.c.v. cannulae were surgically implanted as previously described in chapter 
two. Surgery took place on diestrus for the non-pregnant rats, and day 7 for the pregnant 
rats. Estrous cycles were monitored after surgery in the non-pregnant rats and only rats 
with two consecutive regular cycles were used. Experimental procedures were carried 
out at the end of the second estrous cycle. After surgery, rats were individually caged, 
and water intake and body weight were monitored. Food intake was monitored for the 
two days before the experimental procedure to ensure normal food intake after surgery. 
On day 13 of pregnancy, and on metestrus for the non-pregnant rats, food was 
removed from the cages one hour prior to the start of the dark phase. After a fasting 
period of approximately 16 hours rats received an i.c.v. injection of either 4 µg leptin 
diluted in aCSF (2 µglµl) or vehicle (aCSF without leptin) as previously described 
(chapter two). The maximal activation of leptin-induced STAT3 in the hypothalamus has 
been shown to occur approximately 30 minutes after i.c.v. leptin administration 
(McCowen et al. 1998; Hubschle et al. 2001). A preliminary experiment examining the 
peak time of leptin-induced STAT3 phosphorylation was undertaken to confirmed this in 
the individual hypothalamic areas. At various time points after leptin administration (0, 
15, 30, 45 or 60 minutes) non-pregnant rats were killed and samples were processed for 
western blot analysis. Following these results, all experimental rats were killed thirty 
minutes after injection. Serum blood samples were also collected at this time and leptin 
concentrations were measured by RIA, as previously described in chapter two. 
Antibodies 
The phospho-STAT3 (pSTAT3) antibody (#9131 Cell Signaling Technology, 
Inc., Beverly, MA) was used in both the western blot immuno-detection and the 




tyrosine 705, the site that induces dimerisation, nuclear translocation and DNA binding of 
this protein (Darnell et al. 1994). The pSTAT3 antibody was a rabbit polyconal antibody 
raised against a synthetic phosphopeptide corresponding to residues around Y705 of 
mouse STAT3. The total STAT3 specific antibody used was a rabbit polyclonal antibody 
(Santa Cruz Biotechnology, Santa Cruz, CA c-20 sc-482) raised against a peptide 
mapping to the carboxy terminus of mouse STAT3. This antibody detects all STAT3 
irrespective of phosphorylation state. A monoclonal STAT3 antibody (Zymed 
Laboratories Inc. San Francisco CA 13-7000) was also used. 
Western blot Analysis 
Western blotting ( or immunoblotting) is commonly used to identify specific 
proteins in a tissue sample. The protein samples are solubilised with sodium 
dodecylsulfate (SDS) and reducing agents, and then separated by SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE). The denatured polypeptides bind SDS in proportion to 
their molecule weight and become negatively charged. These complexes then migrate 
through a polyacrylamide gel in accordance with the size of the polypeptide. The 
separated proteins in the gel can then be transferred to the surface of a thin support 
membrane matrix, such as nitrocellulose, when a voltage gradient is created 
perpendicular to the gel. Negatively charged molecules will migrate out from the gel, 
move towards the positive electrode, and become bound to the surface of the membrane. 
This membrane can then be probed with antibodies to detect the proteins of interest. All 
solutions for the western blot procedure were made with Milli Q water. 
Microdissection 
Thirty minutes after treatment with leptin or vehicle, rats were decapitated and 
brains were rapidly removed from the skull, then trimmed with a razor blade to discard 
parts that were surplus to these studies. Cuts in the coronal plane were made midway 









surrounding tissue. Brains were then frozen on dry ice, wrapped in aluminum foil, sealed 
in an air-tight plastic bag to prevent desiccation, and stored at -80°C until 
microdissection. 
Coronal sections, 300 µm thick, were collected through the hypothalamus in a 
cyrostat at -9°C then thaw-mounted onto glass slides and refrozen. Microdissection of 
these sections was carried out using a dissecting microscope, a frozen aluminum stage to 
maintain the temperature of the slides, and sterile blunted micropunch needles. Slides 
were placed on the frozen stage and discrete areas of the hypothalamus were 
microdissected using a punch technique (Palkovits et al. 1988). Five hypothalamic areas 
were punched from these sections using a 500 µm diameter micropunch needle (see 
figure 3.1 & table 3.1). Separate, sterile needles were used to microdissect each area, to 
eliminate the possibility of contamination by tissue carry-over. Tissue was placed in 45 
µl of 62.5 mM Tris, pH 6.8, containing 0.1 % SDS and Complete protease inhibitor 
(Roche Diagnostics GmbH, Mannheim, Germany). Complete tablets contain a cocktail 
of protease inhibitors that inhibit a broad range of serine and cysteine proteases therefore 
protecting proteins isolated from animal tissues. One Complete tablet was dissolved per 
7 ml of 62.5 mM Tris. Additional inhibitors phenylmethylsulfonyl fluoride (1 mM) and 
sodium orthovanadate (1 mM) were also present, to inhibit serine proteases and tyrosine 
phosphatase, respectively. Samples were briefly sonicated then stored at -80°C. 
Table 3.1: Microdissection of discrete brain regions 
Hypothalamic Section co-ordinates punches total protein amount of 
region relative to bregma* per brain (µg) ± sem protein 
loaded (µg) 
Arcuate nucleust -1.9, -2.2, -2.5, -2.8, -3.1 5 42.2 ± 1.1 7.5 
DMH -2.5, -2.8, -3.1 6 43.9 ± 1.5 7.5 
LH -2.2, -2.5, -2.8, -3.1 8 58.2 ± 1.6 10 
SON -1.0, -1.3, -1.6 6 47.4 ± 1.0 7.5 
VMH -2.5, -2.8, -3.1 12** 83.4 ± 2.3 10 
*Based on the atlas of Paxinos and Watson (1997) 
t Single punch per section, centred on the third ventricle 
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Figure 3.1: Diagrams of coronal rat brain sections indicating the location of micropunches 
of selected hypothalamic nuclei. The arcuate nucleus (Arc), dorsomedial nucleus (D:MII), 
lateral hypothalamus (lat), supraoptic nucleus (SON) and ventromedial nuelus (VMH) of 
the hypothalamus were removed with a 500 µm diameter needle. The section coordinates 
represent the approximate position (relative to Bregma) of the rostral face of each section 





Determination of protein concentrations 
Protein concentrations for all samples were determined by a modification of the 
Lowry method using a protein assay kit (Bio-Rad Laboratories Inc, Hercules, CA, USA) 
which uses changes in colour to estimate protein concentrations. A standard curve was 
constructed using known concentrations of bovine serum albumin (0.468 - 7.5 µg per 5 
µl). Standards were assayed in triplicate while samples were assayed in duplicate on a 
microtitre plate. Each well contained 5 µl of sample or standard, plus 225 µl of the 
protein assay reagents. After a 15-minute incubation at room temperature, absorbance of 
the solution in each well was measured at the 655 nm wavelength in a spectophotometer, 
using a Bio-Rad microtitre plate reader. Data were processed with Bio-Rad MicroPlate 
Manager software. All samples from one brain area were processed on the same 
microtitre plate . 
Polyacrylamide Gels 
The SDS-PAGE gel consisted of two components, a lower resolving gel and a 
upper stacking gel. The gels were cast in plastic gel cassettes (NOVEX 1 mm gel 
cassettes). The resolving gel contained 7.5% acrylamide, and 0.1 % SDS buffered with 
375 mM Tris (pH 8.8) and the stacking gel contained 4% acrylamide and 0.1 % SDS 
buffered with 25 mM Tris (pH 6.8). To catalyse the polymerisation of the acrylamide, 
0.05% ammonium persulfate and 0.05% N,N,N' ,N'-tetramethylethylenediamine 
(TEMED) were added to the gel solutions just prior to use. Approximately three quarters 
of the gel cassette was filled with the resolving gel solution, then covered with Milli Q 
water and left to set overnight at 4°C. The stacking gel solution was cast on top of the set 
resolving gel and a 15-tooth plastic comb was placed in the solution before it set, to 
create wells at the top of the gel. The stacking gel was left to set for approximately 20 








Western blot procedure 
Gel loading buffer was added to each sample at a ratio of 5 µl for each 10 µg of 
protein the sample contained, resulting in the following concentrations, 167mM 2-~ 
mercaptoethanol, 0.058% bromophenol blue, 18.67% glycerol, 0.1 % SDS, 62.5 mM Tris 
(pH6.8). Equal amounts of each sample (see table 3.1) were then incubated at 96° for 2 
minutes. The reducing agent, 2-~ mercaptoethanol, combined with the heating helps to 
denature the proteins. After brief centrifugation (5 s), samples were loaded in a 
predetermined order into the wells of the SDS-PAGE gel. Precision protein standards 
(Bio-Rad, Hercules, CA), a blend of recombinant proteins, and a positive sample for 
pSTAT3 were also loaded into separate wells in the gel. The protein standard solution 
provided protein markers of known sizes serving as a reference to assist accurate 
identification of the protein of interest by molecular weight. The positive sample 
consisted of a tissue sample that had previously tested positive for pST AT3 and was used 
to ensure that the immuno-detection for each membrane was successful. 
Proteins were separated in each sample according to molecular weight by 
electrophoresis. Gels were run at a constant 125 volts for two hours, in running buffer 
(25 mM Tris, 150 mM glycine, 3 mM SDS) using the NOVEX X-Cell Surelock Minicell 
system (lnvitrogen). Proteins were then electrotransferred to nitrocellulose membrane 
(0.45 µm pore size) using NOVEX X-Cell II blotting module (lnvitrogen) in transfer 
buffer (10% methanol, 12 mM Tris, 96 mM glycine). During this procedure the gels 
were opposed to the nitrocellulose membrane. Prior to the transfer, the nitrocellulose 
membrane was briefly soaked in transfer buffer. Any air bubbles created between the gel 
and membrane were removed and pieces of Whatman 3 MM filter paper were positioned 
on either side of the gel/membrane complex. This 'sandwich' was surrounded by foam 
pads, pre-soaked in transfer buffer and free of air bubbles, then placed in a cassette and 
positioned in the electo-blotting tank. The cassette and tank were filled with cold transfer 
buffer and run at 200mA for 2 hours. At the conclusion of this time the membranes were 





Membrane immuno-detection of total STAT3 and phosphorylated STAT3 
Initially membranes were stained with red ponceau stain (ponceau powder 
dissolved in acetic acid at a ratio of O. lg: 1ml), which reversibly stains proteins. This 
staining procedure was carried out to visualise all protein on the membrane to confirm 
accurate protein loading and protein transfer. At this time, the protein standards were 
visualised and their positions were recorded on the membrane using a pencil. The 
Ponceau staining was removed by washing the membrane in water followed by phosphate 
buffered saline (12 mM Na2HP04, 3.6 mM NaH2P04, 140 mM NaCl) with 0.1 % Tween-
20 (PBS-T) until the red colour had disappeared. After destaining, membranes were 
incubated in blocking solution (PBS-T containing 5% non fat milk powder) for 1 hour at 
room temperature. Membranes were then incubated overnight at 4°C with pSTAT3 
specific antibody (1: 1000 dilution) in the blocking solution. Next, membranes were 
incubated for 1 hour at room temperature in a goat anti-rabbit peroxidase-conjugated 
antibody at a 1:5000 dilution in PBS-T. Between each incubation, membranes underwent 
a series of three 10-minute washes in PBS-Tat room temperature and all incubations took 
place on a rocking platform. 
Immunolabelled bands were visualised by the enhanced chemiluminescence 
(ECL) method (Amersham Life Sciences, Piscataway, NJ, USA) that uses the oxidation 
of luminol by horseradish peroxidase in the presence of chemical enhancers such as 
phenols. The light produced by this reaction peaks after approximately 5 minutes and 
slowly decays with a half-life of 60 minutes. The maximum light emission is at a 
wavelength of 428 nm and this can be detected by exposure to blue-light sensitive 
autoradiography film (Kodak Biomax MR film). After the final washes, membranes 
were blotted dry and incubated in a 1:1 solution of the ECL reagents (total volume 4 ml) 
for 1 minute at room temperature. Following the incubation, membranes were blotted to 
remove any excess ECL solution and placed between two thin pieces of plastic then the 
edges of plastic were heat-sealed to create an airtight covering to surround the membrane. 
The membranes were then positioned in an X-ray exposure cassette (Amersham 








membrane for between 30 s and 2 hours depending on the strength of the signal. A 
Kodak X-OMAT M35 processor was used to develop the autoradiography film. 
Following the exposure to autoradiography film, membranes were removed from 
the air-tight plastic covering and washed three times for five minutes in PBS-T. 
Membranes were then incubated in stripping buffer (62.4 mM Tris-HCI, pH 6.7, 2% 
SDS, lOOmM 2-mercaptoethanol) at 25°C for 45 minutes to remove antibodies. 
Membranes were then washed three times for ten minutes, after which the ECL detection 
process was repeated. A clear film after 30 minutes of exposure to the membranes 
ensured complete removal of the antibodies. Membranes were then reprobed with a 
STAT3 specific antibody (Santa Cruz Biotechnology) following the same conditions 
described above. Autoradiography film was exposed to the reprobed membrane, as 
above, to detect the total ST AT3 signal. 
Data analysis 
Images of the bands on the autoradiography film were captured using a BioRad 
Model GS-700 Imaging Densitometer. The optical density of the bands corresponding to 
phosphorylated ST AT3 and total STA T3 was measured using the BioRad Molecular 
Analyst computer program (version 2.1). Activation of STAT3 for each sample was 
determined as the ratio of phosphorylated STAT3 to total STAT3 present in the sample 
and this value was used for statistical comparisons. Differences between the activation of 
STAT3 of the groups were analysed using two way ANOVA followed by Fisher's PLSD 
post hoc test. Differences between total STAT3 levels of the physiological states were 
analysed using one way ANOV A followed by Fisher's PLSD post hoc test. The 





Immunohistochemistry uses the immunological reaction between an antigen and 
antibody raised against this antigen (primary antibody) to identify and locate the protein 
of interest within a tissue specimen. The visualisation of this complex usually involves 
an initial amplification of the signal using a biotinylated anti-lg antibody raised against 
the species of the primary antibody followed by streptavidin/horse radish peroxidase 
complex. An enzymatic reaction then converts the antigen-antibody complex into a 
visible precipitate. 
Perfusions 
Rats were anaesthetised via a single i.p. injection containing 0.2 ml of Heparin 
(400 IU/100 g body weight) and sodium pentobarbital (17 mg/100 g body weight for 
pregnant rats or 6 mg/100 g body weight for diestrous rats). Once the rat was sufficiently 
anaesthetised, as measured by a lack of response to a pinch of the hind paw, the chest 
cavity was opened to expose the heart. A blunt needle connected via tubing to a variable 
pressure perfusion apparatus, was inserted through the ventricle, into the aorta and held in 
place with a haemostat. Ice cold physiological saline (approximately 50 mls) was flushed 
through the rat until the fluid was running clear from the left atrium. Rats were then 
perfused with approximately 200 ml of ice cold 2% paraformaldehyde in 0.1 M 
phosphate buffer (pH 7.3), with pressure maintained at 90 mm Hg. Ice cold solutions 
were used to help prevent decreases in intracellular ATP levels during perfusion, as this 
can lead to dephosphorylation of phosphoproteins. During the time of perfusion, the 
descending aorta and inferior vena cava were clamped to direct the fluid towards the head 
of the animal. 
At the completion of the perfusion process, the brain was carefully removed and 
placed in fixative overnight at room temperature. Brains were then immersed in 0.1 M 
phosphate buffered 30% sucrose solution and left at 4°C until the brain had sunk to the 
bottom, indicating that the sucrose had sufficiently infiltrated the perfused brain. Brains 
were then frozen in mounting medium (Tissue Tek). The rapid freezing process used 
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isopentane cooled in liquid nitrogen to maintain even freezing of the brain. Frozen brains 
were stored at -80°C until sectioning. Coronal sections (35 µm) were cut on a cryostat (-
200C) and collected in six sequential series, each of which contained sections 210 µm 
apart. Sections were cut through the arcuate nucleus and ventromedial nucleus of the 
hypothalamus (VMH) and stored in cyroprotectant at -20°C until further processing. 
Phosphorylated STAT3 staining procedure 
Free-floating tissue sections were used for this procedure and one series of 
sections was used from each rat. All washes consisted of three 5 minute incubations in 
phosphate buffered saline (5 mM NaH2P04.H20, 5 mM Na2HP04.2H20, 140 mM NaCl, 
pH 7.2) with 0.25% triton-X (PBS/0.25% triton-X) on an orbital shaker. Sections were 
removed from storage, washed and then treated for 20 minutes at room temperature in 
H20 containing 1 % NaOH and 1 % H202 to block endogenous peroxidase activity. 
Following this, sections were incubated for 10 minutes in 0.3% glycine, to remove any 
residual aldehydes from fixation, then incubated for 10 minutes in 0.03% SDS at room 
temperature. Sections were then blocked in 3% normal goat serum in PBS/0.25% triton 
X-100/0.02% sodium azide (blocking solution) for one hour at room temperature and 
then incubated overnight at 4°C in blocking solution containing the pSTAT3 antibody 
(1:1000 dilution). On the following day, sections were washed, incubated with a 
biotinylated secondary goat anti-rabbit antibody for one hour (1: 1000, in blocking 
solution without sodium azide), and then treated with an avidin-biotin-peroxidase 
complex (Vectastain Elite ABC kit) for one hour. After sections were washed, the 
sections were incubated in 0.05 M Tris-HCl (pH 7.8) then the peroxidase signal was 
visualised with a 3,3 '-diaminobenzideine reaction (DAB substrate kit from Vector) with 
the addition of 0.1 % nickel sulfate resulting in a purple/black precipitate. This reaction 
was stopped by two washes in PBS for 10 minutes. Sections were then mounted on ATS 
coated slides and left to dry. Slides were dehydrated through an alcohol series (70%, 
95%, 100%, five minutes per incubation) ending with two 20 minute xylene incubations. 








The sections were viewed on an Olympus BXS 1 research microscope. Images of 
the arcuate nucleus and VMH were captured with a SPOT digital camera, using the 10 X 
objective. The number of pSTAT3 positive cells were counted using NIH image 
computer software (version 1.63). To define the area of interest, the boundary of the 
selected nucleus was drawn, creating an enclosed area. This image was then converted to 
binary, and a standard threshold was set. The number and size of dots was automatically 
counted and recorded. Prior to the start of section analysis, the range of dot sizes 
corresponding to specific pSTAT3 labelled cells was determined. To account for miss 
counting of dots due to close proximity, print outs of the images with numerically 
labelled dots along with dot size records were visually assessed, and any miss-counted 
dots were added to the total number of dots. 
For each section there were three areas of interest, the medial arcuate, the lateral 
arcuate and the dorsomedial VMH (figure 3.2). At least three sections were analysed per 
rat and analysis was done blind to treatment groups. For each rat, the average number of 
cells counted in each area was used for statistical comparisons. These data were not 
corrected for double counting, but any systematic error should be the same for each group 
as the section thickness and size of the objects counted did not change between groups. 
These results, therefore, show relative number of pSTAT3 expressing cells and not the 
absolute cell counts. This method to compare relative levels of leptin-induced pSTAT3 
has been previously used to assess leptin signaling in diet-induced obese rats (Levin et al. 
2004). 
Differences between groups were analysed by two-way ANOV A followed by 
Fisher's PLSD post hoc test. The significant level for all statistics was set at P < 0.05 . 










Figure 3.2: A Diagram of coronal rat brain section indicating the areas analysed for cell 
counts positive for pSTAT3. The section coordinates represent the approximate position 
relative to Bregma. B Coronal leptin-treated rat brain section with the boundaries of the 
areas of interest defined. Areas of interest were ventromedial nucleus (1), medial arcuate 
(2), and lateral arcuate nucleus (3) . The number of pSTAT positive cells were counted 







Food intake and serum leptin concentrations 
Prior to fasting, pregnant rats for both the western blot and immunohistochemistry 
analysis of pST AT3, had significantly greater body weights and 24 hour food intake 
compared to the non-pregnant rats ( data not shown). At time of death, serum leptin 
concentrations were low in vehicle-treated fasted non-pregnant and pregnant rats, 
whereas, the leptin-treated fasted rats had significantly increased serum leptin 
concentrations (figure 3.3) 
STA T3 phosphorylation in response to i.e. v. leptin administration 
The polyclonal STAT3 antibody detected a strong protein band at the expected 
size of approximately 92 kDa, which was also confirmed with the use of the monoclonal 
STAT3 antibody (figure 3.4A). The pSTAT3 antibody detected a band of a similar size 
(figure 3.4B). Consistent with previous studies maximal STAT3 phosphorylation was 
detected at 30 minutes post injection (figure 3.5). Subsequently all rats were killed 30 
minutes after leptin or vehicle treatment. 
There were no differences in total levels of ST AT3 protein in the non-pregnant 
and pregnant rats except in the VMH, where there were lower levels of total ST AT3 in 
pregnant rats compared to non-pregnant rats (figure 3.6). In the arcuate nucleus, leptin 
treatment led to a marked increase in STAT3 activation in non-pregnant rats but not in 
the pregnant rats (figure 3.7 A). While not significantly different, vehicle-treated 
pregnant rats tended to have a higher level of basal STAT3 activation in the arcuate 
nucleus compared to vehicle-treated non-pregnant rats. In the VMH, leptin treatment led 
to a robust increase in STA T3 phosphorylation in non-pregnant rats, with a significantly 
smaller increase in the percentage of ST AT3 that became phosphorylated in pregnant rats 
(figure 3.7B). In contrast with the arcuate nucleus and the VMH, in the DMH and lateral 













pregnant and non-pregnant groups (figure 3.7C & D). While STAT3 was detected in the 
SON, leptin treatment did not induce STAT3 phosphorylation in this area in either group 
(figure 3.8). 
Following the results from the western blot analysis, the number of pST AT3 
positive cells in the VMH and arcuate nucleus after vehicle or leptin treatment was 
measured in pregnant and non-pregnant rats. In the non-pregnant rats, leptin induced a 
robust increase in ST AT3 phosphorylation in the VMH, and both the medial and lateral 
arcuate nucleus (figure 3.9). In the pregnant rats, leptin induced a significant increase in 
pSTAT3 positive cells in the VMH, however the number of pSTAT3 positive cells in the 
leptin-treated pregnant rats was greatly reduced compared to that observed in the leptin-
treated non-pregnant rats (P < 0.05) (figure 3.10). Leptin treatment induced an increase 
in the number of pSTAT3 positive cells during pregnancy in both the medial and lateral 
portions of the arcuate nucleus similar to the non-pregnant rats (figure 3.11). In both the 
medial and lateral arcuate nucleus basal levels of pSTAT3 expression tended to be 
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Figure 3.3: Serum leptin concentrations 30 minutes after i.e. v. leptin or vehicle administration 
in fasted non-pregnant and day 14 pregnant rats. Values represent the mean± sem (n=6-







Figure 3.4: A Immunoblot of STAT3 protein in rat hypothalamic tissue using a rabbit 
polyclonal antibody (a) or a monoclonal STAT3 antibody (b). B Immunoblot of STAT3 
(a) and pSTAT3 (b) protein in rat hypothalamic tissue after leptin treatment. pSTAT3 was 
detected at a similar molecular mass as STAT3. To visually compare the molecular mass 
of pSTAT3 and STAT3 proteins, membranes were cut in two and membrane sections were 
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Figure 3.5: Immunoblots of pSTAT3 (top) and STAT3 (bottom) protein in the arcuate 
nucleus (A) and VMH (B) after leptin treatment in non-pregnant rats. Lanes represent the 
tissue sample from individual animals killed at different times following leptin treatment. 
The maximum levels of pSTAT3 were detected 30 minutes post injection. 
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Figure 3.6: STAT3 levels in the arcuate 
nucleus (A), VMH (B), DMH (C), 
lateral hypothalamus (D) and SON (E) 
in non-pregnant and pregnant rats. 
Immunoblots show bands corresponding 
to STAT3 from five representative non-
pregnant and pregnant rats. Band 
intensities are expressed as arbitrary 
units, with each bar representing the 
mean ± sem (n = 5-7). * significant 
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Figure 3.7: Activation of STAT3 in the arcuate nucleus (A), the VMH (B), the DMH 
(C), and the lateral hypothalamus (D) after i.c.v. administration of leptin or vehicle in 
fasted non-pregnant and pregnant rats (n=5-7). Immunoblots show bands corresponding 
to pSTAT3 (top) and STAT3 (bottom) from three representative rats from each treatment 
group. Activation of STAT3 was determined by the amount of pSTAT3 expressed as a 
percentage of the total amount of STAT3 detected in each sample. Values represent mean 
± sem. * significant with respect to vehicle-treated group (P < 0.05). t significant with 














Figure 3.8: STAT3 was not phosphorylated in the SON after leptin treatment in any group. 
Immunoblots of pSTAT3 (top) and STAT3 (bottom) proteins from three respresentative 
leptin-treated non-pregnant and pregnant rats. The first lane ( +ve con) in each immunoblot 
represents the VMH of a leptin-treated non-pregnant rat, serving as a positive control for 
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Figure 3.9: Leptin-induced STAT3 phosphorylation (purple/black stain) in the medial 
basal hypothalamus. Coronal brain sections from non-pregnant (top) and pregnant (bottom) 
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Figure 3.10: A Leptin-induce phosphorylation of STAT3 in representative sections of 
the dorsomedialVMH from non-pregnant (left) and pregnant (right) rats. B Cells positive 
for pSTAT3 were counted in the four treatment groups (n=5-6 per group) and expressed 
as mean ± sem. * significant with respect to vehicle-treated group (P < 0.05). t significant 
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Figure 3.11: Leptin-induced phoshorylation of STAT3 in representative sections of the 
medial (A) and lateral (B) arcuate nucleus from non-pregnant (left) and pregnant (right) 
rats. Values represent mean± sem for the number of cells positive for pSTAT3 in each 
treatment group (n=5-6 per group) in the medial (A) and lateral (B) arcuate nucleus. 





In the previous chapter, day 14 pregnant rats did not respond to i.c.v. leptin 
administration, supporting the hypothesis that pregnancy is a state of leptin resistance. 
The present study demonstrates that pregnancy-induced leptin resistance is associated 
with impaired activation of the JAK/STAT3 signal transduction pathway, specifically in 
the VMH and arcuate nucleus. This impaired activation of leptin-target neurons in the 
hypothalamus may underlie the lack of satiety response to leptin observed in mid-
pregnant rats. 
The phosphorylation of STAT3 is a vital step in the activation of the JAK/STAT 
signalling pathway by leptin (McCowen et al. 1998). While both techniques used in this 
study measured the activation of the JAK/STAT signalling pathway in response to leptin 
they reveal different aspects of this activation. The western blot analysis measured the 
total amount of pSTAT3 and STAT3 in the tissue samples. To accurately interpret the 
western blot data, the degree of activation was determined by expressing the amount of 
pST A T3 in each sample as a percentage of total ST AT3 in the sample. This accounted 
for any changes in STAT3 levels that may potentially influence total levels of pSTAT3. 
The western blot results, therefore, convey the relative magnitude of the leptin-induced 
activation. The immunohistochemistry analysis provides better anatomical resolution, 
and measured the number of cells that were positive for pSTAT3, but does not 
specifically measure the level of activation. These methods did not allow for the 
identification of the cell type in which STAT3 was phosphorylated. It has previously 
been shown, however, that leptin-induced activation of the JAK/STAT3 pathway in the 
hypothalamus is limited to neurons and not glial cells (Hubschle et al. 2001). 
The ventromedial nucleus of the hypothalamus has long been recognised as one of 
the primary regions of the brain involved energy homeostasis. Using translocation of 
STAT3 to the nucleus or induction of c-fos as markers of activation, leptin administration 
has consistently been shown to activate neurons within the VMH (Elmquist et al. 1997; 
Elmquist et al. 1998a; Hubschle et al. 2001; Levin et al. 2004). The phenotype of these 






pSTAT3 within the VMH in the present study was limited to the dorsomedial region of 
this nucleus (Elmquist et al. 1997; Hubschle et al. 2001; Levin et al. 2004). The results 
from this study demonstrate that leptin-induced pSTAT3 is impaired in the VMH during 
pregnancy. Both the magnitude of activation and the number of cells expressing pSTAT3 
were decreased compared to non-pregnant animals. It is possible that the reduced 
activation in some neurons meant that these cells were below the threshold for inclusion 
in the cell counts, contributing to the decreased number of cells positive for pSTAT3. 
While decreases in ST A T3 phosphorylation during pregnancy suggest that there is 
impaired activation of leptin-target neurons at this time, the functional significance of this 
reduction has yet to be elucidated. 
Classically the ventromedial region of the hypothalamus has been regarded as the 
satiety centre of the hypothalamus, due to the hyperphagia and obesity that is displayed 
after lesion to this area (Hetherington et al. 1940; Hervey 1959). It is unlikely, however, 
that the consequences of these lesions are solely due to the disruption of the ventromedial 
nucleus of the hypothalamus (VMH). While the VMH is the most prominent histological 
unit of the ventromedial region of the hypothalamus and is completely destroyed in 
typical lesions to this region, lesions restricted to the VMH do not result in hyperphagia 
(Gold 1973; Parkinson et al. 1990). Moreover, lesions caudal and lateral to the VMH, 
parasagittal knife cuts rostrolateral to the VMH and midbrain lesions all produce 
hyperphagia and obesity even when the VMH remains intact (Anand et al. 1951; Spraque 
et al. 1961; Gold 1970; Gold 1973). Specific VMH lesioned rats are deemed to have a 
metabolic obesity as despite normal food intake levels, these rats have significantly 
increased fat mass (Parkinson et al. 1990). Furthermore, when the typical ventromedial 
region lesioned rats are food restricted a state of obesity still develops, also suggesting 
that there are disruptions in regulation of metabolism (Tokunaga et al. 1986; Parkinson et 
al. 1990). These lesions are associated with increased insulin concentrations, reduced 
plasma glucose, alterations in the autonomic nervous system, disrupted diurnal feeding 
patterns and reduced thermogenic activity of brown adipose tissues (Bray et al. 1979; 
Bray et al. 1981; Seydoux et al. 1981; Shimazu et al. 1981; Sclafani et al. 1983; Bray 
1984; Tokunaga et al. 1986; Parkinson et al. 1990; Choi et al. 1999). It is likely that the 
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disruption of the VMH in these ventromedial region lesioned rats can account for some of 
these alterations in metabolism. 
Both chemical and electrical stimulation of VMH neurons results in the increased 
uptake of glucose by peripheral tissues such as brown adipose tissue, the heart and 
skeletal muscles (Shimazu et al. 1991; Sudo et al. 1991). The mechanism behind this 
increased uptake of glucose is independent of changes in insulin concentrations but 
mediated via activation of sympathetic innervation of the tissues (Shimazu et al. 1991; 
Sudo et al. 1991; Takahashi et al. 1992; Minokoshi et al. 1994; Haque et al. 1999). The 
role of leptin activity in the VMH may involve regulation of metabolic events such as 
glucose uptake by peripheral tissues. Both intravenous (i. v.) and i.e. v. leptin 
administration to mice results in increased glucose uptake in muscle and BAT without 
changes in insulin concentrations and, similar to leptin action on food intake, i.c.v. 
administration is more potent than i.v. administration indicating a central target for this 
effect (Kamohara et al. 1997). The combined actions of central leptin and peripheral 
insulin administration have been shown to produce a synergistic action in increasing 
glucose uptake in peripheral tissues (Haque et al. 1999). When leptin is administrated 
directly into the VMH, glucose uptake is increased in peripheral tissues in the rat, 
whereas this is not observed with administration to the lateral hypothalamus (Minokoshi 
et al. 1999). Furthermore the mediation of this action of leptin is through the sympathetic 
nerves innervating the peripheral tissues (Haque et al. 1999) and leptin-induced activation 
of the sympathetic nervous system is mediated by administration of leptin to the VMH 
but not the arcuate nucleus, DMH or PVN (Satoh et al. 1999). While not specifically 
demonstrated, if leptin induces peripheral glucose uptake by activation in the VMH then 
this must involve the dorsomedial region of the ventromedial nucleus as this is the only 
region of this nucleus that has been shown to respond to leptin (Elmquist et al. 1997; 
Elmquist et al. 1998a; Hubschle et al. 2001; Levin et al. 2004). 
The decreased leptin-induced activation of VMH neurons during pregnancy may 
be involved in the prevention of leptin-induced increases in peripheral tissue glucose 
uptake. Reduced uptake of glucose by maternal tissue and redirection to the fetus is a 
key metabolic adaptation of pregnancy (Herrera 2000). Previously, the limiting of 
glucose uptake by peripheral maternal tissues has been attributed to maternal peripheral 
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insulin resistance (Rushakoff et al. 1983; Leturque et al. 1986; Hauguel et al. 1987; 
Nolan et al. 1994). However, considering that central leptin can increase glucose uptake 
independent of insulin and that the actions of both central leptin and peripheral insulin 
can synergistically increase tissue glucose uptake (Haque et al. 1999), it is not 
unreasonable to hypothesise that the combination of peripheral insulin resistance and 
central leptin resistance would allow for an overall reduction, or at least prevent 
stimulation, of glucose uptake by the maternal body and thus, allowing the redirection of 
glucose to the fetal-placental unit. 
Thermogenesis in BAT constitutes a significant component of energy expenditure 
in small mammals. The VMH plays an important regulatory role in the thermogenesis in 
BAT, which is mediated through sympathetic neural activity (Shimazu et al. 1980; 
Perkins et al. 1981; Minokoshi et al. 1986). Both electrical stimulation and 
microinjections of leptin in the VMH results in glucose uptake by BAT, which can be 
prevented by surgical sympathetic denervation of BAT (Shimazu et al. 1991; Sudo et al. 
1991; Minokoshi et al. 1999). Therefore, leptin-induced activity in the VMH may also be 
involved in the regulation of thermogenesis in BAT by leptin. Pregnancy-induced 
hyperphagia, unlike hyperphagia in a non-pregnant rat, is not associated with enhanced 
BAT activity (Abelenda et al. 1987). Therefore, it is possible that the decreased 
activation of the VMH observed in the present study may result in reduced leptin-induced 
thermogensis. 
The state of leptin resistance during pregnancy was assessed by examining the 
feeding response to exogenous leptin. In light of the results from the present study, it 
may also be important to examine the actions of leptin on energy expenditure during 
pregnancy. Measuring leptin-induced UCPl levels in BAT as an indicator of 
thermogenic activity (Scarpace et al. 1997; Scarpace et al. 1998) and the rate of glucose 
uptake by 2-[3H] deoxyglucose incorporation in peripheral tissues after central leptin 
administration (Minokoshi et al. 1999) may reveal the extent to which these leptin-
induced activities are influenced by the state of leptin resistance during pregnancy and 




In the arcuate nucleus, western blot analysis indicated that leptin treatment did not 
increase overall phosphorylated STAT3 levels during pregnancy, however a marked 
increase in pSTAT3 positive cells was observed in the immunohistochemistry analysis. 
While not significantly increased, basal levels of pST AT3 tended to be higher in the 
arcuate nucleus of pregnant rats compared to non-pregnant rats using both 
methodologies. The different measures may, in part, explain the differences in the results 
observed in the arcuate nucleus, leading to the suggestion that there is a decrease in the 
degree of STAT3 phosphorylation per cell, rather than a change in number of cells 
responding. 
It is reasonable to postulate that leptin-induced signal transduction may be 
differentially regulated within the orexigenic and anorectic neuron populations in the 
arcuate nucleus. The majority of NPY-/AgRP-containing neurons are situated in the 
medial portions of the arcuate nucleus, while POMC-containing neurons are mainly 
located in the lateral portions (Hakansson et al. 1998). Therefore, in an attempt to 
distinguish between these neuron populations, the medial and lateral subdivisons of the 
arcuate nucleus were analysed separately for the number of pST AT3 positive cells. In 
the western blot analysis, the arcuate nucleus tissue sample collected using the 
micropunch technique would primarily have corresponded to the medial region of this 
hypothalamic nucleus. Based on anatomical location, these results led to the hypothesis 
that during pregnancy the POMC neurons located in the lateral arcuate nucleus are 
relatively unaffected, while the NPY/AgRP neurons in the medial region of the arcuate 
nuclues may have reduced phosphorylation of STAT3 per cell. This hypothesis will be 
further examined in chapter five. 
In the DMH and lateral hypothalamus, leptin-induced phosphorylation was 
observed in both leptin-treated groups although no difference was detected between 
physiological states. These results demonstrate that the disrupted leptin signal 
transduction is limited to specific regions within the hypothalamus and is not a general 
phenomenon of all leptin target neurons during pregnancy. Furthermore, the reduced 
STAT3 levels in the VMH and not the arcuate nucleus suggest that there maybe different 
mechanisms involved in the impaired signalling in these areas. 
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STAT3 protein levels were similar to non-pregnant levels on day 14 of pregnancy 
in all areas except in the VMH, where lower levels of STAT3 were observed during 
pregnancy. Decreased levels of the signalling molecule STAT3 is a potential mechanism 
to reduce the functional capacity of this signalling pathway, however, results from ob/ob 
mice suggest otherwise. Despite reduced medial basal hypothalamic levels of STAT3 
protein and mRNA, ob/ob mice demonstrate a similar sensitivity as wild type littermates 
for the activation of STAT3 after leptin administration (Vaisse et al. 1996; Hakansson-
Ovesjo et al. 2000). These data suggest that STAT3 concentrations are not limiting. 
Therefore decreased levels of STA T3 may not greatly impair the capacity of leptin 
activation of this signal transduction pathway. The reduced STAT3 protein and mRNA 
in the ob/ob mice suggest that unimpaired leptin signalling plays a role in the long term 
maintenance of ST AT3 protein levels (Hakansson-Ovesjo et al. 2000). While ST AT3 
mRNA levels in ob/ob mice do not change as a consequence of a single dose of leptin 
(Emilsson et al. 1999), the long term involvement of leptin in the regulation of STAT3 is 
unknown. Interluekin-6, which also activates a JAK/STAT3 signalling pathway, 
regulates levels of STAT3 via STAT3-induced transcription (Ichiba et al. 1998; 
Narimatsu et al. 2001), raising the possibility that regulatory mechanisms between leptin 
and STAT3 may also exist. Potentially, the decrease in STAT3 levels, therefore, may be 
the result of the impaired signalling in the VMH during pregnancy and not a primary 
cause of this impaired leptin signal transduction pathway. Although, it should also be 
mentioned that not all examples of reduced leptin signalling result in decreased STAT3 
proteins levels, such as the leptin resistant age-induced obese rats (Scarpace et al. 2001). 
Studies examining the hypothalamus as a whole, however, may not be sensitive enough 
to detect region specific changes. Alternatively, the decreased STAT3 levels may not be 
due to reduced transcription of STAT3 mRNA, but may reflect increased degradation of 
this protein. Protein degradation has be suggested as a possible mechanism involved in 
inhibiting JAK/STA T signal transduction (Starr et al. 1999). Measuring the expression 
levels of STAT3 mRNA may be the next step in elucidating the causes of the reduced 
STAT3 protein levels during pregnancy. 
Similar to a number of other studies, serum leptin concentrations were 
substantially increased after the i.c.v. administration of exogenous leptin (McCowen et al. 
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1998; Scarpace et al. 2001; Sahu 2002). This increase has been shown to be due to the 
exogenous leptin leaking from the cerebral ventricles into the blood circulation, and not 
due to increased secretion of leptin from adipocytes (Shek et al. 2000; Scarpace et al. 
2001). Scarpace et al (2001) found that maximum levels of STAT3 phosphorylation 
were induced after i.c.v. administration of leptin at doses of 250 ng or greater, however 
no further increases were observed as doses increased. Similarly, the same pattern is 
observed for decreases in food intake following leptin administration (Halaas et al. 1995). 
It is likely that the leptin dose used in the present study could have been reduced with 
similar results in terms of pST A T3 levels. In future, using lower leptin doses that induce 
near maximal pSTAT3 levels but do not result in supra-physiological serum leptin 
concentrations, such as 250 ng, may be more appropriate. Despite the supra-maximal 
dose used in this study (Cusin et al. 1996; Scarpace et al. 2001), pregnant animals had a 
decreased response compared to non-pregnant animals indicating the robustness of this 
impaired response during pregnancy. The experimental design, involving fasting and a 
high leptin dose, examined the maximal response of STAT3 phosphorylation after leptin 
treatment. It would be of interest to measure the endogenous level of pST AT3 in 
pregnant rats, as despite the higher endogenous leptin concentrations it is likely, 
considering the impaired maximal response, that pST AT3 levels in the non-fasted 
pregnant rat will be reduced compared to the non-pregnant rats. 
In conclusion, these results indicate that leptin-induced activation of STAT3 is 
impaired in day 14 pregnant rats in association with the leptin resistance previously 
observed at this time point. This impairment was specifically observed in the VMH, 
while results in the arcuate nucleus suggested a possible decrease in the degree of STAT3 




Chapter four: Leptin receptor mRNA expression in the 
hypothalamus during pregnancy 
Introduction 
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The actions of leptin are mediated through the leptin receptor, specifically the Ob-
Rb isoform that has full signal transduction capabilities. The short forms of the leptin 
receptor (Ob-Rs) in the rat consist of Ob-Ra, Ob-Re, Ob-Rf, which have alternatively 
spliced intracellular domains, and Ob-Re, which is the only form that lacks the 
transmembrane domain. The Ob-Rb isoform is most highly expressed in the 
hypothalamus, and is predominantly localised in the arcuate nucleus, dorsomedial 
nucleus (DMH) and the ventromedial nucleus (VMH) of the hypothalamus (Pei et al. 
1997; Guan et al. 1997; Elmquist et al. 1998b). Ob-Ra is also expressed in the 
hypothalamus, with Ob-Re and Ob-Rf mRNA undetectable using in situ hybridisation 
(Guan et al. 1997) but detected when using RT-PCR (Garcia et al. 2000; Hileman et al. 
2002; Denis et al. 2003). High expression levels of Ob-Ra mRNA have been detected in 
the choroid plexus (Tartaglia et al. 1995; Pei et al. 1997; Guan et al. 1997; Hileman et al. 
2002) whereas Ob-Rf mRNA is only expressed at moderate levels (Guan et al. 1997; 
Hileman et al. 2002). Similarly, Ob-Re mRNA has also been detected at high levels in 
this area (Hileman et al. 2002) but others have only found moderate levels of this isoform 
(Guan et al. 1997). 
Results from the previous chapter demonstrate impaired leptin-induced activation 
of the JAK/STAT3 signalling pathway during pregnancy. This decrease in activation 
may reflect a decrease in leptin receptor expression, but there is conflicting evidence as to 
whether hypothalamic leptin receptor expression changes during pregnancy. On day 18 
of pregnancy, a decrease in mRNA for Ob-Rb in the hypothalamus has been observed 
(Garcia et al. 2000), whereas others have reported that mRNA levels and protein levels 
for the receptor remain relatively stable across pregnancy (Seeber et al. 2002; Rocha et al. 
2003). All of these prior studies, however, have examined leptin receptor expression in 





nuclei of the hypothalamus. Considering that pregnancy-induced suppression of 
JAK/STAT3 signalling was region specific it seemed likely that potential changes in 
leptin receptor expression are limited to discrete areas of the hypothalamus. The aim of 
this study was to determine if pregnancy-induced leptin resistance was associated with a 
differential change in expression levels of leptin receptors in discrete nuclei of the 
hypothalamus 
Methods 
Groups of rats were killed by decapitation between 0800 and 1000 h on diestrus, 
day 7, 14, and 21 of pregnancy and day 7 of lactation. The brains were rapidly removed 
and frozen on dry ice. The choroid plexus and six hypothalamic areas were 
micropunched from frozen coronal brain sections (300 µm) as described previously in 
chapter three (see table 4.1 and figure 4.1). 
Table 4.1: Microdissection of discrete brain regions 
Brain region Section co-ordinates no. of punches 
relative to bregmat per brain 
Choroid plexus -0.1, -0.4, -0.7 
Caudal arcuate nucleus -2.5, -2.8, -3.1 
Rostral arcuate nucleus -1.9, -2.2 
Dorsomedial nucleus -2.5, -2.8, -3.1 
Paraventricular nucleus -1.9, -2.2 
Supraoptic nucleus -1.0, -1.3, -1.6 
V entromedial nucleus -3.1 
tBased on the atlas of Paxinos and Watson (1997) 
*Single punch per section, centred on the third ventricle 
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Figure 4.1: Diagrams of coronal rat brain sections indicating the location of micropunches 
of selected hypothalamic nuclei and choroid plexus. The rostral arcuate nucleus (rArc), 
caudal arcuate nucleus (cArc), dorsomedial hypothalamus (DMH), paraventricular nucleus 
(PVN) and ventromedial nucleus of that hypothalamus (VMH), were removed with a 500 
µm diameter needle. The choroid plexus (ChP) was removed with a 300 µm diameter 
needle. Location of supraoptic nucleus is shown in figure 3.1. The section coordinates 
represent the approximate position (relative to Bregma) of the rostral face of each section 
collected for microdissection. All regions were dissected from a number of sequential 






Total cellular RNA was extracted from the microdissected brain regions using 
TRizol Reagent. TRizol Reagent is a mono-phasic solution of phenol and guanidine 
isothiocyanate, and facilitates the isolation of total cellular RNA. Micropunched tissue 
was placed in 995 µl of TRizol along with 5 µl of glycogen (20 µglµl) to aid in the 
precipitation of the small amount of RNA. Samples were briefly sonicated to ensure 
complete homogenisation, then incubated for 5 minutes at room temperature to permit the 
complete dissociation of the sample. After the addition of 200 µl of chloroform, the tube 
was shaken vigorously by hand for 15 seconds to completely mix the contents, then 
allowed to stand for 3 minutes at room temperature before centrifugation at 12 000 x g 
for 15 minutes at 4°C. The addition of chloroform, followed by centrifugation separates 
the solution into three phases, the lower phenol-chloroform phase, the interphase and a 
colourless upper aqueous phase. The RNA remains exclusively in the aqueous phase, 
which comprises of approximately 60% of the original volume of TRizol. The aqueous 
phase was then transferred to another tube containing 500 µl of isopropyl alcohol to 
precipitate the RNA. Samples were incubated at -20°C for 20 minutes, followed by 
centrifugation at 12 000 x g for 10 minutes at 4°C. The RNA precipitate forms a gel-like 
pellet located on the bottom of the tube, and the addition of the glycogen which is co-
precipitated with the RNA allows for the visualisation of this pellet when the initial 
sample size is small. The supernant was removed and the pellet was washed by vortexing 
after the addition of 1 ml of 75 % ethanol in DEPC treated water, and then centrifugation 
at 4°C for 5 minutes at 7500 x g. Ethanol was then removed and RNA pellets were 
briefly air dried before the addition of 20 µl of RNase-free water. To dissolve the pellets, 
samples were incubated at 57.5°C for 10 minutes. 
To denature any contaminating DNA, samples were treated with DNase I 
(amplification grade). To each sample, 1 µl DNase I (1 U/1 µl), and 1 µl of lOx DNase 
reaction buffer diluted in 8 µl of RNase-free water, was added and samples were 
incubated at room temperature. After 15 minutes, 0.5 µl of 25mM EDTA was added to 
inactivate the enzyme and samples were left to incubate at 65°C for 5 minutes. At the 
end of this procedure the total RNA was in a volume of 30 µI. 
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Real-time quantitative RT-PCR 
Reverse Transcription 
As total RNA concentrations were extremely low, it was impractical to quantify 
total RNA in each sample and still have sufficient sample volume remaining for the 
reverse transcription. Equal volumes of total RNA were transcribed into first strand 
cDNA for each sample using PE Applied Biosystems GeneAmp Gold RNA PCR 
reagents kit (PE Biosystems, Foster City, CA, USA). Reaction components were stored 
at -20°C and all reagents except the enzymes were thawed, mixed by vortexing and kept 
on ice prior to use. A master mix of reagents was made in order to increase the precision 
of the results. Making a master minimizes the volume loss due to pipetting, and reduces 
the possibility of contamination due to reagent transfers. The components of the master 
mix are listed in table 4.2. The enzymes, RNase Inhibitor and Multiscribe Reverse 
Transcriptase, are sensitive to air oxidation so were kept at -20°C until immediately 
before use. The total volume of the RT reaction for each tube was 20 µl, consisting of 
11.3 µl of the reverse transcription (RT) master mix, and 8.7 µl of total RNA. The RT 
reaction was carried out in a thermal cycler, with the cycling conditions consisting of an 
incubation at 25°C for 10 minutes and then reverse transcription for 12 minutes at 42°C. 
Table 4.2: RT Master Mix Preparation 
Component 
5x RT-PCR Buffer (150mM Tris-HCL + lOOmM KCI, pH 8.3) 
MgC12 (25 mM) 
dNTP Blend (10 mM Deoxyribonucleotide triphosphates) 
DTT (lOOmM dithiothreitol in RNase free water) 
Oligo d(T)16 
RNase Inhibitor (20U/µl) 

















10 Units/20 µI 






Probe and Primer design 
Oligonucleotide primers and probes specific for five of the leptin receptor 
isoforms (figure 4.2) were designed for use in TaqMan real-time PCR using Primer 
Express software (PE Applied Biosystems). Separate forward (sense) and reverse 
(antisense) primers, and probe were designed for the Ob-Re isoform of the receptor, and 
for a housekeeping gene, ~-actin (table 4.3). A common forward primer, directed against 
the extracellular segment that is common to all isoforms, and separate isoform-specific 
reverse primers, directed against the intracellular domain, allowed for the specific 
detection of the four other receptor isoforms (table 4.4). A fluorogenic TaqMan probe 
was designed to hybridise with part of the extracellular domain of the receptor between 
the primers, that was common to these four isoforms. The probe was an oligonucleotide 
that had both a reporter fluorescent dye (FAM) and a quencher dye (TAMRA) attached. 
The ~-actin probe reporter dye was VIC. When the dyes are in close proximity, the 
quencher greatly reduces the fluorescence emitted by the reporter dye. During each 
extension cycle, the Taq DNA polymerase cleaves the reporter dye from the probe, 
thereby releasing the reporter dye signal. 
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Figure 4.2: Schematic representation of the leptin receptor. Ob-R demonstrates the 
extracellular, transmembrane (TM) and intracellular regions of the isoforms Ob-Ra, b, c 
and f. Shaded areas indicate identical regions between these isoforms,from nucleotide 
position 2667 (Genebank accession number U60151) the C-terminal sequences are divergent 
among these isoforms (indicated by white region which varies in length for the different 
isoforms). Isoform Ob-Re lacks a transmembrane domain and is identical to the other 
isoforms until nucleotide position 2389. Locations of forward primer (F), reverse primer 
(R), and probe (P) are indicated. Isoforms a, b, c and f share the same forward primer and 
probe but have specific reverse primers. Ob-Re has separate forward, and reverse primers 





Table 4.4: Primers and Probe for Ob-Ra, b, c, and Ob-Rf 
Leptin Primer Nucleotide Sequence Accession 
receptor Number 
common sense 5' -CTCTCCAGAGAATGAAAAAGTTGTTT-3' U60151 
probe 5 '-ACGATGTTCCAAACCCCAAGAATTGTTCC-3' 
Ob-Ra anti sense 5'-CTCTTTGAAGTATCTCATGACCACTACA-3' AF304191 
Ob-Rb anti sense 5 '-TTTGAGCATCTTTTT ACCAAGCAT-3' U60151 
Ob-Re anti sense 5'-AAGGTCACTTTTTAAGTATTACCCAAGATATC-3' AF007818 
Ob-Rf antisense 5'-AGGATATAGAGTGGATGCCGTCA-3' U53144 
Real-time PCR 
MicroAmp Optical 96-well reaction plates were used for Real-time PCR reactions 
(PE Applied Biosystems). Each plate contained of the samples from one brain area, a 
dilution series of stock cDNA and no template controls. All reactions were carried out in 
duplicate. A reaction mix containing primers and probes at optimised final 
concentrations of 300 nM and 200 nM respectively, TaqMan Universal PCR Master Mix 
(lx) and RNase-free water was prepared. Template cDNA (1.5 µl) was added to each 
well along with 13.5 µl of reaction mix so that the final reaction volume in each well was 
15 µI. The no template control consisted of 13.5 µl reaction mix and 1.5 µl of water 
instead of template cDNA. A stock of cDNA containing relatively high levels of leptin 
receptor mRNA was used to create a two-fold dilution series that was also assayed on 
each plate. 
An ABI PRISM 7700 Sequence Detection System (Centre for Gene Research, 
University of Otago) was used to detect fluorescence during each PCR cycle. The 
thermal cycling conditions were set at 50°C for 2 minutes and 95°C for 10 minutes 
initially, followed by 15 seconds at 95°C (melting step) and 1 minute at 60°C 
(anneal/extend step) for 40 cycles. The initial steps were important to activate the 




PCR reactions, and to activate the AmpliTaq Gold DNA polymerase present in the 
TaqMan Universal PCR Master Mix. 
Data Analysis 
The amount of fluorescence detected in each well was continuously monitored 
throughout the 40 cycles of amplification. Raw data were displayed as an amplification 
plot with changes in fluorescence relative to an internal standard reference (LogRn) 
plotted against cycle number (see figure 4.3). In the linear portion of the amplification 
plot a threshold value was set. The cycle number during which fluorescence first exceeds 
this threshold (CT) was calculated for each sample. The mean ~ value and standard 
deviation for the duplicates of each sample were calculated. Any sample with a ~ value 
of greater than 38 was discarded as the fluorescence signal at this late stage is possibly 
due to non-specific amplification. Any B-actin sample with a ~ value above 30 was also 
discarded as this corresponded to very low RNA levels in the original sample and hence 
the leptin receptor isoforms were undetectable. Typically less than three samples were 
discarded per 96 well plate. 
Data were analysed using the relative quantification technique by PE Applied 
Biosystems (1998). This method allows for the comparison of the amount of target RNA 
in each sample group to the amount in the same brain region from an arbitrary reference 
group without requiring the precise amount of RNA present in each sample to be 
measured. Each sample was analysed for mRNA sequences of the five leptin receptor 
isoforms and B-actin. For each sample, the~ value for B-actin was subtracted from the 
~ value from the corresponding leptin receptor (~CT) to correct for differences in the 
amount of starting tissue. This value was then combined with the other ~CT values from 
the other samples in the same animal group, to form the average ~CT value and standard 
deviation for each animal group. Due to the exponential nature of the amplified product, 
comparisons of the results to the diestrous control group can be determined using the 
formula, relative quantification = 2-McT, where ~~CT is the average diestrous ~CT 
subtracted from the average experimental group~~ value. This calculation provides a 




experimental animal group relative to diestrus, resulting in an amount expressed in fold 
differences relative to the diestrous amount. 
Statistical Analysis 
For each hypothalamic region and the choroid plexus, statistical analysis was 
carried out on average 8CT using the non-parametric Kruskal-Wallis test. If a significant 
H-statistic was detected, the Mann-Whitney U test was applied to compare each group 
with diestrus. The significant level was set a P < 0.05 and data are expressed as mean ± 
sem. Positive and negative error bars are uneven, as they represent exponential variation 
plotted on a linear scale. 
Results 
A serial two-fold dilution curve using a stock cDNA template was constructed for 
each of the leptin receptor isoforms. The amplification plots of the duplicate dilutions 
demonstrate the accuracy and reproducibility of this technique (figures 4.3). The two-
fold dilutions were detected approximately one cycle apart as predicted by the 
exponential nature of PCR amplification, illustrating the precision of the method over a 
wide range of starting cDNA concentrations. The linear relationship between ~ 
(threshold cycle) and initial cDNA amount demonstrates the quantitative nature of this 
assay (figures 4.3). A requirement for the 88Ct quantitation method for real-time PCR is 
that the efficienices of the reaction for the target gene and house-keeping gene are 
similar. Plotting 8Ct (target Ct - beta-action Ct) versus the dilution series yeilded 
gradients of 0.06, 0.02, 0.04, 0.1 for Ob-Ra, Ob-Rb, Ob-Re, and Ob-Rf, respectively, 
meeting the requirements for using the 88Ct method. No amplification was detected in 
either the no reverse transcription control or the no template control samples. Ob-Re 
mRNA was not detected in any of the brain areas examined. The other four isoforms, 
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Figure 4.3: Amplification plots for the serial dilutions (two-fold) of a stock cDNA for 
Ob-Ra (A), Ob-Rb (B), Ob-Re (C, see next page) and Ob-Rf (D, see next page). Change 
in fluorescence of the PCR product plotted against cycle number. Ct (threshold cycle) is 
the cycle number when the PCR product is first detected, and is determined by the point 
of interception of the threshold value (indicated by threshold line) and the amplification 
plot. The threshold line is positioned in the linear portion of the amplification plot which 
corresponds to the exponential phase of the reaction. Inserted log graph shows the linear 
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Ventromedial nucleus of the hypothalamus 
At all time points during pregnancy, there were reduced expression levels of Ob-
Rb mRNA in the VMH (figure 4.48). On days 7, 14, and 21 during pregnancy, Ob-Rb 
mRNA levels were decreased 3.1-, 2.4-, and 2.0-fold respectively, compared to diestrus 
(P < 0.05). On day 7 of lactation, Ob-Rb mRNA expression was no longer significantly 
different to diestrus. There was a trend for a similar pattern of reduced expression of the 
other receptor isoforms during pregnancy but this did not reach statistical significance 
(figure 4.4). 
Rostral Arcuate Nucleus 
In the rostral arcuate nucleus, significant changes in all receptor isoforms were 
observed. The short forms of the receptor, Ob-Ra, Ob-Re and Ob-Rf, had significantly 
reduced mRNA expression levels on day 7 of pregnancy, with decreases of 1.9-, 4.5- and 
3.2-fold respectively (figure 4.5). Ob-Re mRNA was also significantly reduced by 3.2-
fold on day 21 of pregnancy (figure 4.5C). Expression of Ob-Ra and Ob-Re mRNA was 
decreased 1.8- and 2.8- fold, respectively, on day 14 of pregnancy but these results were 
not statistically significant. Ob-Rb mRNA expression was significantly increased 2.3-
fold on day 7 of lactation compared to diestrous (figure 4.58). 
Caudal Arcuate Nucleus 
While mRNA for all four of the leptin receptor isoforms was detected in the 
caudal arcuate nucleus, no significant changes in expression levels compared to diestrus 













Figure 4.4: Mean± sem levels of expression of Ob-Ra (A), Ob-Rb (B), Ob-Re (C) and 
Ob-Rf (D) in the ventromedial nucleus of the hypothalamus during pregnancy and lactation 
(lact). All values are expressed as a ratio of the diestrous value (Di), n=5-8. * significant 











































































Figure 4.5: Mean± sem levels of expression of Ob-Ra (A), Ob-Rb (B), Ob-Re (C) and 
Ob-Rf (D) in the rostral arcuate nucleus of the hypothalamus during pregnancy and lactation 
(lact). All values are expressed as a ratio of the diestrous value (Di), n=5-8. * significant 
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Figure 4.6: Mean± sem levels of expression of Ob-Ra (A), Ob-Rb (B), Ob-Re (C) and 
Ob-Rf (D) in the caudal arcuate nucleus of the hypothalamus during pregnancy and lactation 
(lact). All values are expressed as a ratio of the diestrous value (Di), n=5-8. * significant 




Dorsomedial nucleus of the hypothalamus 
In the DMH, Ob-Re mRNA expression was significantly increased 1.7-fold on 
day 7 of lactation compared to diestrus (figure 4.7C). Expression levels of the other 
leptin receptor isoforms were not significantly different to diestrus during pregnancy or 
lactation (figure 4.7). 
Paraventricular nucleus and Supraoptic Nucleus 
Expression levels of mRNA for the various leptin receptor isoforms remained 
relatively stable throughout pregnancy and lactation in the paraventricular nucleus. There 
were no significant differences in mRNA expression levels between any time point and 
diestrus for each of the receptor isoforms (figure 4.8) . Similar results were seen in the 
SON (figure 4.9). 
Choroid Plexus 
In the choroid plexus, there was a significant change in expression of Ob-Ra 
mRNA during pregnancy compared to diestrus (figure 4.9A). On days 7 and 21, Ob-Ra 
mRNA was significantly decreased by 2.8- and 2.0-fold, respectively, compared to 
diestrus. On days 14 of pregnancy, and 7 of lactation there was a 1.8-fold reduction in 
Ob-Ra mRNA levels but this was not significant. Compared to diestrus, there were no 
significant changes in mRNA expression of the other receptor isoforms during pregnancy 
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Figure 4.7: Mean± sem levels of expression of Ob-Ra (A), Ob-Rb (B), Ob-Re (C) and 
Ob-Rf (D) in the dorsomedial nucleus of the hypothalamus during pregnancy and lactation 
(lact). All values are expressed as a ratio of the diestrous value (Di), n=5-8. * significant 
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Figure 4.8: Mean± sem levels of expression of Ob-Ra (A), Ob-Rb (B), Ob-Re (C) and 
Ob-Rf (D) in the paraventricular nucleus of the hypothalamus during pregnancy and 




















Figure 4.9: Mean± sem levels of expression of Ob-Ra (A), Ob-Rb (B), Ob-Re (C) and 
Ob-Rf (D) in the supraoptic nucleus of the hypothalamus during pregnancy and lactation 
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Figure 4.10: Mean± sem levels of expression of Ob-Ra (A), Ob-Rb (B), Ob-Re (C) and 
Ob-Rf (D) in the Choroid plexus during pregnancy and lactation (lact). All values are 
expressed as a ratio of the diestrous value (Di), n=5-8. * significant with respect to diestrus 





The sensitivity of the hypothalamus to circulating leptin concentrations can be 
modulated by the expression of the leptin receptor. It has been proposed that an increase 
in hypothalamic Ob-Rb expression will ultimately result in enhanced sensitivity to leptin, 
and conversely a decrease will led to reduced sensitivity to leptin (Baskin et al. 1998). 
Further to this, leptin sensitivity may be modified by changes in the Ob-Rb/Ob-Rs ratio. 
Increasing this ratio might increase leptin sensitivity, whereas reductions in this ratio 
might decrease the sensitivity of the hypothalamus to leptin (Bennett et al. 1998). The 
aim of this study, therefore, was to examine the expression levels of mRNA for the 
various leptin receptor isoforms during pregnancy. It was hypothesised that region-
specific changes in receptor expression levels are involved in pregnancy-induced leptin 
resistance and the associated impaired activation of the JAK/STAT3 pathway. The five 
leptin receptor isoforms that have been identified in the rat were examined in six areas of 
the hypothalamus and in the choroid plexus. In most cases, the expression levels for the 
various isoforms of the leptin receptor remained relatively stable across the time points 
(diestrus, days 7, 14 and 21 of pregnancy and day 7 of lactation), however, significant 
changes in expression of various receptor isoforms were observed in the VMH, DMH, 
rostral arcuate nucleus and choroid plexus. 
The modulation of leptin sensitivity by regulating the ratio of the long and short 
forms of the receptor is based on the idea that the short isoforms of the receptor may act 
as competitive inhibitors of leptin signalling by forming inactive heterodimer receptor 
complexes with the long form of the receptor (Vaisse et al. 1996; White et al. 1997a; 
Bennett et al. 1998). In vitro, the co-transfection of increasing amounts of truncated Ob-
R results in only a slight decrease in signalling potential, suggesting that the short 
isoforms of the receptor play only a moderate, if any, dominant negative suppression role 
(White et al. 1997a). Furthermore, using targeted knock outs of specific regions of the 
receptor required for signal transduction, it was shown that ligand binding may result in 
higher order oligomerisation of the receptors (Zabeau et al. 2004). Since only two 




would be highly resistant to dominant negative suppression (Zabeau et al. 2004). Current 
evidence indicates that it is unlikely that the short isoforms play a major role in limiting 
signal transduction suggesting that the ratio of Ob-Rb/Ob-Rs does not greatly impact 
sensitivity to leptin. At this point in time, the functions of the short forms of the receptor 
are not clear. 
Relative quantitation of mRNA for Ob-R isoforms across pregnancy was 
determined using real-time RT-PCR. During amplification in the real-time RT-PCR 
procedure, increasing amounts of fluorescence are generated by the cleavage of the 
probe. The amount of fluorescence is measured at the end of each cycle, generating an 
amplification plot for the entire 40 cycles of the reaction. This amplification plot 
provides a more complete account of the PCR reaction than assaying the product 
accumulation after a set number of cycles. Furthermore, the potential rate-limiting 
effects of reagent and enzyme concentrations on the accumulation of PCR product are 
less likely to influence results in real-time RT-PCR as the threshold is set in the 
exponential phase of the reaction when these components are not limiting. 
The most salient finding of this study was the decreased expression of Ob-Rb 
mRNA in the VMH on days 7, 14 and 21 of pregnancy, as this is consistent with the 
decreased activation of the JAK/STAT3 pathway observed in chapter three. Whether the 
significant changes observed in leptin receptor mRNA expression levels during 
pregnancy in this study reflect levels of protein expression has not been measured. While 
in some cases, leptin receptor mRNA expression levels have been shown to reflect the 
receptor protein levels (Martin et al. 2000), parallel changes in mRNA and protein are not 
always observed (Madiehe et al. 2000). Indeed, it cannot be assumed that mRNA levels 
unequivocally correlated with protein expression. Nevertheless, the Ob-Rb mRNA 
results are consistent with our previous results examining leptin activation of the 
JAK/STAT3 pathway. The activation of pSTAT3 has been determined to be a useful 
marker of functional activation of Ob-Rb by leptin (Levin et al. 2004). While mRNA 
data alone does not guarantee that Ob-Rb protein or function is reduced, combined with 
previous results of a concurrent reduction in leptin-induced pSTAT3, these results imply 
that Ob-Rb protein may also reduced during pregnancy. Decreased availability of Ob-Rb 





activation of JAK2 and, hence, reduced STAT3 phosphorylation. Whether or not this 
decrease in Ob-Rb mRNA can fully account for the impaired STAT3 phosphorylation 
during pregnancy is yet to be determined. The specific down-regulation of Ob-Rb 
mRNA in the VMH would explain, at least partially, the state of leptin resistance during 
pregnancy. 
On day 7 of pregnancy, mRNA expression of the short forms of the receptor (Ob-
Ra, c and f) were decreased in the rostral arcuate nucleus compared to diestrus. It is 
unlikely that this decrease in Ob-Rs results in an increase in leptin sensitivity in the 
rostral arcuate nucleus as most evidence suggests that the Ob-Rb/Ob-Rs ratio does not 
greatly effect leptin sensitivity. Furthermore, results from chapter two indicate that while 
the day 7 pregnant rats did show a hypophagic response to leptin, the observed increased 
leptin concentrations and food intake do not support a state of increased leptin sensitivity. 
Also in the rostral arcuate nucleus, an increase in Ob-Rb mRNA was observed on day 7 
of lactation compared to diestrus. 
Previous studies examining hypothalamic leptin receptor mRNA during 
pregnancy have either found no change in expression (Seeber et al. 2002; Rocha et al. 
2003) or a decrease in Ob-Rb mRNA on day 18 of pregnancy (Garcia et al. 2000). These 
studies examined the hypothalamus as a whole, therefore limiting the ability to detect 
region specific changes in expression. The microdissection of the hypothalamus 
performed in the present study allowed for the examination of specific nuclei, thus we 
were able to detect a specific decrease of Ob-Rb mRNA in the VMH while expression 
levels remained relatively stable in the DMH, arcuate nucleus, PVN and SON. Previous 
accounts of leptin receptor expression during lactation have produced conflicting results. 
Both Garcia et al (2000) and Seeber et al (2002) did not detect any changes in Ob-Rb 
mRNA during lactation when examining the hypothalamus as a whole, whereas others 
have observed a decrease in these expression levels compared to non-lactating rats (Denis 
et al. 2003). When areas of the hypothalamus are examined separately, Ob-Rb mRNA 
has been shown to increase in the SON and decrease in the VMH during lactation, with 
no change in the PVN, the arcuate nucleus and the DMH (Brogan et al. 2000). The 
reasons for the differences in results are not clear, and may be due to the range of time 




expression ( conventional and real-time RT-PCR, in situ hybridisation) and the tissue 
sample examined (whole hypothalamus vs. discrete areas of the hypothalamus). Further 
work is required to confirm the changes in leptin receptor mRNA during lactation. 
The mechanisms involved in the regulation of the leptin receptor in the 
hypothalamus are not well characterised, especially in terms of the different isoforms of 
the receptor and the different areas of expression. The up-regulation of Ob-Rb mRNA 
expression levels in the hypothalamus induced by fasting is a well established 
modification in receptor expression, and is suggested to be due to the decrease in leptin 
concentrations accompanying the fasting period (Lin et al. 1997; Baskin et al. 1998). 
Similarly, ob/ob mice, which lack leptin, have increased Ob-Rb mRNA levels, and these 
can be reduced by the administration of leptin (Lin et al. 1997; Baskin et al. 1998) . 
Furthermore, fasting in obi ob mice does not further increase receptor levels (Lin et al. 
1997). Using overexpression of the leptin gene in the hypothalamus, Ob-Rb expression 
can be reduced, and removal of central leptin treatment increases Ob-Rb expression, 
demonstrating a role for central leptin concentrations in the regulation of Ob-Rb (Wilsey 
et al. 2004). Leptin receptor mRNA expression in the hypothalamus increases during the 
light phase, and decreases during the dark phase, consistent with an inverse relationship 
with leptin (Xu et al. 1999). This pattern of expression is limited to only some of the 
receptor isoforms. Ob-Rb, c and e, demonstrate this nocturnal decrease, whereas Ob-Ra 
and f, remain at constant levels during the light and dark phase (Denis et al. 2003). These 
results suggest that leptin receptor mRNA, especially Ob-Rb, can be regulated by leptin. 
One possibility therefore, is that elevated leptin during pregnancy may result in down-
regulation of the leptin receptor. Such effect would not be uniform across all brain 
regions, however, as this down-regulation was specific to the VMH. Similarly, low 
leptin concentrations in lactation are likely to lead to increased expression of the leptin 
receptor, as was detected in the rostral arcuate nucleus in the present study. An inverse 
relationship between leptin and its receptor, however, is not always apparent. In diet 
induced obese rats, increased leptin concentrations are not reflected by decreased Ob-Rb 
mRNA expression (Sahu et al. 2002) and, in some studies, during lactation the low serum 
leptin concentrations are not associated with increased Ob-Rb mRNA expression (Brogan 
et al. 2000; Denis et al. 2003 ). 
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Pregnancy is associated with high progesterone concentrations and it is possible 
that this hormone is involved in the pregnancy-induced changes in leptin receptor 
expression. Female rats treated with progesterone, at concentrations similar to pregnancy 
(Butcher et al. 1974), have increased food intake that is not associated with changes in 
serum leptin concentrations, suggesting a role for progesterone in regulating the 
sensitivity of the hypothalamus to leptin (Grueso et al. 2001). Progesterone has been 
shown to suppress the expression of Ob-Rb mRNA in human endometrium, in vitro 
(Koshiba et al. 2001), and, while not specifically investigated in the hypothalamus, these 
results suggesting that progesterone can modify leptin sensitivity by regulating Ob-Rb 
mRNA expression. It was not possible to identify the location of the down-regulation of 
Ob-Rb mRNA within the VMH. Leptin activity in the VMH has been localised to the 
dorsomedial region of this nucleus (chapter three), therefore it can be assumed that this is 
the location of the long form of the leptin receptor within the VMH. It is highly unlikely 
that there is any direct interaction of progesterone on Ob-Rb mRNA in the VMH as 
progesterone receptors are not detected in the dorsomedial region of the VMH (Fox et al. 
1990). 
On days 7 and 21 of pregnancy, Ob-Ra mRNA was reduced in the choroid 
plexus compared to diestrus. The choroid plexus is a proposed site of leptin receptor 
mediated transport of leptin into the brain (Tartaglia et al. 1995; Zlokovic et al. 2000; 
Peiser et al. 2000a). Transport of leptin into the brain appears to be saturated at the high 
serum leptin concentrations observed during obesity (Van Reek et al. 1997; Banks et al. 
1999). Further to this, equivalent CSF leptin concentrations are seen in obese rats and 
lean control rats despite greatly increased serum leptin concentrations in the former, 
leading to decreased CSP/serum leptin concentration ratios in the obese rats (Wu-Peng et 
al. 1997; lshizuka et al. 1998). A decrease in Ob-Ra, a proposed mediator of leptin 
transport, in the choroid plexus may be associated with reduced leptin entry into the brain 
during pregnancy, consistent with the hypothesis that impaired leptin transport 
contributes to the state of leptin resistance. Whether or not impaired leptin transport into 
the brain during pregnancy contributes to the state of leptin resistance, our previous 





These results show a number of changes in leptin receptor mRNA expression in 
the hypothalamus during pregnancy in the rat that may contribute to the developing state 
of leptin resistance. The down-regulation of Ob-Rb mRNA observed in the VMH, and 
the decreased activation of the JAK/STAT3 signalling pathway previously observed in 
this area during pregnancy, are consistent with the state of leptin resistance during 
pregnancy. Furthermore, a reduction in mRNA expression for a proposed leptin 
transporter molecule, Ob-Ra, in the choroid plexus, suggest a possible decrease in leptin 
transport into the brain at this site, supporting the hypothesis that reduced leptin entry 
into the brain may also contribute to the pregnancy-induced state of leptin resistance. 
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Chapter five: Leptin-induced pSTAT3 in specific 




The most well characterised neuron populations that are regulated by leptin are 
the NPY/AgRP neurons and the POMC neurons, situated in the arcuate nucleus. These 
neuron populations are both first order leptin responsive neurons that integrate the leptin 
signal with the neural circuits involved in energy homeostasis (Cowley et al. 2003; 
Zigman et al. 2003 ). NPY is one of the most potent orexigenic factors known and the 
production of this neuropeptide within the hypothalamus is almost exclusively limited to 
the arcuate nucleus (Chronwall et al. 1985; de Quidt et al. 1986). The POMC cleavage 
product a-MSH mediates the anorectic function of the POMC neurons, while AgRP 
which is colocalised with NPY, is an endogenous antagonist of the melanocortin system. 
Leptin negatively regulates the mRNA expression levels of AgRP and NPY, and 
positively regulates POMC mRNA expression. The regulation of AgRP and POMC by 
leptin is mediated, at least in part, through the JAK/ST AT3 signalling pathway (Bates et 
al. 2003; Munzberg et al. 2003), however the involvement of STAT3 in the regulation of 
NPY is yet to be specifically confirmed. 
Despite the elevated leptin concentrations during pregnancy, AgRP mRNA in the 
hypothalamus is increased (Rocha et al. 2003), and a-MSH levels are reduced in the 
medial basal hypothalamus (Khorram et al. 1984) without changes in POMC mRNA 
(Mann et al. 1997; Douglas et al. 2002; Rocha et al. 2003). Furthermore, NPY mRNA 
and protein levels remain relatively stable during pregnancy (Ciofi et al. 1991; Wilding et 
al. 1997; Rocha et al. 2003), although NPY mRNA has been observed, using in situ 
hybridisation, to increase in late pregnancy (Garcia et al. 2003). Hence, pregnancy-
induced leptin resistance may involve a disruption of the leptin signal to prevent it 
influencing the activity of these neurons. 
'> 
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Although pST A T3 immunohistochemistry suggested that the number of neurons 
that were leptin responsive in the arcuate nucleus did not change during pregnancy, 
western blot analysis indicated that there was a significant loss of response to leptin 
activation in this area during pregnancy. It is possible that these apparently conflicting 
results may be due to differential changes in leptin action on the different neuronal 
populations expressing the leptin receptor in the arcuate nucleus. Hence, the aim of this 
section was to analyse the leptin-induced activation of specific neuron populations within 
the arcuate nucleus during pregnancy . 
Methods 
Experimental procedure 
Brain sections collected from pregnant and non-pregnant rats in chapter three 
were processed for double-label immunohistochemistry. Briefly, coronal brain sections 
(35 µm) from vehicle- or leptin-treated non-pregnant and pregnant rats were collected in 
six series, with each series containing sections through the arcuate nucleus and the 
ventromedial nucleus 210 µm apart. One series of sections was used to stain for both a-
MSH and pSTAT3, while another series of sections was used to stain for both AgRP and 
pSTAT3. 
Antibodies 
Details of the pSTAT3 specific antibody have previously been described in 
chapter three. The a-MSH specific antibody was a sheep polyclonal antibody (Chemicon 
International, Temecula, CA AB5087) raised against the C-terminal end of the protein. 
The AgRP specific antibody was a rabbit polyclonal antibody (Phoenix Pharmaceuticals, 
Inc Belmont CA G-003-53) raised against the 83-132-NH2 (Human) fragment of the 
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peptide. Optimal working dilutions were determined to be 1:60000 for the sheep anti-a-
MSH antibody and 1:2000 for the rabbit anti-AgRP (83-132)-NH2 antibody. 
a-MSH and pSTA T3 staining 
Free-floating tissue sections were used for this procedure and one series of 
sections was used from each rat. All washes consisted of three five minute incubations in 
buffer (PBS/0.25% triton-X/130 mM NaCl, pH 7.2) on an orbital shaker at room 
temperature. Sections were removed from storage, washed and then incubated for 20 
minutes at room temperature in 0.9% H202 to block endogenous peroxide activity. 
Sections were then washed and incubated in blocking buffer (buffer containing 3% 
normal donkey serum and 0.02% sodium azide) for 1 hour at room temperature. 
Following this, sections were incubated overnight at room temperature in blocking buffer 
containing the a-MSH antibody (1:60000 dilution). After approximately 18 hours, 
sections were washed then incubated with a biotinylated donkey anti-sheep antibody for 1 
hour (1:500 dilution in blocking solution without sodium azide), and then treated with an 
avidin-biotin-peroxidase complex (Vectastain Elite ABC kit) for 1 hour. After washing, 
the sections were incubated in 0.05 M Tris-HCI (pH 7.3) for 5 minutes then the 
peroxidase signal was visualised with a 3,3 '-diaminobenzideine reactions (DAB substrate 
kit from Vector) resulting in a brown precipitate. This reaction was stopped by three 10 
minute incubations in buffer. Staining for pST AT3 was then carried out as previously 
described in chapter three . 
AgRP and pSTAT3 staining 
Staining for AgRP was similar to the a-MSH staining procedure. The only 
differences were in the conditions for the antibody incubations. The AgRP specific 
antibody was used at a dilution of 1:2000 in blocking buffer containing 5% normal goat 
serum, and incubated for two nights at 4°C. The incubation with the biotinylated 




temperature. Staining for pSTAT3 was then carried out as described previously in 
chapter three. 
Analysis 
The sections were viewed on an Olympus BX51 research microscope. The 
number of a-MSH positive cells and the number of these cells which were also positive 
for pST A T3 were counted in each section. Only cells that had a distinguishable 
purple/blue nucleus surrounded by brown cytoplasmic staining were considered to be 
double labelled. At least three sections were analysed per rat and all analysis was done 
blind to the treatment group. For each rat, the average number of positive cells per 
section was calculated and used for statistical comparisons between treatment groups. To 
determine the overall proportion of a-MSH positive cells colocalised with pSTAT3 for 
each group, the average number from each animal in the group was pooled. While this 
experiment was not specifically designed to assess the proportion of cells double labelled 
in different regions of the arcuate nucleus, data from sections at the same rostral-caudal 
position were pooled for analysis. Differences between groups were analysed by two-
way ANOVA followed by Fisher's PLSD post hoc test. The significance level for all 
statistics was set at P < 0.05. All data are presented as the mean ± sem. AgRP analysis 
was not completed as the staining for AgRP was too faint to ensure accurate results. 
Results 
a-MSH and pSTA T3 colocalisation 
Cell bodies containing a-MSH in the arcuate nucleus were predominantly situated 
in the lateral regions but were also readily visible in more medial regions of the nucleus 
(figure 5.1). Similar to previous reports, nerve fibers containing a-MSH were 




hypothalamus (figure 5 .1 ), as well as extrahypothalamic brain regions (Bagnol et al. 
1999; Munzberg et al. 2003). Due to the distinct intracellular distribution of a-MSH and 
pSTAT3, immunolabelling for these proteins could easily be analysed using two different· 
colour reaction productions (see figures 5.2 and 5.3A). Leptin treatment led to a 
significant increase in the percentage of a-MSH positive neurons that were also positive 
for pSTAT3 in both the non-pregnant and pregnant groups (figure 5.3B). The percentage 
of neurons that were positive for both C and pST AT3 after leptin treatment did not differ 
between pregnant and non-pregnant rats (Figure 5.3B). The number of neurons stained 
positive for a-MSH did not differ between any of the groups (figure 5.3C). 
Approximately 71 % and 70% of a-MSH positive neurons were colocalised with pSTAT3 
in the non-pregnant and pregnant groups respectively. Between 1000 and 1700 a-MSH 
positive neurons were counted per group. Comparisons between colocalisation of 
pSTAT and a-MSH in the rostral and caudal regions of the arcuate nucleus indicated that 
there were no differences in the percentage of a-MSH and pSTAT3 colocalised in 
difference regions of the arcuate nuclues. 
AgRP and pSTAT3 colocalisation 
AgRP positive neurons were identified in the medial region of the arcuate nucleus 
(figure 5.4A). Preliminary results indicated that colocalisation of pSTAT3 in AgRP 
positive neurons was detectable in both non-pregnant (figure 5.4B) and pregnant (figure 
5.4C). Unfortunately when all sections were processed in a single run for analytical 
purposes, the AgRP was deemed to be too faint to produce reliable results for 
quantification. While AgRP staining was detectable when colocalised with pSTAT3 (see 
figures 5.4B and C), identification of cells positive for AgRP staining only was not 
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Figure 5.1: Leptin-induced STAT3 phosphorylation (purple/black nuclei stain) and alpha-
MSH (brown stain) in the medial basal hypothalamus. Coronal brain sections from non-
pregnant (top) and pregnant (bottom) rat 30 minutes after i.c.v. administration of vehicle(left) 
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Figure 5.2: Leptin-induced pSTAT3 and alpha-MSH in the arcuate nucleus of non-pregnant 
and pregnant rats. Representative sections of the arcuate nucleus from leptin-treated non-
pregnant (A) and pregnant (B) rats stained for pSTAT3 (purple/black nuclei stain) and 






























Figure 5.3: Percentage of alpha-MSH neurons colocalised with leptin-induced pSTAT3 
A Examples of alpha-MSH positive neurons that are positively stained for pSTAT3 (black 
arrows) or negative for pSTAT3 staining (green arrow). Red arrow indicates pSTAT3 
positive/alpha-MSH negative neuron. B Bars represent mean± sem for the percentage 
of alpha-MSH positive neurons that were also positively stained for pSTAT3 in each 
treatment group (n = 5-6 per group) in the arcuate nucleus. * significant with respect to 
vehicle-treated groups (P < 0.05). C Bars represent mean ± sem for number of alpha-
























Figure 5.4: AgRP staining in the arcuate nucleus. Representative section (A) through the 
arcuate nucleus of a pregnant rat stained for AgRP (brown stain). Representative section 
from the arcuate nucleus of leptin-treated non-pregnant (B) and pregnant (C) rats stained 
for pSTAT3 (purple/black nuclei stain) and AgRP (brown stain). 
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Discussion 
To further investigate leptin-induced STAT3 activation in the arcuate nucleus 
during pregnancy, the percentage of neurons in different populations that are activated by 
leptin was investigated. Immunohistochemistry can not be considered quantitative for the 
amount of staining per cell but can provide relative estimates of the number of positively 
stained cells. The relative proportions of double-labelled cells can therefore provide 
useful estimates to the degree of colocalisation in different treatment groups. The 
distribution of a-MSH and AgRP matched previous reports for POMC neurons and 
NPY/AgRP neurons respectively (Schwartz et al. 1997; Thornton et al. 1997; Broberger 
et al. 1998; Hahn et al. 1998; Mizuno et al. 1998; Haskell-Luevano et al. 1999). Results 
from the present study indicate that there was no difference in the colocalisation of a-
MSH and pST AT3 between the pregnant and non-pregnant groups. The staining for 
AgRP and pST A T3 did not yield results suitably reliable for quantitation thus the 
proportion of colocalisation was not determined. 
The melanocortin neural pathway is responsive to leptin and mediates, at least 
part of, the satiety actions of leptin. Transgenic mice with specific deletion of leptin 
receptors in POMC neurons are mildly obese, confirming that these neurons play an 
important role in the regulation of energy homeostasis by leptin (Balthasar et al. 2004). 
Activation of ST AT3 plays a critical role in leptin stimulation of pomc gene transcription 
in POMC neurons (Bates et al. 2003; Munzberg et al. 2003). The loss of satiety response 
to leptin during pregnancy may involve an inability of leptin to fully activate this neural 
pathway. In support of compromised regulation by leptin is the relatively stable POMC 
mRNA (Mann et al. 1997; Douglas et al. 2002; Rocha et al. 2003) and decreased a-MSH 
(Khorram et al. 1984) in the medial basal hypothalamus observed during pregnancy, 
despite elevated leptin concentrations. The results from the present study indicate that 
the mechanisms causing this compromised regulation is downstream, or independent of 
leptin-induced STAT3 phosphorylation. 
Using pSTAT3 as a marker of activation can provide relevant information about 
the functional activation of Ob-Rb by leptin. JAK phosphorylation is critical to the 
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activation of Ob-Rb and therefore is implicated in all of the identified signalling 
pathways activated by leptin (Ihle et al. 1995; Bjorbaek et al. 1997; Ghilardi et al. 1997; 
Banks et al. 2000a; Bjorbaek et al. 2001). As pSTAT3 was induced by leptin in a-MSH 
neurons during pregnancy, this indicates that JAK phosphorylation is unlikely to be 
impaired. Also, it suggests that leptin receptor expression in these neurons during 
pregnancy is similar to non-pregnant levels, consistent with the results from chapter four 
indicating no change in Ob-Rb mRNA expression levels in the arcuate nucleus during 
pregnancy. While these results demonstrate that the number of a-MSH neurons that are 
responsive to leptin is similar in pregnant and non-pregnant rats, slight changes in degree 
of responsiveness would be undetectable using these methods. 
Previously, a-MSH content in the medial basal hypothalamus has been shown to 
gradually decline during gestation, and on day 14, the time point used in the present 
study, a-MSH levels were significantly reduced compared to non-pregnant levels 
(Khorram et al. 1984). Decreased a-MSH potentially results in a decreased inhibition of 
food intake, consistent with the hyperphagia of pregnancy. During pregnancy there was 
no change in the number of a-MSH positive neurons in the arcuate nucleus compared to 
non-pregnant rats. This suggests that the decrease in a-MSH is due to reduced 
expression per neuron and not a decrease in the number of neurons expressing a-MSH. 
Aside from a-MSH, POMC is the precursor molecule for a number of other 
products, such as ~-endorphin. In contrast to a-MSH, ~-endorphin increases during 
pregnancy (Wardlaw et al. 1983; Petraglia et al. 1985; Mann et al. 1997; Douglas et al. 
2002). Due to unchanging POMC mRNA levels, it has been suggested that post-
translational processing is altered during pregnancy to account for the increase in ~-
endorphin (Douglas et al. 2002). This has not been specifically demonstrated in the 
arcuate nucleus, but changes in enzymes involved in the generation of ~-endorphin occur 
in the POMC neurons in the spinal cord during pregnancy (Varshney et al. 1999). It 
could be speculated that if conditions favoured ~-endorphin production then this may 
negatively impact on the production of a-MSH. 
The current results indicate that leptin-induced pSTAT3 in POMC neurons is not 
impaired during pregnancy. Leptin regulation of POMC neurons, however, does appear 
to be compromised during pregnancy given that POMC expression is not activated by the 
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rising leptin concentrations. To further elucidate the role of leptin in regulating POMC 
gene expression during pregnancy, acute levels of POMC mRNA could be measured 
after exogenous leptin administration and endogenous decreases of leptin through fasting. 
This would indicate whether leptin-induced regulation of POMC expression is impaired 
during pregnancy. To test whether reduced a-MSH plays a role in the hyperphagia of 
pregnancy and is associated with leptin resistance, it would be possible to examine the 
response to the administration of exogenous a-MSH or agonist. Normal a-MSH-induced 
decreases in food intake in pregnant rats after a-MSH administration would implicate the 
POMC neurons as a site of pregnancy-induced leptin resistance. Diet-induced obese rats, 
while not responsive to leptin, have increased sensitivity to exogenous a-MSH agonists 
indicating that the activation of the endogenous melanocortin system is defective, and 
that the POMC neurons are a likely site of leptin resistance (Hansen et al. 2001; Scarpace 
et al. 2003). 
In the present study approximately 70% of a-MSH positive neurons were also 
positive for leptin-induced pST AT3 in both pregnant and non-pregnant groups and this 
number remained constant throughout the arcuate nucleus. Others have reported lower 
levels of colocalisation (approximately 38% ), although when areas were analysed 
separately, in the rostral arcuate nucleus colocalisation of pST AT3 was observed in a 
high proportion of a-MSH positive neurons similar to the present study (Munzberg et al. 
2003). It may be that stringency in the criteria for determining whether a cell was 
double-labelled differed between studies. Furthermore, the study by Munzberg et al 
(2003) used non-fasted male rats, as opposed to the fasted female rats used in the current 
study. Fasting increases sensitivity to leptin by increasing Ob-Rb mRNA, especially in 
the arcuate nucleus (Baskin et al. 1998). This fasting-induced increase in receptor 
combined with the central administration compared to peripheral administration of leptin 
in the previous study, may have led to increased activation of leptin-responsive neurons. 
The peripheral dose of leptin was greater than the central dose, but it is well documented 
that lower doses i.c.v. are required for a similar response to peripheral administration 
(Campfield et al. 1995). Furthermore, female rats are more sensitive to the satiety actions 
of exogenous leptin administration (Clegg et al. 2003), possibly due to the higher 
expression levels of Ob-Rb mRNA in post-pubertal female rats compared to male rats 
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(Smith et al. 2003). Consequently it may be that a higher proportion of a-MSH neurons 
are colocalised with leptin-induced pSTAT3 in females compared to males, although this 
has yet to be directly tested. 
Due to faint staining of the double-label immunohistochemistry, reliable 
quantification of the colocalisation of pSTAT3 and AgRP staining was not possible. 
Single-labelled AgRP staining was originally performed in all groups to confirm the 
location of these neurons. AgRP positive staining was only observed in the medial 
region of the arcuate nucleus similar to previous reports (Wilson et al. 1999). AgRP is 
colocalised with NPY in the arcuate nucleus (Broberger et al. 1998; Hahn et al. 1998), 
therefore AgRP can be used as a marker for these NPY neurons. Double-labelled 
neurons were detected in both leptin-treated pregnant and non-pregnant rats suggesting 
that at least some NPY /AgRP neurons were responsive to leptin in both groups. This 
experiment needs to be repeated, however, to determine if there are changes in the 
number of NPY I AgRP neurons that are responsiveness to leptin during pregnancy. 
Interestingly, increased mRNA for AgRP has been detected in the hypothalamus 
during pregnancy (Rocha et al. 2003) consistent with a decreased response of these 
neurons to leptin. In the present study, it was observed that AgRP was more easily 
detected in the pregnant rats compared to non-pregnant rats, tentatively suggesting that 
the protein may be more abundant in the former group. Increased neuropeptide protein in 
the cell bodies may be due to an increase in synthesis as suggested by earlier mRNA 
analysis (Rocha et al. 2003). To test this hypothesis, a rigorous analysis of AgRP protein 
is required. 
Immunohistochemisty is inherently qualitative and comparisons of levels of 
staining cannot be considered adequate evidence of changes in protein levels. Fasting 
induces an increase in the number of cells expressing AgRP as well as increases in 
overall AgRP mRNA levels (Hahn et al. 1998). Potentially, the increase in AgRP mRNA 
during pregnancy (Rocha et al. 2003) involves an increase in the number of neurons 
expressing AgRP. Relative quantification of neurons positively stained for AgRP, as 
opposed to assessing intensity of staining per neuron, may therefore provide a feasible 
way to compare differences between pregnant and non-pregnant rats. It may be more 
appropriate to use non-fasted rats, however, as potential for differential responses to 
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fasting, with respect to increasing AgRP expression, in the two physiological states may 
confound results. If increases in AgRP are involved in pregnancy-induced hyperphagia 
then it would be expected that blocking the action of this neuropeptide would reduce food 
intake in pregnant rats. While there is no current AgRP antagonist, using a-MSH to 
change the ratio of AgRP to a-MSH, or by using antisense mRNA to suppress AgRP 
mRNA may provide useful alternatives in examining the role of AgRP during pregnancy. 
There are conflicting reports regarding the levels of NPY during pregnancy. NPY 
mRNA and protein levels have been shown to remain relatively stable during pregnancy 
(Ciofi et al. 1991; Wilding et al. 1997; Rocha et al. 2003), yet, using in situ hybridisation, 
NPY mRNA levels have been observed to increase in late pregnancy (Garcia et al. 2003). 
The high leptin concentrations of pregnancy without a parallel decrease in NPY mRNA 
suggest disrupted leptin regulation of this neuropeptide. Fasting during pregnancy 
decreases leptin concentrations and has been shown to further increase NPY mRNA 
expression levels in the arcuate nucleus (Garcia et al. 2003). This may be the result of 
these neurons responding to the change in leptin concentrations or due to other factors 
that may be influencing NPY mRNA during this fasting period. Leptin-induced pSTAT3 
was observed in NPY/AgRP neurons during pregnancy, suggesting that these neurons 
retain a degree of responsiveness to leptin, however, comparisons between the levels of 
colocalisation in pregnant and non-pregnant groups were not quantified. 
This chapter focused on leptin activation of neurons involved in leptin regulation 
of appetite within the arcuate nucleus. In conclusion, leptin-induced pSTAT3 is 
colocalised with both a-MSH- and AgRP-positive neurons in pregnant and non-pregnant 
rats. Colocalisation was only quantified in the a-MSH neurons and similar proportions 
of a-MSH neurons were positive for pSTAT3 in the leptin-treated pregnant and non-
pregnant rats. These results indicate that POMC neurons remain responsive to leptin 
during pregnancy. It is possible, that the amount of activation per cell is reduced during 
pregnancy and therefore these neurons are less responsive to leptin but this could not be 
assessed by the methods employed in this study. Furthermore, disruption of intracellular 
events further downstream of ST AT3 phosphorylation and translocation or other 
signalling mechanisms may underlie the altered regulation of these neuropeptides by 
leptin during pregnancy. 
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Chapter six: Leptin concentrations in the cerebrospinal 
fluid during pregnancy 
Introduction 
Leptin is produced and secreted by adipocytes distributed around the body, yet the 
central nervous system, especially the hypothalamus, is the major target tissue. Entrance 
of leptin into the brain is thought to take place at the choroid plexus which forms the 
blood-cerebrospinal fluid-barrier and/or the endothelium of brain capillaries which form 
the blood-brain-barrier. The movement of leptin into the brain occurs via a saturable, 
active transport mechanism (Banks et al. 1996; Koistinen et al. 1998) and this mechanism 
is likely to vary at the different sites of entrance into the brain (Zlokovic et al. 2000; 
Banks et al. 2000b). The short isoforms of the leptin receptor, especially Ob-Ra and Ob-
Re have been suggested as likely transporter molecules involved in the transport 
mechanisms of leptin into the brain (Tartaglia 1997; Wu-Peng et al. 1997; Bjorbaek et al. 
1998a; Kastin et al. 1999; Hileman et al. 2000; Hileman et al. 2002). 
The cerebrospinal fluid (CSF) reflects the extracellular environment of the CNS 
(Burns et al. 1976) and CSF leptin concentrations have previously been used to measure 
the levels of leptin that are exposed to the brain (Wu-Peng et al. 1997; Ishizuka et al. 
1998; Burguera et al. 2000; Grueso et al. 2001; Rocha et al. 2001; Scarpace et al. 2001; 
Mikolajczak et al. 2002; Asakuma et al. 2004). The ratio between CSF and plasma leptin 
concentrations can indicate the proportion of leptin that is transported into the brain, and 
is therefore a useful estimate of leptin transport into the brain. 
Impaired access of leptin into the brain may be a potential mechanism that 
contributes to leptin resistance. A number of leptin-resistance obese rodents can not 
respond to peripherally administrated leptin but can respond to centrally administrated 
leptin, implying that there is impaired leptin entry into the brain (Cusin et al. 1996; 
Halaas et al. 1997; Van Reek et al. 1997). Obese humans have low CSP/serum leptin 
concentration ratios compared to lean individuals, also suggesting that transport into the 
CSF is limiting in obesity (Caro et al. 1996; Schwartz et al. 1996b). However the CSF 
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leptin concentrations in lean and obese individuals are not significantly different 
therefore indicating that the system may be saturated even at leptin concentrations in lean 
individuals. Despite the central leptin resistance demonstrated during pregnancy in 
chapter two, results from chapter four indicating decreased Ob-Ra mRNA in the choroid 
plexus during pregnancy suggest that impaired leptin access into the brain may also 
contribute to pregnancy-induced leptin resistance. The aim of this study was to measure 
CSF leptin concentrations in pregnant and non-pregnant rats to further examine whether 
there is impaired transport of leptin into the brain during pregnancy. 
When collecting CSF samples most studies have collected a single sample prior to 
death, while under anaesthesia. Previously, Bouman and van Wimersma Greidanus 
(1979) developed a technique for repeated sampling of CSF in rats with the specific aim 
to measure brain-endocrine interactions. With this in mind, the technique was set up to 
minimize negative effects of sampling on hormone concentrations by collection of the 
CSF without anaesthesia and with reduced stress levels (Bouman et al. 1979). The 
present study used a modification of this sampling procedure to collect serial CSF 




Surgery took place on diestrus for non-pregnant rats and day 11 of pregnancy for 
the pregnant rats. Prior to surgery, and until parturition, food and water intake, and body 
weight were monitored daily. To take into account the daily changes in leptin 
concentrations, plasma and CSF samples were collected twice a day. The first sample 
was collected between 10 am and 12.30 pm to represent lower, light phase leptin 
concentrations, while the second sample was collected between 10 pm and 12.30 am to 
represent the higher, dark phase leptin concentrations. When sampling took place during 
the dark phase, a dim yellow light was used for illumination. Sample collection began 
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the day after surgery and continued for five days following surgery for the pregnant rats 
(days 12-17 of pregnancy). For the non-pregnant rats, samples were only collected for 
the first three days. 
Surgery 
On day 11 of pregnancy or diestrus for the non-pregnant group, rats underwent 
surgery for the implantation of a cannula into the cisterna magna to allow sampling of 
CSF and a cannula in the right jugular vein to allow frequent blood sampling. By using a 
range of different cannula placement co-ordinates and cannula lengths, the optimal 
positioning of the guide cannula into the cisterna magna was determined to allow 
collection of CSF in conscious, unrestrained rats. Requirements that had to be fulfilled to 
be classified as optimal positioning were sufficient flow to collect 100 µl in a limited 
time (maximum 15 minutes), no blood contamination of the CSF sample, and the ability 
for the procedure to be repeated without impaired collection. 
Surgery for the implantation of a chronic stainless stell cannula in the cisterna 
magna was performed similar to the intracerebroventricular cannula placement surgery. 
Once the rat was positioned in the stereotaxic apparatus as described previously (chapter 
two), a small incision, approximately 1.5 cm long, was made using a scalpel in the skin 
covering the posterior region of the skull. The connective tissue and periosteum covering 
the skull was cleared away using the scalpel blade followed by a sterile cotton bud. 
Three holes were drilled into the skull and screws were placed in these holes to anchor 
the cannula in position. Two holes were positioned in the parietal bones, one on either 
side of the sagittal suture, while the hole for the third screw was positioned in the 
interparietal bone, as far lateral as possible (figure 6. lA). Another hole was drilled in the 
interparietal bone, directly rostral to the suture formed between this bone and the 
occipital bone, in line with the sagittal suture (figure 6.lA). The 22-gauge guide cannula 
(8 mm in length below the pedestal) was positioned directly over this opening, then 
inserted 7 .5 mm below the level of the skull at an angle of 15° off vertical (figure 6. lB & 
C). Powdered dental cement was placed on the skull, surrounding the screws and the 
pedestal of the cannula, to which acrylic liquid was then applied. Care was take to ensure 
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that the dental cement mixture totally surrounded all the screws and cannula. Once the 
dental cement mixture hardened, an internal cannula, attached via a piece of silicon 
tubing (internal diameter 0.025" by 0.037") to a 1 ml syringe, was inserted into the guide 
cannula. A vacuum was slowly created in the syringe to assess the flow of CSP from the 
cannula. The internal cannula was then removed and the open end of the guide cannula 
was then sealed with a plastic cap until the time of sample collection. Following the 
placement of the cisterna magna guide cannula, a cannula was surgically inserted into the 
right jugular vein as previously described (chapter two). 
Sample Collection 
Firstly, the plasma samples from the jugular cannula were obtained as previously 
described (chapter two), then a 100 µl sample of CSP was obtained from the cannula in 
the cisterna magna. For the initial sample, rats were gently restrained in a towel, 
however, rats soon became familiar to the sampling procedure and restraint was not 
required. A 28-gauge internal cannula was connected via a piece of silicon tubing 
(internal diameter 0.025" by 0.037", approximate length of 12 cm) to a 1 ml syringe. The 
internal cannula was designed to protrude 2 mm beyond the tip of the guide cannula 
(figure 6.18). Once the plastic cap was removed from the guide cannula, the internal 
cannula was inserted its full length into the guide cannula. A vacuum was created in the 
syringe to start the flow of CSP into the tubing. Approximately 100 µl of CSP was 
collected in the tubing and syringe unit before the internal cannula was removed from the 
guide cannula. In some instances the internal cannula needed repositioning to initiate 
CSP flow. Collection time varied from 30 seconds to 15 minutes, but remained relatively 
constant in each rat. Following the removal of the internal cannula, the guide cannula 
was then sealed. CSP samples were transferred to 0.5 ml microfuge tubes and were 
briefly centrifuged to determine if there was any blood contamination. Samples with 
blood contamination were not assayed. The internal needle was then washed with 


















Figure 6.1: A Dorsal aspect of the skull (modified from Paxinos and Watson, 1988) 
indicating the position of the cannula (grey circle). The position of the screws are also 
indicated (X). B Diagram indicating the location of the cannula in the cistema magna 
(modified from Boumand and Van Wimersma Greidanus, 1983). The end of the guide 
cannula is positioned 7 .5 mm below the surface of the skull and the internal cannula projects 
a further 2 mm. C Diagram indicating the angle of implantation of the cannula. 
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Radioimmunoassay 
Leptin concentrations were determined using a rat leptin RIA kit as previously 
described (chapter two) with some additional modifications. The assay was performed at 
one quarter the volume suggested by the manufacturers due to the small sample sizes, and 
the primary antibody concentration was halved to increase sensitivity at the low end of 
the standard curve. The standard curve (figure 6.2) with these modifications was 
validated with the quality controls, which fitted with their expected values. All samples 











Figure 6.2: Leptin standard curve from RIA used to measure CSF and plasma leptin 
concentrations. The x-axis shows the concentration of the standard and the y-axis shows 




The success of this technique was determined by the percentage of rats at each 
time point from which approximately 100 µl of CSP was obtained. Overall a CSP 
sample was successfully obtained from 63% of rats at each time point. Samples were 
contaminated with blood only 7% of the time, whereas approximately 30% of samples 
were not collected as the flow of CSP was impeded. 
For the first 2 days, plasma leptin concentrations were significantly increased in 
the pregnant rats compared to the non-pregnant rats (figure 6.3). On the third day of 
sampling (day 14 of pregnancy), there was no difference in leptin concentrations between 
the pregnant and non-pregnant rats. From day 14 of pregnancy the leptin concentrations 
progressively decreased in the pregnant rats. Although there was some variation in 
plasma leptin concentrations, by day 21 of pregnancy, concentrations were significantly 
decreased compared to the other time during pregnancy (days 12-20). 
A considerable proportion of CSP samples were below the detection limits of the 
leptin radioimmunoassay. The average CSP concentration from samples collected from 
the two physiological states were pooled for statistical analysis without taking into 
account time of day or whether there were multiple samples from the same rat. There 
was a trend towards increased CSP leptin concentrations in samples (n=l8) from 
pregnant rats compared to samples (n=9) from non-pregnant rats but this was not 
significant (figure 6.3B). Similarly, plasma leptin concentrations collected at the same 
time as CSP samples in which leptin concentrations were detected were pooled, and there 
was no difference between samples from pregnant and non-pregnant rats (figure 6.3C). 
There was no significant difference between the CSP/plasma leptin concentration ratios 
for the non-pregnant and pregnant rats (figure 6.4A). Furthermore, the time of day (light 
vs. dark phase) did not affect CSP/plasma leptin concentration ratios in either the 
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Figure 6.3: A Mean(± sem) plasma leptin concentrations in pregnant (n=lO) and non-
pregnant rats (n=4-6). Shaded areas represent the time period when cerebrospinal fluid 
(CSF) samples were collected. Samples (plasma and CSF) were collected during the light 
phase (am) and the dark phase (pm). B Mean (± sem) plasma CSF non-pregnant and 
pregnant rats. C Mean (± sem) plasma leptin concentrations in non-pregnant and pregnant 
rats in samples matching CSF samples used in B. Both light and dark phase results are 
pooled. t significant with respect to control non-pregnant values. *significant with respect 
to the other time points during pregnancy (P < 0.05). 
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Figure 6.4: A Mean (± sem) CSF to plasma leptin concentration ratio in non-pregnant 
and pregnant rats. Samples are pooled from both light and dark phases of the light cycle 
B Mean (± sem) CSF to plasma leptin concentration ratio during the light and dark phases 
in non-pregnant and pregnant rats. 
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Food and water intake, and body weight were monitored for the duration of the 
experiment to assess the well being of the rats. These data were compared to data 
collected in untreated pregnant rats from chapter two to determine the effects of the 
surgery and sampling procedure on these parameters during pregnancy (figure 6.5). 
Following surgery (day 11) there was a significant difference in weight gain between the 
control and experimental pregnant rats which was maintained for the duration of the 
monitoring period (figure 6.5A). Unlike the control rats which had a progressive increase 
in weight until parturition, following surgery the experimental rats did not begin to 
significantly increase body weight until day 17 of pregnancy. From day 18 to parturition 
the experimental rats did increase in body weight but total weight gain remained less than 
the control rats. Furthermore, following parturition, the body weight of the control rats 
was greater than day 9 of pregnancy, however, the body weight of the experimental rats 
was significantly less than day 9 of pregnancy. There were no differences in litter size 
and number of pup deaths in the 24 hours following parturition between the two groups 
(table 6.1). 
The pregnant rats that underwent the sampling procedure had significantly 
reduced food intake during the sampling period and for the duration of the monitoring 
period compared to normal food intake levels observed during pregnancy (figure 6.58). 
Food intake was reduced during the sampling period compared to food intake prior to 
surgery, however, food intake returned to pre-surgery levels by day 19, three days after 
the conclusion of the CSF sampling period (figure 6.58). While food intake did increase, 
values were still significantly reduced compared to normal food intake levels during 
pregnancy. Overall, there was no significant difference between the water intake of the 
experimental and control rats for the duration of the monitoring period (figure 6.5C). The 
rats that underwent surgery had significantly reduced water intake the day following 
surgery but this decrease was only transient. 
Table 6.1: Litter size and pup mortality in the control and experimental group 
Treatment Litter size Pup mortality during 
Control pregnant group 
CSF sampling pregnant group 
14.5 ± .76 
14.3 ± .68 
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Figure 6.5: A Mean (± sem) weight gain from day 9 of pregnancy to day 1 of lactation 
in control pregnant rats (from chapter two, n=ll) and pregnant rats from which serial CSF 
samples were collected (experimental, n=lO). Bars represent mean (± sem) food intake 
(B) and water intake (C) in the experimental (n=lO) and control (n=ll) pregnant groups. 
Shaded area represents time when CSF samples were collected. t significant with respect 
to control pregnant values. * significant with respect to values on day 9 of pregnancy for 
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Discussion 
The ratio of cerebrospinal fluid leptin concentration compared to plasma has been 
used as an indicator of the proportion of peripheral leptin that gains access to the brain. 
Samples were collected twice daily between days 12 and 16 of pregnancy, however, as 
the assay was not sensitive enough to detect the low leptin concentrations in a 
considerable proportion of the samples, the results from the different time points were 
pooled so that an overall comparison between physiological states could be made. 
Similar to previous reports, the present results indicate that CSF leptin concentrations 
were approximately ten-fold lower than plasma leptin concentrations (Ishizuka et al. 
1998; Grueso et al. 2001). The ratio between CSF and plasma leptin concentrations did 
not differ between non-pregnant and pregnant rats, indicating that a similar proportion of 
leptin in the plasma gains access to the cerebrospinal fluid during pregnancy. These 
results suggest access of leptin into the brain is not impaired during pregnancy. 
Plasma leptin concentrations were significantly greater on days 12 and 13 of 
pregnancy compared to the non-pregnant rats, however, on day 14 of pregnancy leptin 
concentrations were not significantly different to non-pregnant rats. Furthermore, from 
day 14 onwards leptin concentrations began to progressively decrease compared to days 
12 and 13. Previously it has been shown that leptin concentrations in the blood remain 
high until the day before parturition (Amico et al. 1998; Lopez-Soriano et al. 1998; 
Garcia et al. 2000; Seeber et al. 2002). Also when pooled, there was no significant 
increase in leptin concentrations during pregnancy in either CSF or plasma samples. This 
is likely to be due to the pooling of the samples from both the light and dark phase, and 
because of the overall reduced leptin concentrations from day 14 of pregnancy onwards. 
In genetic models of obesity in rats, there are similar or slightly greater leptin 
concentrations in the CSF compared to lean animals, but due to the increase plasma leptin 
concentrations, the ratio between CSF and plasma leptin concentrations is dramatically 
reduced (Wu-Peng et al. 1997; Ishizuka et al. 1998; Burguera et al. 2000). This suggests 
that either the transport system is saturated at leptin concentrations similar to lean 














obese Koletsky rat, which due to a non-sense mutation of the leptin receptor gene results 
in leptin receptors that lack a transmembrane domain, have decreased CSP/plasma leptin 
ratios, but similar CSF leptin concentrations as lean rats (Wu-Peng et al. 1997). The lack 
of receptor, despite similar CSF leptin concentrations suggests leptin can gain access to 
the CSF through mechanisms that do not involve the leptin receptor (Wu-Peng et al. 
1997). The similar CSP/plasma leptin ratio in the pregnant and non-pregnant rats suggest 
that the decrease in Ob-Ra mRNA in the choroid plexus observed in chapter four during 
pregnancy may not result in decreased transport of leptin into the brain. These data must 
be viewed with caution, however, as there are a number of observations suggesting that 
experimental conditions were not optimal. 
This technique was successful in terms of the repetitive collection of CSF in 
conjunction with plasma collection. Following surgery, however, and for the duration of 
the monitoring period, the pregnant rats had reduced food intake compared to food intake 
previously measured in untreated pregnant rats ( chapter two). This decrease in food 
intake suggests a disturbance to the well being of the rat, and is likely to compromise the 
results of this study. Potential reasons for this reduced food intake include stress of 
surgery, stress of sampling, removal of CSF and/or illness. Stress induced by surgical 
procedures has been shown to decrease food intake (Varma et al. 1999). Interestingly, in 
previous chapters food intake was not significantly influenced by the surgical procedures, 
but in this study the combination of jugular and cisterna magna cannula placements may 
have a greater effect on the rats than either jugular or lateral ventricle cannula placement 
separately. In addition, as sampling began the day after surgery, the short recovery 
period in these rats may increase the likelihood of stress from surgery influencing food 
intake. The short recovery period after surgery was selected to maximize the chances 
that the cannula would remain patent, allowing serial collection of CSF samples. In most 
cases the cannula remained patent for about a week following surgery, which is similar to 
the success rates described by others (Kiser 1982; Lai et al. 1983; De La Riva et al. 
1985). 
The likely reason that flow of CSF from the cannula would be prevented is due to 
blockage from growth of fibrous tissue at the tip of the cannula, or, due to biological 
variation, the cannula is positioned adjacent to either the medulla oblongata, the occipital 
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bone or the dura which may impede the flow of CSF (Kiser 1982; Sarna et al. 1984; 
Kornhuber et al. 1986; Huang et al. 1996). Using scanning electron microscopy, the 
restriction and blockage of CSF flow has been demonstrated to be due to aggregations of 
platelets and fibrin threads in and around the cannula tip, and in some cases, dome shaped 
growths of the posterior altanto-occipital membrane have been observed to cover the 
cannula opening (Huang et al. 1995; Huang et al. 1996). The degree to which fibrous 
growths may block the cannula in the present study is unknown. It is likely that the 
repetitive insertion of the internal cannula, which projected 2 mm beyond the guide 
cannula, would prevent any surrounding fibrous tissue from permanently blocking the 
guide cannula, however dislodged tissue during insertion could acutely block the internal 
cannula. To aid in the collection of CSF, longitudinal openings in the side of the cannula 
instead of the tip have been used to reduce the chance of cannula blockage (Bouman et al. 
1979; Lai et al. 1983). The duration of patency of these cannula, however, was not 
longer than that observed in this study. 
Both the stress of handling and the physiological stress of CSF removal may be 
involved in acutely reducing feeding after collection of the sample, especially during the 
dark phase when the majority of feeding occurs in rats (Kersten et al. 1980; Varma et al. 
1999). Estimates of CSF volume in a rat (approximately 300 g) range from 330 µl - 580 
µl (Meek et al. 1973; Lai et al. 1983; Al-Sarraf et al. 2003) while the volume of the 
cisterna magna has be estimated at 190 µl (Burns et al. 1976). These values indicate that 
each sample of CSF was approximately 17-30% of the total volume. Removal of this 
fluid may negatively effect the rat, and assuming a constant rate of production of 
approximately 2.2 µI/min (Cserr 1965), it would take 45 minutes to replace the lost 
volume. Similar to other reports, during the collection of the CSF samples rats did not 
appear to be disturbed and demonstrated grooming and exploratory behaviours 
suggesting the procedure was relatively stress free (Y aksh et al. 1976; Bouman et al. 
1979; Lai et al. 1983; Huang et al. 1995). 
The possibility of illness, which is commonly associated with reduced feeding 
(Hart 1988; Kent et al. 1992) is also a major influence potentially affecting the food 
intake of these rats. The introduction of foreign material into the CSF has a high 












white blood cells and accumulation of platelets and macrophages have been observed 
with the chronic implantation of a cannula in the cisterna magna (Westergren et al. 1991; 
Huang et al. 1995; Huang et al. 1996). Indeed, during chronic cannulation of the cisterna 
magna it is difficult to avoid a meningeal reaction. While sterilised cannulae can reduce 
and postpone this inflammation, complete prevention is almost impossible (Westergren et 
al. 1991). To prevent infections in previous studies, as well as sterilising cannula, 
antibiotic solutions have been mixed with drinking water, sampling needles have been 
soaked in antibacterial cleansing reagents and antibiotics have been administrated at the 
time of surgery (Kiser 1982; Lai et al. 1983; Sarna et al. 1984; Westergren et al. 1991). 
While internal cannulae were cleaned between samples, the reduction in food intake 
indicate that it is possible the rats suffered an infection during this procedure. In future, it 
would be advisable to store both the injection needles and the cannula plugs in ethanol 
while not in use and rinse just before the collection of the sample. 
Body temperature could have been monitored during the experiment to aid in 
assessing the well being of the rats. As plasma samples were collected for the duration of 
the experiment, it might also be possible to measure cytokine concentrations such as 
interleukin-lj3, interleukin-6 and tumor necrosis factor-a which are increased during an 
immune response (Johnson 1998), and may be useful retrospective markers m 
determining whether the rats were suffering from an infection during the experiment. 
Previously, leptin concentrations have been shown to increase, albeit transiently, 
after the induction of an immune response (Barbier et al. 1998; Moshyedi et al. 1998; 
Francis et al. 1999; Roberts et al. 1999). Therefore, it is unlikely that the lower than 
expected leptin concentrations observed during pregnancy after day 14 are induced 
directly by a challenge to the immune system. Fasting dramatically decreases leptin 
concentrations, and reduced food intake can result in a parallel decrease in leptin 
concentrations (Bi et al. 2003). In food-restricted pregnant rats, where food intake was 
maintained at pre-pregnancy levels, plasma leptin concentrations decline progressively 
compared to non-food-restricted pregnant rats (Nieuwenhuizen et al. 1999), indicating the 
reduced food intake in the present study is a likely explanation for the lower than 






Despite the manipulations these pregnant rats were subjected to, there were no 
differences in littersize, pup mortality or timing of birth, similar to what is observed in 
food-restricted pregnant rats (Nieuwenhuizen et al. 1999). The rats in the present study 
did not progressively increase in bodyweight as expected in pregnant rats, but maintained 
similar bodyweight throughout the sampling period. Bodyweight did increase after this 
period of time, from about day 17, and this is likely to be due to the rapid fetal growth 
that takes place in the later stages of pregnancy. Interestingly, after giving birth untreated 
pregnant rats still had significantly increased body mass compared to day 9 of pregnancy, 
indicating that during the last 12 days of pregnancy conceptus free body weight is 
increasing. In the present study however, body weight after giving birth was significantly 
decreased compared to day 9 of pregnancy, suggesting maternal body mass was being 
used to supply the fetal unit with the required resources for the rapid growth period. 
The results from this study indicate that there is no difference in the ratio of CSF 
to plasma leptin concentrations in pregnant and non-pregnant rats. This suggests that 
leptin access to the brain is not impaired during pregnancy and hence does not contribute 
to pregnancy-induced leptin resistance. The conclusions from these results are only 
tentative due to the negative consequences of the experimental procedure on the rats and 
the lack of sensitivity of the RIA to detect the low leptin concentrations in the CSF 
samples. Food intake was reduced and there were changes to the normal pattern of body 
weight gain during pregnancy. These effects may have been the result of an inadequate 
recovery period after surgery and/or infection due to foreign material in the CSF. 
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Chapter Seven: Summary 
The adipose-derived hormone leptin, primarily acts in the hypothalamus to 
decrease appetite and increase energy expenditure thereby maintaining body fat levels 
around a set point. Pregnancy is a physiological state where this feedback mechanism is 
not beneficial. Successful reproductive efforts are highly demanding on the resources of 
the maternal body, thus it is imperative that the maternal body can store energy above the 
body's normal set point without restraint. The aim of the work presented in this thesis 
was to characterise the proposed state of leptin resistance during pregnancy in the rat. 
Food intake, fat mass and serum leptin concentrations increase during pregnancy 
suggesting that the feedback loop between adipose tissue and appetite is disrupted and a 
state of leptin resistance exists. In support of this, there is an attenuation of the satiety 
response to exogenous leptin administration in pregnant rats. Furthermore, as leptin was 
administered into the lateral ventricle, this result demonstrates that pregnancy is a state of 
central leptin resistance. Leptin concentrations in the CSF, a useful measure of leptin 
availability to the brain, were not reduced during pregnancy, further supporting the idea 
of central leptin resistance. This state of leptin resistance would allow increases in food 
intake and fat mass without negative feedback by leptin, therefore it is an important 
metabolic adaptation of pregnancy. 
The actions of leptin in body weight homeostasis are more than just the 
suppression of food intake, as leptin also regulates energy expenditure. For example 
leptin increases thermogensis in BAT (Scarpace et al. 1997). Pregnancy-induced leptin 
resistance was determined by the inability of leptin to induce a hypophagic response but 
it is highly likely that other responses to leptin are impaired in association with this state 
of leptin resistance. Unlike hyperphagia observed in non-pregnant rodents, hyperphagia 
during pregnancy is not associated with increased thermogenesis (Andrews et al. 1986; 
Abelenda et al. 1987) suggesting a loss of this response to leptin. In the future, 
examining other leptin-induced responses during pregnancy will be important to further 





The results from this thesis have clearly established that pregnancy is a state of 
leptin resistance. Furthermore potential mechanisms underlying the leptin resistance 
have been investigated. Three key sites have been suggested in the literature as potential 
targets involved in suppressing the transduction of the peripheral leptin signal to the 
functional outcome of satiety. Impairments of leptin transport from the peripheral 
circulation into the brain, activation of first order leptin responsive neurons, and 
activation of efferent pathways could contribute to a state of leptin resistance (Friedman 
et al. 1998; Banks et al. 1999; Kalra et al. 1999; Burguera et al. 2000). As our early 
results demonstrated a state of central leptin resistance, impaired responsiveness of first-
order leptin-target neurons was investigated as a potential mechanism in the development 
of pregnancy-induced leptin resistance. The phosphorylation of STAT3 in response to 
leptin and hypothalamic mRNA expression levels for the various leptin receptor isoforms 
were used to examine the activation of leptin target neurons during pregnancy. In terms 
of signal transduction events the interaction of the ligand with receptor initiates the 
intracellular pathways while the phosphorylation of STAT3 is one of the early steps in 
the activation of the JAK/ST AT signalling pathway. As one of the aims of this thesis 
was to examine the mechanisms underlying leptin resistance during pregnancy, assessing 
the early events involved in leptin signal transduction was an appropriate place to begin 
these investigations. 
There are now a number of studies that have used leptin-induced pSTA T3 as a 
marker for leptin activity in the hypo!halamus (Scarpace et al. 2001; Levin et al. 2004; 
Munzberg et al. 2004), however, leptin has been shown to activate other pathways 
besides from the JAK/STAT pathways. Examining leptin-induced pSTAT3 can reveal 
some information about the activation of these pathways as well as the activation of the 
JAK/STAT pathway. Leptin-induced pSTAT3 requires phosphorylation of the leptin 
receptor which is mediated by phosphorylated JAK2 proteins (Banks et al. 2000a). The 
phosphorylation of JAK2 proteins is induced by leptin binding to the receptor and is a 
common point of activation that is required by all known leptin-induced signalling 
pathways (Bjorbaek et al. 2004). Therefore changes in the pSTAT3 response to leptin 
may potentially reflect changes to JAK2 activation and hence the activation of other 








events in the JAK/STAT pathways and other leptin-induced pathways, need to be 
examined before the mechanisms underlying pregnancy-induced leptin resistance can be 
fully elucidated. For example, despite there being no detectable difference in STAT3 
activation in response to leptin in the DMH, lateral hypothalamus, and a-MSH neurons 
within the arcuate nucleus in non-pregnant and pregnant rats, it is possible that further 
downstream events, such as STAT3 dimer-DNA binding, are impaired during pregnancy. 
The responsiveness of VMH neurons to leptin was decreased during pregnancy, 
and there was also evidence suggesting decreased responsiveness in the arcuate nucleus. 
Both these area of the hypothalamus mediate the functions of leptin and while the arcuate 
nucleus is an integral part of leptin regulation of appetite, the role of leptin-induced 
activity within the VMH is not clear. 
In the arcuate nucleus, which is considered to be the major site of first-order 
leptin-target neurons involved in the satiety response of leptin, it is unknown whether the 
degree of attenuation in signalling detected in chapter three can account for the total lack 
of hypophagic response to exogenous leptin during pregnancy. While western blot 
analysis indicated that leptin did not increase ST AT3 phosphorylation, 
immunohistochemistical analysis indicated that a similar number of cells were responsive 
to leptin in pregnant and non-pregnant rats. Further work is required to determine the 
degree of responsiveness of arcuate nucleus neurons to leptin during pregnancy. 
Furthermore, our results demonstrate that anorectic POMC neurons remain responsive to 
leptin during pregnancy, however impaired signalling through the JAK/STAT pathway 
further downstream of ST AT3 phosphorylation can not be ruled out by the methods used. 
It is also possible that other intracellular events within target neurons are potentially 
impaired during leptin resistance. This is supported by indirect evidence, as NPY mRNA 
and AgRP mRNA have been shown to increase during pregnancy despite increased leptin 
concentrations suggesting that leptin regulation of these peptides is disrupted (Garcia et 
al. 2003; Rocha et al. 2003). Leptin-induced STAT3 signalling does not appear to be 
involved in NPY regulation, and may only be partly responsible for leptin-induced 
changes in AgRP regulation (Bates et al. 2003). Therefore, regulation of other signalling 
pathways by leptin may be compromised in these critical first-order leptin responsive 








are not the main site of leptin resistance. Impaired events in the energy balance neural 
circuits downstream of these first-order neurons may be implicated in pregnancy-induced 
leptin resistance. For example, modulation of leptin-induced sensitivity to CCK or 
changes in MCR-4 receptor dynamics may contribute to leptin resistance, despite 
maintained responsiveness of first order target neurons. 
The most robust finding in this thesis was the reduced activation of leptin 
responsive neurons in the VMH during pregnancy. Expression of Ob-Rb mRNA was 
also decreased in the VMH suggesting that reduced Ob-Rb could account for the 
impaired leptin-induced activation of STAT3 during pregnancy. Classically the VMH 
has been regarded as the satiety centre of the hypothalamus, however more recently the 
function of the VMH has shifted to other areas of energy homeostasis such as 
thermogensis, glucose metabolism and sympathetic nervous system regulation (Sudo et 
al. 1991; Minokoshi et al. 1994; Haque et al. 1999; Minokoshi et al. 1999; Satoh et al. 
1999). Hyperphagia-induced thermogensis and peripheral glucose uptake are inhibited as 
part of the maternal adaptations during pregnancy and in the non-pregnant state are 
regulated by leptin (Scarpace et al. 1997; Scarpace et al. 1998; Minokoshi et al. 1999). It 
is tempting to speculate that reduced leptin activity in the VMH contributes to these 
alterations during pregnancy. The decrease in receptor expression suggests that all leptin 
induced signalling events in these neurons will be reduced during pregnancy. Further 
work is required to determine the functional significance of reduced signalling of the 
various pathways during pregnancy. Inducing expression of the leptin receptor in the 
VMH during pregnancy using recombinant adeno-associated viral vectors encoding the 
leptin-receptor gene, similar to what has been done in fa/fa rats (Keen-Rhinehart et al. 
2004) may be an interesting study for the future to examine the role of the decreased 
receptor expression in the VMH during pregnancy. 
Unlike the arcuate nucleus, there is almost no knowledge of the phenotype of the 
neurons within the VMH that are responsive to leptin. The VMH is known to contain 
glucose-responsive (G-R) neurons that increase their firing rates in response to increases 
in ambient glucose concentrations (Oomura et al. 1969). G-R neurons have long been 
thought to be integral in the neural circuits regulating energy homeostasis. Destruction of 








to the long-term regulation of body weight (Bergen et al. 1996) but their exact role is still 
unclear. As well as glucose, G-R neurons respond to many signals involved in energy 
homeostasis and have been suggested to be 'metabolic sensing' neurons (Levin et al. 
2002). Most glucose responsive neurons within the VMH are also stimulated by leptin 
(Shiraishi et al. 1999) thus this population of neurons may be key targets in leptin 
regulation of energy homeostasis in the VMH. Further work is required to examine the 
leptin-induced activation of these neurons and the possible functions of this stimulation 
before the role of these neurons during pregnancy can be determined. 
The JAK/STAT pathway is involved in leptin regulation of gene expression. 
Leptin also induces acute changes in neuron activity, which is thought to be mediated via 
other intracellular signalling pathways (Niswender et al. 2003). Changes in the acute 
activity induced by leptin in target neurons may contribute to pregnancy-induced 
hyperphagia and the associated leptin resistance. The decrease of Ob-Rb mRNA in the 
VMH suggests that the stimulatory effect of leptin on VMH neurons, as shown by leptin-
induced depolarisation and increased intracellular Ca2+ concentrations (Shiraishi et al. 
1999; Muroya et al. 2004), would be impaired. Electrophysiological studies using slice 
preparations from the VMH, might be useful to confirm that there are impaired responses 
of VMH neurons to leptin during pregnancy, similar to studies demonstrating impaired 
responses of VMH neurons to leptin in early postnatally overfed obese rats (Davidowa et 
al. 2000). The G-R neurons in the VMH could be specifically selected by testing the 
responses to glucose. Complementary to this, the activation of pSTAT3 in these neurons 
could be analysed, similar to the POMC neurons of the arcuate nucleus in chapter five, 
using a marker to label G-R neurons. 
Leptin resistance is necessary to allow increasing fat mass without subsequent 
feedback from the associated increases in leptin concentrations, however, the contribution 
of leptin resistance in the generation of hyperphagia during pregnancy is unknown. 
Increased food intake was present earlier than the attenuation of the satiety actions of 
leptin suggesting that while leptin resistance plays a role in facilitating hyperphagia, other 
orexigenic mechanisms are involved. An alternative possibility is that during the early 
stages of pregnancy leptin sensitivity gradually declines until a state of total insensitivity 












support of this is the increased food intake despite increased leptin concentrations on day 
7 of pregnancy suggesting reduced sensitivity. This hypothesis of a gradual decrease in 
leptin sensitivity could be examined by assessing the response to lower doses of leptin 
during these early stages of pregnancy. Using lower doses may reveal changes in 
sensitivity that otherwise may have been undetectable due to the supra-maximal dose 
used in the current study. 
A key feature which needs to be addressed in future studies is the cause of this 
state of leptin resistance. It is likely that the changes in the hormonal environment due to 
gestation participate in the adaptations to pregnancy. Indeed, changing concentrations of 
placental lactogen, progesterone, and estrogen have all been implicated in producing the 
physiological alterations in maternal metabolism, such as peripheral insulin resistance 
(Kalkhoff et al. 1969; Landgraf et al. 1977; Herrera et al. 1991; Parsons et al. 1992; 
Gonzalez et al. 2000). Both progesterone and placental lactogen are prime candidates 
contributing to the development of pregnancy-induced hyperphagia and state of leptin 
resistance due to their orexigenic properties (Hervey et al. 1967; Gerardo-Gettens et al. 
1989a; Gerardo-Gettens et al. 1989b; Sauve et al. 1996; Grueso et al. 2001). It is possible 
that the orexigenic properties of these hormones are due to modifying the sensitivity of 
the brain to leptin, however the interactions between these hormones and leptin are yet to 
be fully elucidated. 
The positive energy balance during pregnancy has long been attributed to the 
increased progesterone concentrations (Hervey et al. 1967). Therefore the leptin 
resistance associated with this state of positive energy balance could potentially be 
mediated by progesterone. Rats treated with progesterone, are hyperphagic and tend to 
increase fat mass without changes in leptin plasma or CSF concentrations, suggesting that 
progesterone may modulate the sensitivity of the brain to leptin (Grueso et al. 2001). 
Progesterone receptors are expressed in the arcuate nucleus (Fox et al. 1990; Francis et al. 
2002) thus there is potential for interactions between progesterone and leptin signalling 
within neurons involved in appetite regulation. It is unlikely that progesterone directly 
interacts with the leptin responsive neurons in the VMH, due to the lack of progesterone 
receptors in the dorsal medial VMH (Fox et al. 1990; Francis et al. 2002), however, an 














Pregnancy is also characterised by hyperprolactinemia, which can induce 
hyperphagia and deposition of fat (Moore et al. 1986; Gerardo-Gettens et al. 1989a; 
Gerardo-Gettens et al. 1989b; Byatt et al. 1993; Noel et al. 1993; Sauve et al. 1996). The 
timing of the onset of leptin resistance suggests that events between day 7 and 14 of 
pregnancy induce leptin insensitivity. At this time, the hyperprolactinemic conditions of 
pregnancy change from twice daily surges of prolactin to constantly elevated 
concentrations due to the secretion of placental lactogen (Robertson et al. 1981; 
Robertson et al. 1982; Gunnet et al. 1983; Grattan et al. 1990). These changes in 
secretion patterns may be an important feature involved in the modulation of hyperphagia 
and leptin sensitivity by prolactin. Mimicking these different prolactin secretory profiles 
(daily surges vs. continuously high) in non-pregnant rats and examining the satiety 
response to leptin, will be an important study to investigate the potential role of 
hyperprolactinamia on leptin sensitivity. 
Leptin-induced leptin resistance has been demonstrated in both rats and mice. 
Potentially the increased leptin concentrations during pregnancy could induce a state of 
leptin resistance, however, in most cases of leptin-induced leptin resistance in rodents 
leptin concentrations are higher than that observed during pregnancy. During pregnancy, 
leptin concentrations only increase by approximately two-fold whereas leptin 
concentrations that result in leptin-induced leptin resistance are at least six-fold greater 
than control values (Martin et al. 2000; Sahu 2002). Also the secretion patterns of leptin 
differ; during pregnancy leptin concentrations maintain a diurnal pattern, whereas with 
models of leptin-induced leptin resistance, there are constantly elevated leptin 
concentrations. Furthermore, leptin-induced leptin resistance is associated with an initial 
decrease in food intake (Chen et al. 1996a; Halaas et al. 1997; Martin et al. 2000; Dhillon 
et al. 2001; Beretta et al. 2002; Sahu 2002; Scarpace et al. 2002b ). The earliest reported 
time when the response to leptin becomes refractory is after approximately two weeks of 
leptin treatment (Sahu 2002), although there is a high degree of variation between 
studies. This two week period is very similar to the timing of day 14 of pregnancy, and it 
is possible that the gradually increasing leptin concentrations during pregnancy, as 
opposed to almost immediate high leptin concentrations in leptin-induced leptin resistant 







mice that are treated with leptin to restore fertility, food intake increases from 
approximately the middle of pregnancy, without changes in dose of administered leptin, 
suggesting that increasing leptin concentrations are not necessary for the induction of 
hyperphagia or leptin resistance during pregnancy (Mounzih et al. 1998). 
Leptin resistance during pregnancy is part of the metabolic adaptations of the 
maternal body required for successful gestation. On the other hand, leptin resistance 
associated with diet-induced obesity is a pathological state that appears to result from a 
high caloric intake (Frederich et al. 1995; Maffei et al. 1995; Widdowson et al. 1997; 
Dhillon et al. 2001; Spiegelman et al. 2001). Similar to pregnancy, reduced leptin-
induced pSTAT3 in the VMH has been observed in diet-induced obese rodents by some 
(Levin et al. 2004) but not all (Munzberg et al. 2004) studies. Furthermore, in diet-
induced obese rats there is a reduction in the number of neurons that are responsive to 
leptin in the arcute nucleus (Levin et al. 2004), which was not observed in pregnant rats. 
This may suggest physiological and pathological states of leptin resistance differ in the 
characteristics and underlying mechanisms. 
Leptin resistance is an important adaptation to pregnancy allowing a state of 
positive energy balance. This state is associated with impaired activation of the leptin-
induced JAK/STAT3 signalling pathway in the VMH and arcuate nucleus, and reduced 
expression of Ob-Rb mRNA in the VMH. Important issues to be examined in the future 
include the mechanisms underlying these changes in leptin signal transduction during 
pregnancy, the function of the impaired signalling in the VMH, and the role of leptin 
resistance in pregnancy-induced hyperphagia. In conclusion, the state of leptin resistance 
represents an important adaptation of the maternal brain allowing increased food intake 
and fat mass so that the maternal body can meet the metabolic demands of pregnancy and 
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Leptin concentrations increase during pregnancy, but this 
does not prevent the pregnancy-induced increase in food in-
take, suggesting a state ofleptin resistance. This study inves-
tigated the response to intracerebroventricular leptin admin-
istration in pregnant rats. After fasting, non pregnant, d-7 and 
d-14 pregnant rats received leptin (4 µg) or vehicle, then food 
intake was measured. Serial blood samples were collected in 
another group of rats to determine plasma leptin concentra-
tions. Further groups of d-14 pregnant and nonpregnant rats 
were killed after leptin or vehicle treatment, and brains were 
collected. Hypothalamic nuclei were microdissected, and lev-
els of signal transducer and activator of transcription (STAT)3 
phosphorylation were measured using Western blot analysis. 
Fasting decreased leptin concentrations in both pregnant and 
nonpregnant rats. Leptin treatment significantly reduced 
food intake in nonpregnant and d-7 pregnant rats but not in 
LEPTIN IS PRIMARILY an adipose-derived hormone that acts in the hypothalamus to regulate body fat levels by 
suppressing appetite and increasing metabolic rate (1-3). 
Leptin secretion is proportional to the amount of adipose 
tissue present in the body, therefore providing an indication 
of the current level of body fat (4, 5). The vital role of leptin 
in regulating appetite is illustrated by the ob/ob mouse, 
which lacks leptin and is consequently obese. The actions of 
leptin are mediated through the leptin receptor. Different 
isoforms of the receptor are generated by alternative RNA 
splicing of the leptin receptor gene, resulting in receptors 
with intracellular domains of differing lengths but identical 
extracellular domains (6-8). The long form of the receptor, 
Ob-Rb, is essential for the appetite suppressing effects of 
leptin (6, 8) and is the major isoform expressed on neurons 
within the hypothalamus (7) . 
Like other members of the class 1 cytokine receptor family, 
one of the major intracellular signaling mechanisms of the 
leptin receptor is a JAK/STAT pathway (JAK, Janus kinase; 
STAT, signal transducers and activators of transcription). In 
Abbreviations: AgRP, Agouti-related protein; i.c.v., intracerebroven-
tricular; JAK, Janus kinase; pSTAT, phosphorylated STAT; POMC, pro-
opiomelanocortin; SDS, sodium dodecyl sulfate; STAT, signal trans-
ducer and activator of transcription; VMH, ventromedial hypothalamus. 
Endocrinology is published monthly by The Endocrine Society (http:// 
www.endo-society.org), the foremost professional society serving the 
endocrine community. 
d-14 pregnant rats. In addition, there was no postfasting hy-
perphagic response in the pregnant rats. In the pregnant rats, 
leptin-induced STAT3 phosphorylation was suppressed in the 
arcuate nucleus and, to a lesser extent, in the ventromedial 
hypothalamus (VMH), compared with nonpregnant rats. Un-
stimulated STAT3 levels were also decreased in the VMH dur-
ing pregnancy. Leptin-induced phosphorylation of STAT3 in 
the dorsomedial and lateral hypothalamus was not different 
between pregnant and nonpregnant rats. These data indicate 
that pregnant rats become resistant to the satiety action of 
leptin. Furthermore, leptin-induced activation of the STAT3 is 
impaired during pregnancy, specifically in the arcuate nu-
cleus and VMH. These data support the hypothesis that preg-
nai;i.cy is a state of hypothalamic leptin resistance. (Endocri-
nology 145: 3704-3711, 2004) 
response to leptin, Ob-Rb rapidly becomes phosphorylated, 
a process which is mediated by JAK proteins that are asso-
ciated with the leptin receptor (9-11). Cytoplasmic STAT3 
proteins bind to the activated Ob-Rb, undergo tyrosine-phos-
phorylation induced by JAK2, then dimerize and translocate 
to the nucleus, where they bind to specific promoter se-
quences of target genes to regulate gene transcription. 
Leptin-induced translocation of STAT3 to the nucleus has 
been observed at high levels in neurons within the arcuate 
nucleus, the dorsomedial nucleus, and the ventromedial nu-
cleus of the hypothalamus (12). 
During pregnancy, the maternal body must support the 
growing conceptus as well as prepare for the subsequent 
demands of lactation. This is achieved by the development 
of a state of positive energy balance, mainly due to increased 
food intake. In the rat, food intake is increased by the second 
week of pregnancy and remains high throughout pregnancy 
until the day before parturition (13-15). Fat stores are also 
increased during pregnancy, in preparation for the increased 
energy demands of lactation (14). In rats, mice, and humans, 
leptinconcentrationsincrease during pregnancy (16-21). De-
spite elevated leptin concentrations, hyperphagia persists 
during pregnancy, suggesting a state of leptin resistance. As 
well as being obese, ob/ ob mice are also infertile, and daily 
treatment of leptin can restore fertility in these mice (22). In 
pregnant ob/ ob mice, food intake increases from midgesta-
tion despite daily leptin treatment, also consistent with the 
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hypothesis that a state of leptin resistance develops during 
pregnancy (23). 
The aim of this study was to directly test whether pregnant 
rats are resistant to the acute satiety action of leptin by mea-
suring food intake after a single intracerebroventricular 
(i.c.v.) dose of leptin. furthermore, to determine the mech-
anisms responsible for the hyperphagia observed during 
pregnancy in the presence of increased leptin concentrations, 
we examined whether hypothalamic STAT3 activation in 
response to leptin was altered during pregnancy. 
Materials and Methods 
Animals 
Animals were obtained from our colony at the University of Otago. 
Ten-week-old Sprague Dawley rats were housed under a 14-h light, 10-h 
dark cycle. Temperature was maintained at 22 ± 1 C, and all rats had 
free access to food and water, except when fasted. The estrous cycle was 
monitored by daily cytological examination of vaginal smears. 
Proestrous females were housed overnight with a male rat, and mating 
was confirmed by the presence of sperm in vaginal smears the following 
morning. This day was designated d O of pregnancy, and parturition in 
our colony occurred on the morning of d 22. The day of parturition was 
designated d O of lactation; and on d 2 of lactation, pup litters were 
normalized to 10 pups. All animal experimental protocols were ap-
proved by the University of Otago committee on ethics in the care and 
use of laboratory animals. 
Food intake, fat mass, and serum leptin concentrations 
during pregnancy 
Daily food intake, water intake, and body weight were measured in 
11 individually housed rats for the duration of three estrous cycles and 
the subsequent 22 d of gestation. Food and water intake were not 
measured on the day of mating. To measure fat mass and leptin con-
centrations, groups of rats were killed by decapitation between 0800 and 
1000 hon diestrus; d 7, d 14, and d 21 of pregnancy; and d 7 oflactation. 
Trunk blood was collected and allowed to clot at 4 C overnight, then 
serum was stored at -:-20 C until leptin concentrations were determined 
by RIA (Linea Research, Inc., St. Charles, MO). Total abdominal adipose 
tissue was dissected out and weighed. 
Pattern of plasma leptin concentration during fasting 
and refeeding 
Changes in plasma leptin concentrations during a period of fasting 
and refeeding were determined in both nonpregnant rats and midpreg-
nant (d 12-14) rats to ensure that leptin concentrations decreased in 
response to fasting. Animals were anesthetized with halothane on d 11 
of pregnancy or proestrus for the nonpregnant rats, and an indwelling 
atrial cannula of SILASTIC brand silicon tubing (Dow Corning Corp., 
Midland, MI; internal diameter 0.025 in., external diameter 0.047 in., 
Delgania Silicone) was placed in the right atrium via the right jugular 
vein. The end of the cannula was exteriorized through the skin between 
the scapulae so that it could be readily accessed for blood sampling. 
Blood sampling began at 1800 hon the day after surgery, and 300-µ1 
samples were collected every 4 h for 72 h. At 1800 h on the second day 
of sampling, food was removed from the cages. Food was returned for 
the final 24 h of the sampling protocol. After collection of each sample, 
blood was centrifuged, and red cells were resuspended in an equivalent 
volume of sterile saline and replaced into the rat after the subsequent 
sample collection. Plasma samples were stored at -20 C until leptin 
concentrations were determined by RIA. All samples were measured in 
one assay, and the intraassay coefficient of variation was 11.8%. 
Feeding response to i.c.v. leptin administration 
The feeding response to.i.c.v. leptin administration was determined 
in nonpregnant (diestrus), early pregnant (d 7), and midpregnant (d 14) 
rats. The i.c.v. cannulae (Plastics One, Roanoke, VA) were surgically 
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implanted into diestrous and pregnant rats. Surgery took place on d 1 
for the early pregnancy group and d 7 for the midpregnancy group. 
Animals were anesthetized with ip injections of 2% xylazine hydro-
chloride ( 4 mg/kg) and ketamine hydrochloride (80 mg/kg) and placed 
in a stereotaxic frame. A 23-gauge stainless steel guide cannula was 
implanted 1.3 mm lateral to the midline at bregma (0.0 anterior /pos-
terior position) and 3 mm below the level of the skull. Cannulae were 
fixed to the skull with stainless steel screws and dental cement. The open 
end of the cannula was sealed with a plastic cap until the time of 
injection. After surgery, rats were housed individually; and food intake, 
water intake, and weight gain were monitored daily. 
On d 6 or 13 of pregnancy, and on metestrus for the nonpregnant rats, 
food was removed from the cages, 1 h before the start of the dark phase. 
Rats were fasted to ensure that at the time of injection both pregnant and 
nonpregnant rats had similar low endogenous leptin concentrations. 
Twenty-four hours later, rats received an injection of either 4 µ,g leptin 
(recombinant mouse leptin obtained from Dr. A. F. Parlow, National 
Hormone and Pituitary Program, National Institute of Diabetes and 
Digestive and Kidney Diseases, Torrance, CA) diluted in artificial ce-
rebrospinal fluid (2 µ,g/ µ,l) or vehicle into the left lateral ventricle using 
a 2-µ,l Hamilton syringe connected to a stainless steel injection cannula. 
The injection cannula was designed to protrude 2 mm beyond the tip of 
the guide cannula. The injection was carried out over a 30-sec period, and 
the injection cannula was left in position for an additional 30 sec. After 
the injection cannula was removed, the guide cannula was sealed to 
prevent leakage. One hour post injection, directly before the start of the 
dark phase, pre-weighed food pellets were returned to the rats. The 
amount of food consumed 3 hand 24 h after the injection was measured. 
At the conclusion of the experiment, the placement of the cannula was 
confirmed. Rats received an injection of 2 µ,l of 0.1 % methylene blue to 
the left lateral ventricle approximately 5 min before being killed by 
decapitation. The presence of dye in the third ventricle confirmed correct 
cannula placement. 
STAT3 phosphorylation in response to i.c.v. 
leptin administration 
As described above, i.c.v. cannulae were surgically implanted into 
diestrous and d-7 pregnant rats. On d 13 of pregnancy, and on metestrus 
for the nonpregnant rats, food was removed from the cages, 1 h before 
the start of the dark phase. Sixteen hours later, rats received either an 
injection of leptin or vehicle as described above. Thirty minutes after 
injection, rats were killed by decapitation. The brains were removed and 
immediately frozen on dry ice and stored at -80 C until the microdis-
section of hypothalamic nuclei using a micropunch technique (24). Fro-
zen coronal brain sections (300 µ,m) were cut in a cryostat at -9 C, then 
thaw-mounted onto glass slides and refrozen. Five hypothalamic areas 
were punched from these sections using a 500-µ,m diameter micropunch 
needle (Table 1). Tissue was placed in 45 µ,l of 62.5 mM Tris-HCl (pH 6.8) 
containing 1 % sodium dodecyl sulfate (SDS) and Complete protease 
inhibitor (Roche Diagnostics, Mannheim, Germany). Additional pro-
tease inhibitors, phenylmethylsulfonyl fluoride (1 mM), and sodium 
orthovanadate (1 mM) were also present. Samples were briefly sonicated, 
then stored at -SOC. Protein concentration was determined by a mod-
ification of the Lowry method using a protein assay kit (Bio-Rad Lab-
oratories Inc., Hercules, CA). 
Samples were boiled for 2 min after the addition of loading buffer 
containing 2-{3 mercaptoethanol, then were separated on a 7.5% SDS-
p AGE gel and electrotransferred to nitrocellulose membrane. After 
staining with red Ponceau stain to ensure accurate protein loading and 
protein transfer, membranes were incubated in blocking solution (PBS 
containing 0.1 % Tween 20 and 5% nonfat milk powder) for 1 hat room 
temperature. Membranes were then incubated overnight at 4 C with 
phosphorylated STAT3 (pSTAT) specific antibody (1:1000 dilution; Cell 
Signaling Technology, Inc., Beverly, MA) in the blocking solution. Next, 
membranes were incubated for 1 h at room temperature in a goat 
antirabbit peroxidase-conjugated IgG (Santa Cruz Biotechnology, Santa 
Cruz, CA) at a 1:5000 dilution in PBS containing 0.1 % Tween 20. Between 
each incubation, membranes were washed in PBS containing 0.1% 
Tween-20. Immunolabeled bands were visualized by the enhanced 
chemiluminescence method (Amersham Life Sciences, Piscataway, NJ). 
Membranes were then washed and incubated in stripping buffer (62.4 
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TABLE 1. Microdissection of discrete hypothalamic regions 
Brain regions 
Ladyman and Grattan • Leptin Resistance during Pregnancy 
Section coordinates 
relative to bregmaa 
No. of punches 
per brain 





Dorsomedial hypothalamic nucleus 
Lateral hypothalamic nucleus 
Supraoptic nucleus 
-2.5, -2.8, -3.1 
- 2.2, - 2.5, - 2.8, - 3.1 
- 1.0, -1.3, -1.6 
Ventromedial hypothalamic nucleus -2.5, -2.8, -3.1 
a Based on the atlas of Paxinos and Watson (1997). 
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FIG. 1. Food intake (A), serum leptin concen-
trations (B), and abdominal fat mass (C) dur-
ing pregnancy. Mean ::+: SEM daily food con-
sumption was measured during three estrous 
cycles (E, estrus; D, diestrus) in nonpregnant 
rats and the 21 d of pregnancy after success-
ful mating on the night ofproestrus (n = 11). 
Serum leptin concentrations (ng/ml) and to-
tal abdominal fat mass (g) were measured on 
diestrus, d 7 (D7), 14 (D14), and 21 (D21) of 
pregnancy, and d 7 oflactation (Lact). Values 
represent the mean ::+: SEM (n = 6-8). *, Sig-
nificant with respect to nonpregnant values 
(P < 0.05). 
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45 min, to remove antibodies, and reprobed with a STAT3-specific 
antibody (Santa Cruz Biotechnology), following the same conditions 
described above. Relative levels of pSTAT3 and total STAT3 were quan-
tified by densitometry of autoradiographs. Activation of STAT3 was 
measured as a ratio of pSTAT3 levels compared with total STAT3 de-
tected in each sample. 
Statistical analysis 
Statistical data were analyzed by one-way ANOV A except for the 
sequential plasma samples, where leptin concentration data were as-
sessed by repeated-measures ANOV A. Fisher's post hoc tests were ap-
plied where appropriate. The significance level for all statistics was set 
at P < 0.05. All data are presented as the mean ::+: SEM. 
Results 
Food intake, fat mass, and serum leptin concentrations 
during pregnancy 
Daily food intake levels across the estrous cycle showed 
the well-characterized pattern of reduced food intake at the 
time of estrus (25). Daily food intake increased during preg-
nancy and was significantly higher than nonpregnant levels 
by d 4 of pregnancy (Fig. lA). On d 7 and 14 of pregnancy, 
serum leptin concentrations were significantly greater than 
that observed in nonpregnant rats (Fig lB). By d 21 of preg-
nancy, the day before parturition, serum leptin concentra-
Pregnancy Pregnancy 
hons had decreased to levels similar to the nonpregnant 
values. During lactation, leptin concentrations further de-
creased, to become significantly lower than nonpregnant 
levels. Using total weight of abdominal fat as a measure, fat 
mass was increased during pregnancy, being significantly 
higher than nonpregnant levels on d 14 and 21 of pregnancy 
(Fig lC). Total abdominal fat mass on d 21 of pregnancy 
(11.8 ::'::: 2.3 g) was almost double the amount in nonpregnant 
rats (6.9 ::'::: 1 g) . The amount of abdominal fat present on d 
7 of lactation was not significantly different from nonpreg-
nant values. 
Serial plasma leptin concentrations 
Before fasting, both nonpregnant and midpregnant rats 
displayed a nocturnal increase in plasma leptin concentra-
tions; however, leptin concentrations remained significantly 
higher in pregnant rats compared with nonpregnant rats 
(Fig. 2). Fasting led to the suppression of the nocturnal in-
crease in leptin, and plasma leptin concentrations were sig-
nificantly decreased in all rats compared with prefasting 
levels (Fig. 2). Once food was returned, leptin concentrations 
increased, but the nocturnal surge did not occur in the fol-
lowing 24-h period of refeeding. 
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FIG. 2. Plasma leptin concentrations (ng/ml) for 72 h, 
including a 24-h fasting period and the subsequent 
refeeding period, in nonpregnant (n = 6) and midpreg-
nant (n = 5) rats. Values represent the mean :±: SEM. 
There was a significant change in leptin concentrations 
over the 72-h period and a significant difference in 
leptin concentrations (Cone) between groups (repeated-
measures ANOVA, P < 0.05). *, Significant with respect 
to nonpregnant leptin concentration at the same timepoint 
(P < 0.05); t, significant with respect to prefasting leptin 
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FIG. 3. Food intake for the 24 h before 
fasting, and cumulative food intake for 
the 3 and 24 h after either leptin (4 µ,g) 
or vehicle i.c.v. administration in fasted 
nonpregnant and pregnant rats . Values 
represent the mean :±: SEM (n = 6- 8). 
Although conditions were the same for 
rats before fasting, 24-h prefasting food 
intake bars are split to show food intake 
for the different treatment groups. *, 
Significant with respect to prefasted 
24-h food intake in nonpregnant vehicle 
groups (P < 0.05); t , significant with 
respect to vehicle-treated group of the 
same physiological state (P < 0.05). 
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24 hour 
Feeding response to i.c.u. leptin administration 
To determine whether pregnant rats are resistant to the 
satiety action of leptin, food intake was measured after i.c.v. 
administration of leptin to food-deprived nonpregnant and 
pregnant rats (Fig. 3). Injections were timed such that they 
were administrated 1 h before the end of fasting, at a time 
when endogenous leptin concentrations were still very low 
(see Fig 2). Consistent with the data above, during the 24 h 
before fasting, midpregnant rats had significantly higher 
food intake levels compared with the nonpregnant rats. 
However, in contrast to the above results, early pregnant rats 
in this experiment did not have increased food intake, com-
pared with nonpregnant rats. In nonpregnant rats, leptin 
treatment resulted in a significant reduction in food intake 
compared with vehicle-treated nonpregnant rats after 3 and 
24 h. Similarly, in early pregnant rats, leptin treatment also 
resulted in significantly decreased food intake compared 
with the vehicle-treated d-7 pregnant rats. In the midpreg-
nant rats, there was no difference in food intake between the 
leptin-treated and vehicle-treated rats at any timepoint. 
There was a significant increase between pre- and postfasting 
food intake levels in the vehicle-treated nonpregnant rats. 
However, in the vehicle-treated early pregnant rats, there 
was no significant increase between pre- and postfasting 
food intake levels. Also, on d 14 of pregnancy, the leptin- and 
vehicle-treated rats consumed similar amounts of food dur-
ing the days before and after the 24-h period of fasting. 
Hence, the pregnant rats did not show a fasting-induced 
hyperphagic response. 
3 hour 24 hour 
STAT3 phosphorylation in response to i.c.u. 
leptin administration 
STAT3 phosphorylation levels were measured in a num-
ber of hypothalamic nuclei after i.c.v. administration of leptin 
in nonpregnant and d-14 pregnant rats. Both STAT3 and 
pSTAT3 protein levels were measured. Activation of STAT3 
was determined as the amount of pST AT3 present in the 
sample compared with the total amount of STAT3. There 
were no differences in total levels of STAT3 protein in the 
nonpregnant and pregnant rats except in the ventromedial 
hypothalamus (VMH), where there were lower levels of total 
STAT3 in pregnant rats compared with nonpregnant rats 
(Fig. 4). 
In the arcuate nucleus, leptin treatment led to a marked 
increase in STAT3 activation in nonpregnant rats but not in 
the pregnant rats (Fig. 5A). Although not significantly dif-
ferent, vehicle-treated pregnant rats tended to have a higher 
level of basal STAT3 activation compared with vehicle-
treated nonpregnant rats. In the VMH, leptin treatment led 
to a robust increase in STAT3 phosphorylation in nonpreg-
nant rats, with a significantly smaller increase in the per-
centage of STAT3 that became phosphorylated in pregnant 
rats (Fig 58). In contrast with the arcuate nucleus and the 
VMH, leptin treatment in the dorsomedial hypothalamus 
and lateral hypothalamus induced a similar degree of STAT3 
activation in the pregnant and nonpregnant groups (Fig. 5, 
C and D). In the supraoptic nucleus, there was no difference 
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FIG. 4. STAT3 levels in the VMH (A) and arcuate nucleus (B) in 
nonpregnant and pregnant rats. Immunoblots show bands corre-
sponding to STAT3 from five representative nonpregnant and preg-
nant rats. The intensities of bands corresponding to STAT3 were 
quantitated by densitometry and expressed as arbitrary units, with 
each bar representing the mean± SEM (n = 5-7). *, Significant with 
respect to nonpregnant group (P < 0.05). 
leptin treatment did not induce STAT3 phosphorylation in 
this area in either group (results not shown). 
Discussion 
Pregnancy led to the expected increases in food intake, 
adipose tissue, and serum leptin concentrations, similar to 
previous observations (14, 15, 17, 19, 26). Serum leptin con-
centrations were increased in both early and midpregnant 
rats but were low on d 21 of pregnancy, the day before 
parturition. Previous studies with more frequent sampling 
have shown that leptin concentrations in fact remain high 
throughout pregnancy until this decrease occurs on d 21 of 
pregnancy (19, 26). The paradoxical increased food intake in 
the presence of elevated leptin levels suggests a state of leptin 
resistance during pregnancy. After central administration of 
exogenous leptin, the satiety action of leptin on food intake 
was not observed in midpregnant rats, whereas a marked 
decrease in food intake occurred in nonpregnant rats and 
early pregnant rats. Furthermore, the pregnant rats did not 
display a compensatory hyperphagic response to food de-
privation. Leptin-induced phosphorylation of STAT3 was 
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also suppressed in the arcuate nucleus and the VMH on d 14 
of pregnancy. These results demonstrate that d-14 pregnant 
rats are resistant to the satiety actions of leptin in the hypo-
thalamus. A state of leptin resistance would be advantageous 
during pregnancy to ensure adequate energy reserves to 
meet the demands of the growing conceptus and to prepare 
for the subsequent energy demands of lactation. 
In agreement with our results, it has been shown that 
during late pregnancy (d 17 onwards), daily i.c.v. infusion of 
leptin for 6 d does not decrease food intake until the day after 
parturition (27). Pregnancy d 14 was used in the present 
study because at this time, food intake, fat mass, and leptin 
concentrations are all significantly increased compared with 
nonpregnant values. Pregnancy d 7 was also used because 
our initial results suggested that food intake and leptin con-
centrations were significantly increased at this time com-
pared with nonpregnant values. When early pregnant rats 
were used in a separate experiment to measure the feeding 
response after i.c.v. leptin administration, however, food 
intake was not significantly increased compared with non-
pregnant controls. This discrepancy is also reflected in the 
literature, where previous studies report a wide range of 
timepoints during pregnancy at which food intake becomes 
significantly increased from nonpregnant levels (13-15, 26, 
28, 29). These data, together with our observations, suggest 
that pregnancy-induced hyperphagia develops gradually 
and that there is a degree of variation as to when food intake 
becomes reliably increased compared with nonpregnant lev-
els. The early pregnant rats showed a hypophagic response 
to leptin similar to that of the nonpregnant rats, indicating 
that the pregnancy-induced leptin resistance we observed on 
d 14 of pregnancy develops between d 7 and 14 of pregnancy. 
Based on our earlier observations, this state of leptin resis-
tance appears to develop after food intake increases, sug-
gesting that leptin resistance is not the primary cause of 
pregnancy-induced hyperphagia. However, the suppression 
of the satiety action of leptin during pregnancy would fa-
cilitate the increase in food intake during pregnancy. 
In contrast to results obtained in rats, i.c.v. leptin admin-
istration to mice decreases food intake during all stages of 
pregnancy (30) . Mice have increased levels of leptin-binding 
proteins in the blood during pregnancy, suggesting that lep-
tin resistance in mice may be due to increased interactions 
with binding proteins rather than a central insensitivity to 
leptin (16). Although no increase in binding proteins has 
been seen in the rat (16), an increase in plasma leptin binding 
activity has been reported from midgestation (26). In other 
models of leptin resistance, such as diet-induced obese mice 
and age-related obese rats, defects in both transport of leptin 
into the brain and leptin signal transduction in the hypo-
thalamus appear to contribute to leptin resistance (31-33) . 
The leptin dose used in this study was clearly effective in 
nonpregnant rats and indeed is a maximal dose to reduce 
food intake and induce STAT3 phosphorylation (31, 34). Due 
to the delivery method, our results demonstrate a central 
resistance to leptin but do not rule out the possibility that 
peripheral sites may also contribute to the state of leptin 
resistance during midpregnancy. Although the early preg-
nant rats did not display a central resistance to leptin, it is 
possible that, at this time, there is a state of peripheral leptin 
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FIG. 5. Activation of STAT3 in the arcuate nu-
cleus (A), the VMH (B), the dorsomedial hypo-
thalamus (C), and the lateral hypothalamus (D) 
after i.c.v. administration of leptin (4 µ,g) or 
vehicle in fast ed nonpregnant and pregnant 
rats. Immunoblots show bands corresponding to 
pSTAT3 (top) and STAT3 (bottom) from three 
representative rats from each treatment group. 
Activation of STAT3 was determined by the 
amount ofpSTAT3 expressed as a percentage of 
the amount ofSTAT3 detected for each sample. 
Values represent the mean ± SEM (n = 5-7). In 
the arcuate nucleus (A), STAT3 activation was 
significantly increased after leptin treatment in 
nonpregnant rats but not during pregnancy. In 
the VMH (B), there was reduced activation of 
STAT3 after leptin treatment during preg-
nancy. In the dorsomedial hypothalamus (C) 
and lateral hypothalamus (D), leptin treatment 
significantly increased STAT3 activation in 
both nonpregnant and pregnant rats. *, Signif-
icant with respect to vehicle-treated group (P < 
0.05); t , significant with respect to leptin-
treated nonpregnant group (P < 0.05). 
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resistance. The absence of any difference in food intake be-
tween leptin- and vehicle-treated rats by d 14 of pregnancy 
in the present study, however, i;ndicates that this insensitivity 
to leptin at the central level is more than adequate to suppress 
the satiety actions of leptin during pregnancy. Redundancy 
in this system would not be unexpected, however, because 
maternal malnutrition during pregnancy has a number of 
negative consequences for the offspring, such as increased 
susceptibility to obesity, type 2 diabetes, and hypertension 
(35, 36). 
Similar to nonpregnant rats, leptin concentrations during 
pregnancy displayed a noctural increase. Both light- and 
dark-phase leptin concentrations in pregnancy were in-
creased compared with nonpregnant rats. Previously it has 
been reported that during the dark phase, there was no 
difference between leptin concentrations in pregnant and 
nonpregnant rats (27). The reasons for this inconsistency 
between results is unknown. In the present study, leptin 
concentrations were increased before a detectable increase in 
fat mass. This is consistent with previous results where leptin 
concentrations do not correlate with the amount of adipose 
tissue in pregnant rats, mice, and humans (16, 19-21, 37). The 
source of the increase in leptin concentrations, above that 
which can be accounted for due to increased fat mass, re-
mains unknown. Although it has been reported that the 
placenta produces increasingly high levels of leptin during 
gestation (17, 18), a number of studies in both rats and mice 
have detected only minimal levels of leptin mRNA in the 
placenta (16, 19, 37). Furthermore, in vitro, the mouse pla-
centa has not demonstrated the ability to secrete any detect-
able levels of leptin (38). In the present study, fasting induced 
significant decreases in plasma leptin concentrations in the 
pregnant rats as well as in the nonpregnant rats. This sug-
gests that any placental secretion of leptin must be regulated 
in the same manner as that from adipose tissue. Alterna-
tively, this observation is consistent with the hypothesis that 
the placenta does not contribute any significant amount of 
leptin to circulating concentrations in rats. 
Both the early and midpregnant rats did not show a com-
pensatory hyperphagic response when food was returned 
after 24 h of food deprivation. Little is known about the exact 
causes of the fasting-induced hyperphagic response that was 
observed in the vehicle-treated nonpregnant animals. The 
low levels of leptin during fasting (39) have been implicated 
in this increased hyperphagia, because the administration of 
leptin inhibits this response in fas ted animals (40). It would 
appear that low leptin concentrations do not result in in-
creased food intake in midpregnant rats, further supporting 
the idea that during pregnancy there is a state of insensitivity 
to changes in leptin concentrations. 
To elucidate the mechanisms behind the observed preg-
nancy-induced central leptin resistance, we examined STAT3 
phosphorylation after i.c.v. administration of leptin ind 14 
pregnant rats. One of the major intracellular signaling path-
ways activated byleptinin the hypothalamus is a JAK/STAT 
pathway, and the phosphorylation of STAT3 is a vital step in 
this pathway (41) . In the present study, we observed im-
paired leptin signal transduction through the JAK/STAT3 
pathway in the hypothalamus on d 14 of pregnancy. This 
impaired signal transduction was limited to the VMH and 
arcuate nucleus. In the arcuate nucleus, leptin treatment in-
creased pSTAT3 levels in the nonpregnant rats but not in the 
pregnant rats. There w as less STAT3 protein in the VMH of 
the pregnant rats compared with the nonpregnant rats, and 
the percentage of STAT3 that became phosphorylated in the 
pregnant rats was less than that in the nonpregnant rats. In 
combination, these data demonstrated markedly less leptin-
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Our methods do not allow us to identify whether these 
changes occur in specific cell types; but previously, it has 
been shown that leptin-induced activation of the JAK/ 
STAT3 pathway in the hypothalamus is limited to neurons 
and not glial cells (12). There are two main leptin-responsive 
neuronal populations in the arcuate nucleus involved in ap-
petite regulation, the proopiomelanocortin (POMC) neurons 
and the neuropeptide Y / agouti-related protein (AgRP) neu-
rons. The regulation of POMC and AgRP mRNA by leptin is 
mediated through the JAK/STAT3 intracellular signaling 
pathway (42). The suppressed STAT3 activation in the 
present study would suggest that this regulation of POMC 
and AgRP by leptin is impaired during pregnancy, but there 
is currently no direct evidence for this. However, AgRP 
has previously been implicated in pregnancy-induced hy-
perphagia, because mRNA for this neuropeptide is increased 
during pregnancy (29). Leptin normally has an inhibitory 
effect on AgRP mRNA expression (43), so the suppression of 
leptin-induced activation of STAT3 observed in the arcuate 
nucleus may help explain the increase in AgRP mRNA dur-
ing pregnancy despite high leptin concentrations. A func-
tional JAK/STAT pathway is critical to the regulation of 
POMC mRNA by leptin (42); therefore, our results of sup-
pressed activation of STAT3 suggest that the satiety effect of 
leptin through the melanocortin system is likely to be re-
duced during pregnancy. In support of this is the decrease 
in a-MSH, the anorexigenic peptide product of the POMC 
gene, that has been observed during pregnancy (44). 
The VMH has long been recognized as one of the primary 
regions of the brain involved in suppression of appetite. 
Administration of leptin directly into the VMH leads to de-
creased food intake, even at very low doses that are unable 
to decrease food intake when administrated to the lateral 
ventricle (45). The decrease in the activation of the JAK/ 
STAT3 pathway in the VMH during pregnancy potentially 
results in a decrease of this inhibitory effect of the VMH on 
appetite, consistent with the increased food intake seen dur-
ing pregnancy. 
The mechanisms suppressing leptin-induced STAT3 phos-
phorylation in both the VMH and arcuate nucleus during 
pregnancy are unknown. One possibility is that this decrease 
in activation may reflect a decrease in the receptor number 
in the hypothalamus, because both leptin receptor mRNA 
and protein levels have been shown to be down-regulated in 
obese, leptin-resistant rats (31, 46). However, there is con-
flicting evidence as to whether this occurs during pregnancy. 
Garica et al., 2000 (17), found a decrease in mRNA for the long 
form of the receptor in the hypothalamus during pregnancy, 
whereas others have demonstrated that mRNA levels and 
protein levels are not down-regulated (26, 29). Further work 
is required to clarify the levels of the leptin receptor in dis-
crete hypothalamic nuclei during pregnancy, specifically in 
the VMH and the arcuate nucleus. 
Pregnancy is associated with numerous changes in hor-
mone secretion that are involved in the adaptation of the 
maternal body to the gestational conditions. It is likely that 
the changes in leptin sensitivity during pregnancy are in-
duced by these hormonal changes that accompany preg-
nancy. Progesterone concentrations increase during preg-
nancy (47), and progesterone is a known stimulator of 
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appetite and food intake ( 48, 49). Furthermore, the orexigenic 
effects of progesterone occur without changes to plasma 
leptin concentrations, suggesting that one mechanism by 
which progesterone may stimulate food intake is by mod-
ulating the sensitivity of the hypothalamus to leptin (49). 
Although the role of progesterone in the insensitivity to 
leptin observed during pregnancy in the present study is 
unknown, there is potential for an interaction between these 
signaling pathways, because progesterone receptors are 
found in both the VMH and arcuate nucleus (50, 51 ), the areas 
we found impaired leptin activation of the JAK/STAT path-
way during pregnancy. 
In conclusion, our results indicate that by d 14 of preg-
nancy, i.c.v. leptin administration is unable to suppress food 
intake as it does in nonpregnant rats, thus supporting the 
hypothesis that a state of leptin resistance develops during 
pregnancy. In addition, we have demonstrated that this state 
of leptin resistance is associated with a decrease in leptin-
induced phosphorylation of STAT3 in target areas of the 
hypothalamus. In the arcuate nucleus, leptin treatment did 
not increase pSTAT3 levels in pregnant rats. In the ventro-
medial nucleus, there were lower levels of STAT3 in preg-
nant rats compared with nonpregnant rats, and leptin treat-
ment lead to a smaller percentage increase in STAT3 
phosphorylation in the pregnant rats. Although the mecha-
nisms for the impairment of the JAK/STAT signaling path-
way in the hypothalamus during pregnancy are yet to be 
determined, they appear to be site specific. 
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